BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C; Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86. [PMID: 8366922 DOI: 10.1056/NEJM199309303291401] [Cited by in Crossref: 17481] [Cited by in F6Publishing: 18348] [Article Influence: 582.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu DD, Zhang CY, Zhang JT, Gu LM, Xu GT, Zhang JF. Epigenetic modifications and metabolic memory in diabetic retinopathy: beyond the surface. Neural Regen Res 2023;18:1441-9. [PMID: 36571340 DOI: 10.4103/1673-5374.361536] [Reference Citation Analysis]
2 Colley J, Dambha-Miller H, Stuart B, Bartholomew J, Benton M, Baykoca J, Price H. Home monitoring of haemoglobin A(1c) in diabetes: A systematic review and narrative synthesis on accuracy, reliability and patient acceptability. Diabet Med 2023;40:e15033. [PMID: 36562666 DOI: 10.1111/dme.15033] [Reference Citation Analysis]
3 Hancock M, Burns K, Gan SK, Chew GT. Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks. Curr Opin Endocrinol Diabetes Obes 2023;30:113-22. [PMID: 36668976 DOI: 10.1097/MED.0000000000000797] [Reference Citation Analysis]
4 Arranz Martínez E, Miravet Jiménez S, López Simarro F. 100 years of the commercialization of insulin: A race yet to end. Med Clin (Barc) 2023;160:268-74. [PMID: 36481116 DOI: 10.1016/j.medcli.2022.11.005] [Reference Citation Analysis]
5 Johnson C, D'Eramo Melkus G, Reagan L, Pan W, Amarasekara S, Pereira K, Hassell N, Nowlin S, Vorderstrasse A. Learning in a Virtual Environment to Improve Type 2 Diabetes Outcomes: A Randomized Controlled Trial. JMIR Form Res 2023. [PMID: 36962700 DOI: 10.2196/40359] [Reference Citation Analysis]
6 Aihara M, Jinnouchi H, Yoshida A, Ijima H, Sakurai Y, Hayashi T, Koizumi C, Kubota T, Usami S, Yamauchi T, Sakata T, Kadowaki T, Kubota N. Evaluation of glycated albumin levels in tears and saliva as a marker in patients with diabetes mellitus. Diabetes Res Clin Pract 2023;:110637. [PMID: 36963507 DOI: 10.1016/j.diabres.2023.110637] [Reference Citation Analysis]
7 Wadwa RP, Reed ZW, Buckingham BA, DeBoer MD, Ekhlaspour L, Forlenza GP, Schoelwer M, Lum J, Kollman C, Beck RW, Breton MD; PEDAP Trial Study Group. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. N Engl J Med 2023;388:991-1001. [PMID: 36920756 DOI: 10.1056/NEJMoa2210834] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dia B, Alkhansa S, Njeim R, Al Moussawi S, Farhat T, Haddad A, Riachi ME, Nawfal R, Azar WS, Eid AA. SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism. Pharmaceutics 2023;15:965. [DOI: 10.3390/pharmaceutics15030965] [Reference Citation Analysis]
9 Sagna Y, Bagbila WPAH, Bognounou R, Ilboudo A, Sawadogo N, Kyelem CG, Guira O, Ouedraogo MS, Drabo JY. Comparison of regular with NPH insulin vs. premix insulin in children and adolescents with type 1 diabetes in a resources-limited setting: a retrospective data analysis. J Pediatr Endocrinol Metab 2023. [PMID: 36913487 DOI: 10.1515/jpem-2022-0637] [Reference Citation Analysis]
10 Sterner Isaksson S, Ólafsdóttir AF, Lind M. Design of a randomized cross-over study evaluating effects of carbohydrate intake on glycemic control in persons with type 1 diabetes. Front Nutr 2023;10. [DOI: 10.3389/fnut.2023.1114317] [Reference Citation Analysis]
11 Crossen SS, Wagner DV. Narrowing the Divide: The Role of Telehealth in Type 1 Diabetes Care for Marginalized Communities. J Diabetes Sci Technol 2023;:19322968231157367. [PMID: 36896887 DOI: 10.1177/19322968231157367] [Reference Citation Analysis]
12 Fleeman L, Gilor C. Insulin Therapy in Small Animals, Part 1: General Principles. Vet Clin North Am Small Anim Pract 2023:S0195-5616(23)00021-9. [PMID: 36906469 DOI: 10.1016/j.cvsm.2023.02.002] [Reference Citation Analysis]
13 Fleeman L, Gilor C. Insulin Therapy Part 3: Cats. Vet Clin North Am Small Anim Pract 2023:S0195-5616(23)00023-2. [PMID: 36906468 DOI: 10.1016/j.cvsm.2023.02.004] [Reference Citation Analysis]
14 Kurdi S, Alamer A, Wali H, Badr AF, Pendergrass ML, Ahmed N, Abraham I, Fazel MT. Proof-of-concept Study of Using Supervised Machine Learning Algorithms to Predict Self-care and Glycemic Control in Type 1 Diabetes Patients on Insulin Pump Therapy. Endocr Pract 2023:S1530-891X(23)00062-9. [PMID: 36898528 DOI: 10.1016/j.eprac.2023.03.002] [Reference Citation Analysis]
15 Michalek DA, Onengut-gumuscu S, Repaske DR, Rich SS. Precision Medicine in Type 1 Diabetes. J Indian Inst Sci 2023. [DOI: 10.1007/s41745-023-00356-x] [Reference Citation Analysis]
16 Bangad A, Abbasi M, de Havenon A. Secondary Ischemic Stroke Prevention. Neurotherapeutics 2023. [PMID: 36877331 DOI: 10.1007/s13311-023-01352-w] [Reference Citation Analysis]
17 Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O'Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice. Endocr Rev 2023;44:254-80. [PMID: 36066457 DOI: 10.1210/endrev/bnac022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
18 Biemann R, Isermann B. Metabolisches Gedächtnis bei diabetischer Nierenerkrankung. Diabetologie 2023. [DOI: 10.1007/s11428-023-01016-5] [Reference Citation Analysis]
19 Iken MK, Mateu NC, Johansen LB, Pilgaard KA, Mouritsen AK, Schou AJ, Høst LS, Nannsen AØ, Kristensen K, Hangaard S, Madsen M, Grabowski D. Diabetes Management in Danish Primary School: A Survey of Experiences of Parents of Children with Type 1 Diabetes. Diabetology 2023;4:108-118. [DOI: 10.3390/diabetology4010012] [Reference Citation Analysis]
20 Chagas TA, Dos Reis MA, Leivas G, Santos LP, Gossenheimer AN, Melo GB, Malerbi FK, Schaan BD. Prevalence of diabetic retinopathy in Brazil: a systematic review with meta-analysis. Diabetol Metab Syndr 2023;15:34. [PMID: 36864478 DOI: 10.1186/s13098-023-01003-2] [Reference Citation Analysis]
21 Shin A, Connolly S, Kabytaev K. Protein glycation in diabetes mellitus. Adv Clin Chem 2023;113:101-56. [PMID: 36858645 DOI: 10.1016/bs.acc.2022.11.003] [Reference Citation Analysis]
22 Kesavadev J, Chandran GB, Basanth A, Krishnan G, Shankar A, Jothydev S. Comparing the benefits of applying a vacuum assisted lancing device in reducing lancing pain, improving self-monitoring frequency and reducing HbA1c in people with diabetes. Diabetes Metab Syndr 2023;17:102731. [PMID: 36893684 DOI: 10.1016/j.dsx.2023.102731] [Reference Citation Analysis]
23 Park J, Kim G, Kim BS, Han KD, Kwon SY, Park SH, Lee YB, Jin SM, Kim JH. Insulin Fact Sheet in Type 1 and 2 Diabetes Mellitus and Trends of Antidiabetic Medication Use in Insulin Users with Type 2 Diabetes Mellitus: 2002 to 2019. Diabetes Metab J 2023;47:211-9. [PMID: 36746784 DOI: 10.4093/dmj.2022.0346] [Reference Citation Analysis]
24 Tietze R, Unterweger H, Janko C, Civelek M, Cicha I, Spielvogel H, Alexiou C. Orally administered nanoparticles for gastrointestinal applications. Nanomedicine (Lond) 2023. [PMID: 36856087 DOI: 10.2217/nnm-2022-0324] [Reference Citation Analysis]
25 Yash Sahebrao Chaudhari, Yash Sahebrao Chaudhari, Srushti Sunil Bhujbal, Vidya Ashok Walunj, Neha Satish Bhor, Rutuja Dattatraya Vyavhare. Diabetes Mellitus: A Review. IJARSCT 2023. [DOI: 10.48175/ijarsct-8551] [Reference Citation Analysis]
26 Chen JTC, Austin PC, Luo J, Campitelli MA, Bronskill SE, Yu C, Rochon PA, Lipscombe LL, Lega IC. Patterns of diabetes testing for older adults without diabetes in Ontario's nursing homes: A population-based study. J Am Geriatr Soc 2023;71:720-9. [PMID: 36515210 DOI: 10.1111/jgs.18152] [Reference Citation Analysis]
27 Schiel R, Block M, Steveling A, Stein G, Lücking S, Scherberich J. Serum Uromodulin in Children and Adolescents with Type 1 Diabetes Mellitus and Controls: Its Potential Role in Kidney Health. Exp Clin Endocrinol Diabetes 2023;131:142-52. [PMID: 36104158 DOI: 10.1055/a-1944-2686] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Arranz Martínez E, Miravet Jiménez S, López Simarro F. 100 years of the commercialization of insulin: A race yet to end. Medicina Clínica (English Edition) 2023. [DOI: 10.1016/j.medcle.2022.11.006] [Reference Citation Analysis]
29 Palmer BA, Soltys K, Zimmerman MB, Norris AW, Tsalikian E, Tansey MJ, Pinnaro CT. Diabetes Device Downloading: Benefits and Barriers Among Youth With Type 1 Diabetes. J Diabetes Sci Technol 2023;17:381-9. [PMID: 34809477 DOI: 10.1177/19322968211059537] [Reference Citation Analysis]
30 Mima A, Gotoda H, Lee R, Murakami A, Akai R, Lee S. Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 diabetes: A systemic review and meta-analysis. Metabol Open 2023;17:100236. [PMID: 36923991 DOI: 10.1016/j.metop.2023.100236] [Reference Citation Analysis]
31 Wu X, Zhu D, Shi L, Tu Q, Yu Y, Chen J. AdipoRon accelerates bone repair of calvarial defect in diet-induced obesity mice. Heliyon 2023;9:e13975. [PMID: 36873496 DOI: 10.1016/j.heliyon.2023.e13975] [Reference Citation Analysis]
32 Kaur J, Seaquist ER. Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies. Nat Rev Endocrinol 2023;19:177-86. [PMID: 36316392 DOI: 10.1038/s41574-022-00762-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Witkow S, Liberty IF, Goloub I, Kaminsky M, Otto O, Rabia Y, Boehm IH, Golan R. Simplifying carb counting: A randomized controlled study - Feasibility and efficacy of an individualized, simple, patient-centred carb counting tool. Endocrinol Diabetes Metab 2023;6:e411. [PMID: 36750449 DOI: 10.1002/edm2.411] [Reference Citation Analysis]
34 Hammad N, Hassanein M, Rahman M. Diabetic Kidney Care Redefined with a New Way into Remission. Endocrinol Metab Clin North Am 2023;52:101-18. [PMID: 36754487 DOI: 10.1016/j.ecl.2022.08.002] [Reference Citation Analysis]
35 Figueiredo AR, Matos T, do Vale S. Monitoring of continuous subcutaneous insulin infusion treatment in Portugal and its implications for diabetes management. Hormones (Athens) 2023;22:87-94. [PMID: 36336764 DOI: 10.1007/s42000-022-00412-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 von dem Berge T, Reschke F, Biester T. Aktueller Stand der Insulinpumpentherapie in der Kinderdiabetologie. Pädiatrie up2date 2023;18:41-55. [DOI: 10.1055/a-1981-4040] [Reference Citation Analysis]
37 Zhang G, Romo-Anselmo E, Kwa T, Cohen O, Vigersky R, Chattaraj S. Advances in Insulin Infusion Set in the New Era of Automated Insulin Delivery: A Systematic Review. J Diabetes Sci Technol 2023;17:302-13. [PMID: 36562593 DOI: 10.1177/19322968221145731] [Reference Citation Analysis]
38 Boucsein A, Watson AS, Frewen CM, Sanders OJ, Haszard JJ, Jones SD, Milford-Hughes PJ, de Bock MI, Wheeler BJ. Impact of Advanced Hybrid Closed Loop on Youth With High-Risk Type 1 Diabetes Using Multiple Daily Injections. Diabetes Care 2023;46:628-32. [PMID: 36689621 DOI: 10.2337/dc22-1971] [Reference Citation Analysis]
39 Cioana M, Deng J, Nadarajah A, Hou M, Qiu Y, Chen SSJ, Rivas A, Toor PP, Banfield L, Thabane L, Chaudhary V, Samaan MC. Global Prevalence of Diabetic Retinopathy in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA Netw Open 2023;6:e231887. [PMID: 36930156 DOI: 10.1001/jamanetworkopen.2023.1887] [Reference Citation Analysis]
40 Aleppo G, DeSalvo DJ, Lauand F, Huyett LM, Chang A, Vienneau T, Ly TT. Improvements in Glycemic Outcomes in 4738 Children, Adolescents, and Adults with Type 1 Diabetes Initiating a Tubeless Insulin Management System. Diabetes Ther 2023;14:593-610. [PMID: 36763329 DOI: 10.1007/s13300-023-01366-9] [Reference Citation Analysis]
41 Choi E, Kim S, Cho J, Kim MS, Kwon EK, Kim Y, Kang D, Cho SY. Development and Validation of a Distress Measurement Related to Glucose Monitoring of Diabetes Patients. Diabetes Ther 2023. [PMID: 36857024 DOI: 10.1007/s13300-023-01383-8] [Reference Citation Analysis]
42 Kernan WN, Forman R, Inzucchi SE. Caring for Patients With Diabetes in Stroke Neurology. Stroke 2023;54:894-904. [PMID: 36541212 DOI: 10.1161/STROKEAHA.122.038163] [Reference Citation Analysis]
43 Tarasewicz D, Conell C, Gilliam LK, Melles RB. Quantification of risk factors for diabetic retinopathy progression. Acta Diabetol 2023;60:363-9. [PMID: 36527502 DOI: 10.1007/s00592-022-02007-6] [Reference Citation Analysis]
44 Bruttomesso D, Irace C, Pozzilli P; SAGE study group. A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes. Nutr Metab Cardiovasc Dis 2023;33:631-9. [PMID: 36670006 DOI: 10.1016/j.numecd.2022.11.008] [Reference Citation Analysis]
45 Salam M, Bailey R, Calhoun P, McGill JB, Bergenstal RM, Price D, Beck RW. A Comparison of Continuous Glucose Monitoring Estimated Hemoglobin A1c in Adults with Type 1 or Type 2 Diabetes. Diabetes Technol Ther 2023;25:178-85. [PMID: 36472504 DOI: 10.1089/dia.2022.0387] [Reference Citation Analysis]
46 Aihara M, Irie T, Yasukawa K, Minoura I, Miyauchi N, Nishi M, Katayama N, Yachiku K, Jinnouchi H, Kadowaki T, Yamauchi T, Yatomi Y, Kubota N, Sekimizu K. Development of a high-performance liquid chromatographic glycated albumin assay using finger-prick blood samples. Clin Chim Acta 2023;542:117272. [PMID: 36858193 DOI: 10.1016/j.cca.2023.117272] [Reference Citation Analysis]
47 Gal A, Burchell RK. Diabetes Mellitus and the Kidneys. Veterinary Clinics of North America: Small Animal Practice 2023. [DOI: 10.1016/j.cvsm.2023.01.006] [Reference Citation Analysis]
48 Ulugerger Avci G. A bibliometric perspective to the most cited diabetes articles. J Diabetes Metab Disord 2023. [DOI: 10.1007/s40200-023-01199-0] [Reference Citation Analysis]
49 Imai S, Kajiyama S, Kitta K, Miyawaki T, Matsumoto S, Ozasa N, Kajiyama S, Hashimoto Y, Fukui M. Eating Vegetables First Regardless of Eating Speed Has a Significant Reducing Effect on Postprandial Blood Glucose and Insulin in Young Healthy Women: Randomized Controlled Cross-Over Study. Nutrients 2023;15. [PMID: 36904173 DOI: 10.3390/nu15051174] [Reference Citation Analysis]
50 McVean J, Forlenza GP, Beck RW, Bauza C, Bailey R, Buckingham B, DiMeglio LA, Sherr JL, Clements M, Neyman A, Evans-Molina C, Sims EK, Messer LH, Ekhlaspour L, McDonough R, Van Name M, Rojas D, Beasley S, DuBose S, Kollman C, Moran A; CLVer Study Group. Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial. JAMA 2023. [PMID: 36826834 DOI: 10.1001/jama.2023.2063] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Gomes MB, Santos DC, Drummond K, Pinheiro A, Muniz LH, Leal F, Negrato CA; Brazilian Type 1 Diabetes Study Group (BrazDiab1SG). Prevalence of overweight/obesity and its relationship with metabolic syndrome and fatty liver index in adult patients with type 1 diabetes. A Brazilian multicenter study. Diabetol Metab Syndr 2023;15:28. [PMID: 36823646 DOI: 10.1186/s13098-023-00996-0] [Reference Citation Analysis]
52 Abulqasim J, Alotaibi F, Al Khalifah RA. Safety and user experience with off-label use of a flash glucose monitor (FreeStyle Libre(®) 1) among very young children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2023;36:119-25. [PMID: 36595216 DOI: 10.1515/jpem-2022-0452] [Reference Citation Analysis]
53 Williams TJ, Jeevarathinam AS, Jivan F, Baldock V, Kim P, McShane MJ, Alge DL. Glucose biosensors based on Michael addition crosslinked poly(ethylene glycol) hydrogels with chemo-optical sensing microdomains. J Mater Chem B 2023;11:1749-59. [PMID: 36723375 DOI: 10.1039/d2tb02339c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Perais J, Agarwal R, Evans JR, Loveman E, Colquitt JL, Owens D, Hogg RE, Lawrenson JG, Takwoingi Y, Lois N. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Cochrane Database Syst Rev 2023;2:CD013775. [PMID: 36815723 DOI: 10.1002/14651858.CD013775.pub2] [Reference Citation Analysis]
55 Mudaliar S. The Evolution of Diabetes Treatment Through the Ages: From Starvation Diets to Insulin, Incretins, SGLT2-Inhibitors and Beyond. J Indian Inst Sci 2023;:1-11. [PMID: 36845885 DOI: 10.1007/s41745-023-00357-w] [Reference Citation Analysis]
56 Mameli C, Smylie GM, Galati A, Rapone B, Cardona-Hernandez R, Zuccotti G, Delvecchio M. Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review. Eur J Pediatr 2023;:1-15. [PMID: 36809498 DOI: 10.1007/s00431-023-04833-4] [Reference Citation Analysis]
57 Okajima F. Paradigm sift of the medical care in diabetes. Nihon Ika Daigaku Igakkai Zasshi 2023;19:32-41. [DOI: 10.1272/manms.19.32] [Reference Citation Analysis]
58 Afkarian M. Understanding, and Reversing, Metabolic Memory Is Within Reach. Am J Kidney Dis 2023:S0272-6386(23)00521-8. [PMID: 36805076 DOI: 10.1053/j.ajkd.2022.12.009] [Reference Citation Analysis]
59 Pérez-Fernández A, Fernández-Berrocal P, Gutiérrez-Cobo MJ. The relationship between well-being and HbA1c in adults with type 1 diabetes: A systematic review. J Diabetes 2023;15:152-64. [PMID: 36796311 DOI: 10.1111/1753-0407.13357] [Reference Citation Analysis]
60 Saha S, Saha S, Gayen M. Treatment-duration-wise harm profile of insulin-sodium-glucose co-transporter inhibitor co-treatment in type 1 diabetes mellitus patients. J Diabetes Metab Disord 2023. [DOI: 10.1007/s40200-023-01192-7] [Reference Citation Analysis]
61 McCall AL, Lieb DC, Gianchandani R, MacMaster H, Maynard GA, Murad MH, Seaquist E, Wolfsdorf JI, Wright RF, Wiercioch W. Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2023;108:529-62. [PMID: 36477488 DOI: 10.1210/clinem/dgac596] [Reference Citation Analysis]
62 Yuen YS, Gilhotra JS, Dalton M, Aujla JS, Mehta H, Wickremasinghe S, Uppal G, Arnold J, Chen F, Chang A, Fraser-Bell S, Lim L, Shah J, Bowditch E, Broadhead GK. Diabetic Macular Oedema Guidelines: An Australian Perspective. J Ophthalmol 2023;2023:6329819. [PMID: 36824442 DOI: 10.1155/2023/6329819] [Reference Citation Analysis]
63 Choi SU, Kim YJ, Lee JY, Lee J, Yoon YH. Qualitative and quantitative evaluation of diabetic choroidopathy using ultra-widefield indocyanine green angiography. Sci Rep 2023;13:2577. [PMID: 36781980 DOI: 10.1038/s41598-023-29216-5] [Reference Citation Analysis]
64 Galstyan GR, Mayorov AY, Melnikova OG, Holmskaya NI, Hamradjanov ZA, Milyutin VI, Shestakova MV. Clinical evaluation of the implementation of the first pilot Russian integrated program for an integrated approach to the management of diabetes mellitus “NORMA”. Diabetes mellitus 2023;26:30-38. [DOI: 10.14341/dm13008] [Reference Citation Analysis]
65 Moes RGJ, Huisman EL, Malkin SJP, Hunt B. Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands. Clinicoecon Outcomes Res 2023;15:87-96. [PMID: 36778040 DOI: 10.2147/CEOR.S391626] [Reference Citation Analysis]
66 Fang M, Wang D, Rooney MR, Echouffo-Tcheugui JB, Coresh J, Aurora RN, Punjabi NM, Selvin E. Performance of the Glucose Management Indicator (GMI) in Type 2 Diabetes. Clin Chem 2023:hvac210. [PMID: 36738249 DOI: 10.1093/clinchem/hvac210] [Reference Citation Analysis]
67 Gordon C. Continuous glucose monitoring for type 1 diabetes. Practice Nursing 2023;34:54-60. [DOI: 10.12968/pnur.2023.34.2.54] [Reference Citation Analysis]
68 Holloway D, James S, Ekinci E, Craft J. Systematic review of the effectiveness of nurse-led care in reducing glycated haemoglobin in adults with Type 1 or 2 diabetes. Int J Nurs Pract 2023;:e13135. [PMID: 36733216 DOI: 10.1111/ijn.13135] [Reference Citation Analysis]
69 Erlendsdottir M, Crawford FW. Randomized controlled trials of biomarker targets. Clin Trials 2023;20:47-58. [PMID: 36373783 DOI: 10.1177/17407745221131820] [Reference Citation Analysis]
70 Maahs DM, Prahalad P, Schweiger DŠ, Shalitin S. Diabetes Technology and Therapy in the Pediatric Age Group. Diabetes Technol Ther 2023;25:S118-45. [PMID: 36802194 DOI: 10.1089/dia.2023.2508] [Reference Citation Analysis]
71 Hou Y, Yuan S, Zhu G, You B, Xu Y, Jiang W, Shum HC, Pong PWT, Chen CH, Wang L. Photonic Crystal-Integrated Optoelectronic Devices with Naked-Eye Visualization and Digital Readout for High-Resolution Detection of Ultratrace Analytes. Adv Mater 2023;35:e2209004. [PMID: 36478473 DOI: 10.1002/adma.202209004] [Reference Citation Analysis]
72 Invernizzi A, Chhablani J, Viola F, Gabrielle PH, Zarranz-Ventura J, Staurenghi G. Diabetic retinopathy in the pediatric population: Pathophysiology, screening, current and future treatments. Pharmacol Res 2023;188:106670. [PMID: 36681366 DOI: 10.1016/j.phrs.2023.106670] [Reference Citation Analysis]
73 Roth M, Lehmann T, Kloos C, Schmidt S, Kellner C, Wolf G, Müller N. Metabolic Control, Diabetic Complications and Drug Therapy in a Cohort of Patients with Type 1 and Type 2 Diabetes in Secondary and Tertiary Care between 2004 and 2019. Int J Environ Res Public Health 2023;20. [PMID: 36768000 DOI: 10.3390/ijerph20032631] [Reference Citation Analysis]
74 Suh J, Choi Y, Oh JS, Song K, Choi HS, Kwon A, Chae HW, Kim HS. Association between early glycemic management and diabetes complications in type 1 diabetes mellitus: A retrospective cohort study. Prim Care Diabetes 2023;17:60-7. [PMID: 36609067 DOI: 10.1016/j.pcd.2022.12.006] [Reference Citation Analysis]
75 Sanz R, García P, Romero-Vivó S, Díez JL, Bondia J. Near-optimal feedback control for postprandial glucose regulation in type 1 diabetes. ISA Trans 2023;133:345-52. [PMID: 36116963 DOI: 10.1016/j.isatra.2022.06.033] [Reference Citation Analysis]
76 Moreno-fernandez J, Sastre J, Pinés P, Calderon-vicente D, Gargallo J, Muñoz-rodriguez J. To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study. Endocrinología, Diabetes y Nutrición 2023. [DOI: 10.1016/j.endinu.2022.12.003] [Reference Citation Analysis]
77 Dovc K, Lanzinger S, Cardona-Hernandez R, Tauschmann M, Marigliano M, Cherubini V, Preikša R, Schierloh U, Clapin H, AlJaser F, Pelicand J, Shukla R, Biester T. Association of Achieving Time in Range Clinical Targets With Treatment Modality Among Youths With Type 1 Diabetes. JAMA Netw Open 2023;6:e230077. [PMID: 36808243 DOI: 10.1001/jamanetworkopen.2023.0077] [Reference Citation Analysis]
78 Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapie des Typ-1-Diabetes. Diabetes aktuell 2023;21:30-42. [DOI: 10.1055/a-2012-3827] [Reference Citation Analysis]
79 Ruderman T, Ferrari G, Valeta F, Boti M, Kumwenda K, Park PH, Ngoga G, Ndarama E, Connolly E, Bukhman G, Adler A. Implementation of self-monitoring of blood glucose for patients with insulin-dependent diabetes at a rural non-communicable disease clinic in Neno, Malawi. S Afr Med J 2023;113:84-90. [PMID: 36757071 DOI: 10.7196/SAMJ.2023.v113i2.16643] [Reference Citation Analysis]
80 Yang X, Zeng X, Zhang Y, Kuang W, He D. Evaluation of interference from 16 hemoglobin variants on hemoglobin A(1c) measurement by five methods. Scand J Clin Lab Invest 2023;83:18-22. [PMID: 36534489 DOI: 10.1080/00365513.2022.2155990] [Reference Citation Analysis]
81 Soares AR, Coelho M, Tracey M, Carvalho D, Silva-Nunes J. Epidemiological, Social and Economic Burden of Severe Hypoglycaemia in Patients with Diabetes Mellitus in Portugal: A Structured Literature Review. Diabetes Ther 2023;14:265-91. [PMID: 36680681 DOI: 10.1007/s13300-022-01358-1] [Reference Citation Analysis]
82 Choi SJ, Kim S, Lee WS, Kim DW, Kim CS, Oh SH. Autophagy Dysfunction in a Diabetic Peripheral Neuropathy Model. Plast Reconstr Surg 2023;151:355-64. [PMID: 36355029 DOI: 10.1097/PRS.0000000000009844] [Reference Citation Analysis]
83 Herman WH, Bullock A, Boltri JM, Conlin PR, Greenlee MC, Lopata AM, Powell C, Tracer H, Schillinger D. The National Clinical Care Commission Report to Congress: Background, Methods, and Foundational Recommendations. Diabetes Care 2023;46:e14-23. [PMID: 36701594 DOI: 10.2337/dc22-0611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
84 Hvid H, Brand CL, Hummelshøj T, Jensen S, Bouman SD, Bowler A, Poulsen BR, Tiainen P, Åkertröm T, Demozay D, Hoeg-Jensen T, Ingvorsen C, Pedersen TÅ, McGuire J, Egebjerg T, Cappelen KA, Eliasen IP, Hansen BF, Hennen S, Stidsen CE, Olsen GS, Roed NK. Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models. Diabetologia 2023;66:376-89. [PMID: 36404376 DOI: 10.1007/s00125-022-05828-w] [Reference Citation Analysis]
85 Bruggeman BS, Walker AF, Peters AL, D'Avolio LW, Haller MJ. Blue Circle Health: A Novel Patient-Centered Model of Health Care Delivery for Low-Income Patients With Type 1 Diabetes. J Diabetes Sci Technol 2023;:19322968221149008. [PMID: 36710449 DOI: 10.1177/19322968221149008] [Reference Citation Analysis]
86 Yatish B, Sagar TV. Safety and efficacy of duloxetine versus gabapentin in painful diabetic polyneuropathy. IJCAAP 2023;7:223-227. [DOI: 10.18231/j.ijcaap.2022.042] [Reference Citation Analysis]
87 Shu DY, Chaudhary S, Cho KS, Lennikov A, Miller WP, Thorn DC, Yang M, McKay TB. Role of Oxidative Stress in Ocular Diseases: A Balancing Act. Metabolites 2023;13. [PMID: 36837806 DOI: 10.3390/metabo13020187] [Reference Citation Analysis]
88 Ali AAG, Niinuma SA, Moin ASM, Atkin SL, Butler AE. The Role of Platelets in Hypoglycemia-Induced Cardiovascular Disease: A Review of the Literature. Biomolecules 2023;13. [PMID: 36830610 DOI: 10.3390/biom13020241] [Reference Citation Analysis]
89 Zhang L, Yang L, Zhou Z. Data-based modeling for hypoglycemia prediction: Importance, trends, and implications for clinical practice. Front Public Health 2023;11:1044059. [PMID: 36778566 DOI: 10.3389/fpubh.2023.1044059] [Reference Citation Analysis]
90 Bassi M, Patti L, Silvestrini I, Strati MF, Ponzano M, Minuto N, Maggi D. One-year follow-up comparison of two hybrid closed-loop systems in Italian children and adults with type 1 diabetes. Front Endocrinol (Lausanne) 2023;14:1099024. [PMID: 36777356 DOI: 10.3389/fendo.2023.1099024] [Reference Citation Analysis]
91 Bao YK, Miller CJ, Narayanan SS, Gaddis M, Drees BM. Prevalence and Risk Factors of Major Depression in Patients with Diabetic Retinopathy in a Nationally Representative Survey. Ophthalmic Epidemiol 2023;:1-6. [PMID: 36703305 DOI: 10.1080/09286586.2023.2172189] [Reference Citation Analysis]
92 Aroda VR, Erhan U, Jelnes P, Meier JJ, Abildlund MT, Pratley R, Vilsbøll T, Husain M. Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes. Diabetes Obes Metab 2023. [PMID: 36700417 DOI: 10.1111/dom.14990] [Reference Citation Analysis]
93 Fishman SR, Fernandez Galvis MA, Linnell J, Iribarren P, Jonas VH, Gittleman JM, Tanenbaum M, Scherer M, Weiss L, Walker EA, Crespo-Ramos G, Hoogendoorn CJ, Pham-Singer H, Wu WY, Gonzalez JS. Diabetes-Related Quality of Life: Learning From Individuals Making Lifestyle Changes to Improve Type 2 Diabetes Control. Sci Diabetes Self Manag Care 2023;:26350106221149665. [PMID: 36700517 DOI: 10.1177/26350106221149665] [Reference Citation Analysis]
94 Satoh K, Nagasawa K, Takebe N, Kinno H, Shozushima M, Onodera K, Oda T, Hasegawa Y, Satoh J, Ishigaki Y. Adiponectin Paradox More Evident in Non-Obese Than in Obese Patients with Diabetic Microvascular Complications. Diabetes Metab Syndr Obes 2023;16:201-12. [PMID: 36760589 DOI: 10.2147/DMSO.S387744] [Reference Citation Analysis]
95 Boutsen L, Costenoble E, Pollé O, Erdem K, Bugli C, Lysy PA. Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study. Ther Adv Endocrinol Metab 2023;14:20420188221145550. [PMID: 36699944 DOI: 10.1177/20420188221145550] [Reference Citation Analysis]
96 de Groot M, Myers BA, Baker L, Daily E, Cavaghan M. The Diabetes Tune-Up Group: A Multidisciplinary Approach to Improve Diabetes Distress and A1C Among Adults With Type 1 and Type 2 Diabetes. Sci Diabetes Self Manag Care 2023;:26350106231151405. [PMID: 36661126 DOI: 10.1177/26350106231151405] [Reference Citation Analysis]
97 Di Molfetta S, Caruso I, Cignarelli A, Natalicchio A, Perrini S, Laviola L, Giorgino F. Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab 2023. [PMID: 36661362 DOI: 10.1111/dom.14981] [Reference Citation Analysis]
98 Zhao Q, Zhu J, Shen X, Lin C, Zhang Y, Liang Y, Cao B, Li J, Liu X, Rao W, Wang C. Chinese diabetes datasets for data-driven machine learning. Sci Data 2023;10:35. [PMID: 36653358 DOI: 10.1038/s41597-023-01940-7] [Reference Citation Analysis]
99 Nagao M, Harada T, Tanimura-Inagaki K, Kobayashi S, Fukuda I, Sugihara H, Oikawa S. Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy. Sci Rep 2023;13:1032. [PMID: 36658284 DOI: 10.1038/s41598-023-28138-6] [Reference Citation Analysis]
100 Weiner M, Adeoye P, Boeh MJ, Bodke K, Broughton J, Butler AR, Dafferner ML, Dirlam LA, Ferguson D, Keegan AL, Keith NR, Lee JL, McCorkle CB, Pino DG, Shan M, Srinivas P, Tang Q, Teal E, Tu W, Savoy A, Callahan CM, Clark DO. Continuous Glucose Monitoring and Other Wearable Devices to Assess Hypoglycemia among Older Adult Outpatients with Diabetes Mellitus. Appl Clin Inform 2023;14:37-44. [PMID: 36351548 DOI: 10.1055/a-1975-4136] [Reference Citation Analysis]
101 Urrechaga E. Analytical evaluation and quality assessment of the ARKRAY ADAMS A1c HA-8190V for Hb A1c. Scand J Clin Lab Invest 2023;:1-7. [PMID: 36651844 DOI: 10.1080/00365513.2023.2167231] [Reference Citation Analysis]
102 Sakata T, Shiratori R, Nishitani S. Aptamer-Based Glycated Albumin Sensor for Capacitive Spectroscopy. Anal Chem 2023;95:1480-9. [PMID: 36583969 DOI: 10.1021/acs.analchem.2c04505] [Reference Citation Analysis]
103 Grundman JB, Majidi S, Perkins A, Streisand R, Monaghan M, Marks BE. Applying the use of shared medical appointments (SMAs) to improve continuous glucose monitor (CGM) use, glycemic control, and quality of life in marginalized youth with type 1 diabetes: Study protocol for a pilot prospective cohort study. Contemp Clin Trials Commun 2023;32:101067. [PMID: 36698741 DOI: 10.1016/j.conctc.2023.101067] [Reference Citation Analysis]
104 Yadav N, Kumar Mandal A. Interference of hemoglobin variants in HbA(1c) quantification. Clin Chim Acta 2023;539:55-65. [PMID: 36476843 DOI: 10.1016/j.cca.2022.11.031] [Reference Citation Analysis]
105 González-Sánchez DA, Gutiérrez-Londoño H, León-Giraldo H, Tobón C, Ocampo-Chaparro JM, Reyes-Ortiz CA, González-Solarte KD. [Retinal alterations detected by non-mydriatic retinal camera screening and referral to ophthalmology in a population with high cardiovascular risk]. Semergen 2023;49:101921. [PMID: 36645935 DOI: 10.1016/j.semerg.2022.101921] [Reference Citation Analysis]
106 Horton WB, Snell-Bergeon JK. HbA1c Variability Metrics Predict Coronary Artery Calcium and Cardiovascular Events in Type 1 Diabetes: the CACTI Study. J Clin Endocrinol Metab 2023:dgad019. [PMID: 36637994 DOI: 10.1210/clinem/dgad019] [Reference Citation Analysis]
107 Kowluru RA. Cross Talks between Oxidative Stress, Inflammation and Epigenetics in Diabetic Retinopathy. Cells 2023;12. [PMID: 36672234 DOI: 10.3390/cells12020300] [Reference Citation Analysis]
108 AlHaqwi AI, Amin MM, AlTulaihi BA, Abolfotouh MA. Impact of Patient-Centered and Self-Care Education on Diabetes Control in a Family Practice Setting in Saudi Arabia. Int J Environ Res Public Health 2023;20. [PMID: 36673862 DOI: 10.3390/ijerph20021109] [Reference Citation Analysis]
109 Zanchi A, Jehle AW, Lamine F, Vogt B, Czerlau C, Bilz S, Seeger H, de Seigneux S. Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology. Swiss Med Wkly 2023;153:40004. [PMID: 36652726 DOI: 10.57187/smw.2023.40004] [Reference Citation Analysis]
110 Varkevisser R, Mul D, Aanstoot H, Wolffenbuttel B, Klauw MVD. Differences in lipid and blood pressure measurements between individuals with type 1 diabetes and the general population.. [DOI: 10.21203/rs.3.rs-2442331/v1] [Reference Citation Analysis]
111 Gomułka K, Ruta M. The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy-A Short Review. Int J Mol Sci 2023;24. [PMID: 36674535 DOI: 10.3390/ijms24021024] [Reference Citation Analysis]
112 Miller RG, Mychaleckyj JC, Onengut-Gumuscu S, Orchard TJ, Costacou T. TXNIP DNA methylation is associated with glycemic control over 28 years in type 1 diabetes: findings from the Pittsburgh Epidemiology of Diabetes Complications (EDC) study. BMJ Open Diabetes Res Care 2023;11. [PMID: 36604111 DOI: 10.1136/bmjdrc-2022-003068] [Reference Citation Analysis]
113 Ji L, Jiang X, Hao Q, Cheng Z, Wang K, Pang S, Liu M, Guo Y, Chen X, Su X, Ning T, Liu J, Bian F, Li Y, Zhang Z, Song W, Sun J. Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trial. Diabetes Obes Metab 2023. [PMID: 36594724 DOI: 10.1111/dom.14971] [Reference Citation Analysis]
114 Murphy E, Cooney MT, Mcevoy JW. Atherosclerotic Cardiovascular Disease Prevention in the Older Adult: Part 2. Contemporary Cardiology 2023. [DOI: 10.1007/978-3-031-16594-8_2] [Reference Citation Analysis]
115 McCrimmon RJ, Cheng AYY, Galstyan G, Djaballah K, Li X, Coudert M, Frias JP. iGlarLixi versus basal plus Rapid-Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real-World study. Diabetes Obes Metab 2023;25:68-77. [PMID: 36123617 DOI: 10.1111/dom.14844] [Reference Citation Analysis]
116 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Cusi K, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S49-67. [PMID: 36507651 DOI: 10.2337/dc23-S004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
117 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Gibbons CH, Giurini JM, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Sun JK, Gabbay RA, on behalf of the American Diabetes Association. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S203-15. [PMID: 36507636 DOI: 10.2337/dc23-S012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
118 Lin T, Manfredo JA, Illesca N, Abiola K, Hwang N, Salsberg S, Akhtar Y, Mathioudakis N, Brown EA, Wolf RM. Improving Continuous Glucose Monitoring Uptake in Underserved Youth with Type 1 Diabetes: The IMPACT Study. Diabetes Technol Ther 2023;25:13-9. [PMID: 36223197 DOI: 10.1089/dia.2022.0347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Garg SK, Grunberger G, Weinstock R, Lawson ML, Hirsch IB, DiMeglio LA, Pop-Busui R, Philis-Tsimikas A, Kipnes M, Liljenquist DR, Brazg RL, Kudva YC, Buckingham BA, McGill JB, Carlson AL, Criego AB, Christiansen MP, Kaiserman KB, Griffin KJ, Forlenza GP, Bode BW, Slover RH, Keiter A, Ling C, Marinos B, Cordero TL, Shin J, Lee SW, Rhinehart AS, Vigersky RA; Adult and Pediatric MiniMed™ HCL Outcomes 6-month RCT: HCL versus CSII Control Study Group. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial. Diabetes Technol Ther 2023;25:1-12. [PMID: 36472543 DOI: 10.1089/dia.2022.0421] [Reference Citation Analysis]
120 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S111-27. [PMID: 36507635 DOI: 10.2337/dc23-S007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
121 Gómez Medina AM, Henao Carrillo DC, León Vargas FM, Jojoa Jojoa RI, Quijano Naranjo JE, Rondón-sepulveda MA, García Jaramillo MA, Muñoz Velandia OM. Precisión numérica y clínica en hipoglucemia de la monitorización intermitente de glucosa FreeStyle Libre a través de un transmisor NFC-Bluetooth asociado al algoritmo xDrip+ en pacientes diabéticos en insulinoterapia. Endocrinología, Diabetes y Nutrición 2023. [DOI: 10.1016/j.endinu.2022.11.010] [Reference Citation Analysis]
122 Peltier AC, Davis SN. Diabetic autonomic dysfunction. Primer on the Autonomic Nervous System 2023. [DOI: 10.1016/b978-0-323-85492-4.00125-3] [Reference Citation Analysis]
123 ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 6. Glycemic Targets: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S97-S110. [PMID: 36507646 DOI: 10.2337/dc23-S006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
124 Rogol AD, Laffel LM, Bode B, Sperling MA. Celebration of a century of insulin therapy in children with type 1 diabetes. Arch Dis Child 2023;108:3-10. [PMID: 35725290 DOI: 10.1136/archdischild-2022-323975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Sherr JL, Heinemann L, Fleming GA, Bergenstal RM, Bruttomesso D, Hanaire H, Holl RW, Petrie JR, Peters AL, Evans M. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetologia 2023;66:3-22. [PMID: 36198829 DOI: 10.1007/s00125-022-05744-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Perfect MM, Silva GE, Chin CN, Wheeler MD, Frye SS, Mullins V, Quan SF. Extending sleep to improve glycemia: The Family Routines Enhancing Adolescent Diabetes by Optimizing Management (FREADOM) randomized clinical trial protocol. Contemp Clin Trials 2023;124:106929. [PMID: 36441106 DOI: 10.1016/j.cct.2022.106929] [Reference Citation Analysis]
127 Bak JCG, Serné EH, de Valk HW, Valk NK, Kramer MHH, Nieuwdorp M, Verheugt CL. Gender gaps in type 1 diabetes care. Acta Diabetol 2023;60:425-34. [PMID: 36592220 DOI: 10.1007/s00592-022-02023-6] [Reference Citation Analysis]
128 Magkos F, Reeds DN, Mittendorfer B. Evolution of the diagnostic value of "the sugar of the blood": hitting the sweet spot to identify alterations in glucose dynamics. Physiol Rev 2023;103:7-30. [PMID: 35635320 DOI: 10.1152/physrev.00015.2022] [Reference Citation Analysis]
129 Valentim CCS, Singh RP, Du W, Moini H, Talcott KE. Time to Resolution of Diabetic Macular Edema after Treatment with Intravitreal Aflibercept Injection or Laser in VISTA and VIVID. Ophthalmol Retina 2023;7:24-32. [PMID: 35843487 DOI: 10.1016/j.oret.2022.07.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Aldafas R, Crabtree T, Vinogradova Y, Gordon JP, Idris I. Efficacy and safety of intensive versus conventional glucose targets in people with type 2 diabetes: a systematic review and meta-analysis. Expert Rev Endocrinol Metab 2023;18:95-110. [PMID: 36718676 DOI: 10.1080/17446651.2023.2166489] [Reference Citation Analysis]
131 Rajani L. IMPLEMENTATION OF VISUAL EVOKED POTENTIAL FOR THE DETECTION OF PRERETINOPATHY AND PROGNOSTICATION IN DIABETES MELLITUS. ijsr 2023. [DOI: 10.36106/ijsr/4204143] [Reference Citation Analysis]
132 Balamurugan R, Shalini SS, Harikrishnan M, Velmathi S, Bose A. Glucose biosensing with gold and silver nanoparticles for real-time applications. Gold and Silver Nanoparticles 2023. [DOI: 10.1016/b978-0-323-99454-5.00002-0] [Reference Citation Analysis]
133 Grosso A. Diabetic Retinopathy. Blood Pressure Disorders in Diabetes Mellitus 2023. [DOI: 10.1007/978-3-031-13009-0_17] [Reference Citation Analysis]
134 Ciardullo S, Perseghin G. Control of Blood Glucose and Cardiovascular Risk Profile. Blood Pressure Disorders in Diabetes Mellitus 2023. [DOI: 10.1007/978-3-031-13009-0_28] [Reference Citation Analysis]
135 Wadwa RP, Laffel LM, Franco DR, Dellva MA, Knights AW, Pollom RK. Efficacy and safety of ultra-rapid lispro versus lispro in children and adolescents with type 1 diabetes: The PRONTO-Peds trial. Diabetes Obes Metab 2023;25:89-97. [PMID: 36054737 DOI: 10.1111/dom.14849] [Reference Citation Analysis]
136 Tang M, Berg A, Rhee EP, Allegretti AS, Nigwekar S, Karumanchi SA, Lash JP, Kalim S. The Impact of Carbamylation and Anemia on HbA1c's Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130-7. [PMID: 36399777 DOI: 10.2337/dc22-1399] [Reference Citation Analysis]
137 Khan N, Paterson AD, Roshandel D, Maqbool S, Fazal N, Ali L, Khurram R, Ijaz Maqsood S, Hafiza Benish Ali S, Khan H, Tariq K, Bano S, Azam A, Muslim I, Maria M, Agha Z, Babar M, Khalida Waheed N, Azam M, Qamar R. Role of 19 SNPs in 10 genes with type 2 diabetes in the Pakistani population. Gene 2023;848:146899. [DOI: 10.1016/j.gene.2022.146899] [Reference Citation Analysis]
138 Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, Buckingham BA, Carroll J, Ceriello A, Chow E, Choudhary P, Close K, Danne T, Dutta S, Gabbay R, Garg S, Heverly J, Hirsch IB, Kader T, Kenney J, Kovatchev B, Laffel L, Maahs D, Mathieu C, Mauricio D, Nimri R, Nishimura R, Scharf M, Del Prato S, Renard E, Rosenstock J, Saboo B, Ueki K, Umpierrez GE, Weinzimer SA, Phillip M. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol 2023;11:42-57. [PMID: 36493795 DOI: 10.1016/S2213-8587(22)00319-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 12.0] [Reference Citation Analysis]
139 Cohen SD, Faselis C. Blood Pressure Lowering and Microvascular Complications of Diabetes. Blood Pressure Disorders in Diabetes Mellitus 2023. [DOI: 10.1007/978-3-031-13009-0_19] [Reference Citation Analysis]
140 Iijima Y, Nakayama M, Miwa T, Yakou F, Tomiyama H, Shikuma J, Ito R, Tanaka A, Manda N, Odawara M. Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes. Intern Med 2023;62:681-8. [PMID: 36858619 DOI: 10.2169/internalmedicine.6685-20] [Reference Citation Analysis]
141 Khoury CC, Chen S, Ziyadeh FN. Mechanisms of Diabetic Nephropathy in Humans and Experimental Animals. Blood Pressure Disorders in Diabetes Mellitus 2023. [DOI: 10.1007/978-3-031-13009-0_9] [Reference Citation Analysis]
142 Eland I, Klieverik L, Mansour AA, Al-Toma A. Gluten-Free Diet in Co-Existent Celiac Disease and Type 1 Diabetes Mellitus: Is It Detrimental or Beneficial to Glycemic Control, Vascular Complications, and Quality of Life? Nutrients 2022;15. [PMID: 36615856 DOI: 10.3390/nu15010199] [Reference Citation Analysis]
143 Psoma O, Makris M, Tselepis A, Tsimihodimos V. Short-term Glycemic Variability and Its Association With Macrovascular and Microvascular Complications in Patients With Diabetes. J Diabetes Sci Technol 2022;:19322968221146808. [PMID: 36576014 DOI: 10.1177/19322968221146808] [Reference Citation Analysis]
144 Díaz-Balzac CA, Pillinger D, Wittlin SD. Continuous subcutaneous insulin infusions: Closing the loop. J Clin Endocrinol Metab 2022:dgac746. [PMID: 36573281 DOI: 10.1210/clinem/dgac746] [Reference Citation Analysis]
145 Mkrtumyan AM, Egshatyan LV. Efficacy of semaglutide: an evidence-based review. Medicinskij sovet 2022. [DOI: 10.21518/ms2022-010] [Reference Citation Analysis]
146 Al-Abdulrazzaq D, Khalifa D, Alqaisi T, Al-Juailla F, Othman F, Qabazard S, Al-Kandari H. Health-related quality of life of children and adolescents with type 1 diabetes during the COVID-19 pandemic in Kuwait. Front Public Health 2022;10:1056967. [PMID: 36620301 DOI: 10.3389/fpubh.2022.1056967] [Reference Citation Analysis]
147 Ntavidi S, Katsanou P, Marakomichelakis G, Kasdagli MI, Antiochou E, Mpali I, Kakou AM, Tsioufis K, Dimitriadis G, Lambadiari V. Association of Non-Dipping Blood Pressure Patterns with Diabetic Peripheral Neuropathy: A Cross-Sectional Study among a Population with Diabetes in Greece. Nutrients 2022;15. [PMID: 36615728 DOI: 10.3390/nu15010072] [Reference Citation Analysis]
148 Wang N, Zoungas S, Chalmers J. Benefits of intensified reductions in blood glucose and in blood pressure for patients with type 2 diabetes. Presse Med 2022;52:104160. [PMID: 36565752 DOI: 10.1016/j.lpm.2022.104160] [Reference Citation Analysis]
149 Walls FN, Mcgarvey DJ. Building a macrosystems ecology framework to identify links between environmental and human health: A random forest modelling approach. People and Nature 2022. [DOI: 10.1002/pan3.10427] [Reference Citation Analysis]
150 Tee PP, Wong JSL, Selveindran NM, Hong JYH. Effect of obesity and excessive body fat on glycaemic control in paediatric type 1 diabetes. J Pediatr Endocrinol Metab 2022;35:1474-80. [PMID: 36278759 DOI: 10.1515/jpem-2022-0151] [Reference Citation Analysis]
151 Rony M, Quintero-arias C, Osorio M, Ararso Y, Norman EM, Ravenell JE, Wall SP, Lee DC. Perceptions of the Healthcare System Among Black Men with Previously Undiagnosed Diabetes and Prediabetes. J Racial and Ethnic Health Disparities 2022. [DOI: 10.1007/s40615-022-01488-z] [Reference Citation Analysis]
152 Sahithi K, Kumar. P A, Sushma. E J. CLINICAL PRESENTATION OF CHILDREN WITH TYPE1 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL. GLOBAL JOURNAL FOR RESEARCH ANALYSIS 2022. [DOI: 10.36106/gjra/7808216] [Reference Citation Analysis]
153 Silva Júnior WS, Gabbay MAL, Lamounier RN, Calliari LE, Bertoluci MC. The 2021-2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice. Diabetol Metab Syndr 2022;14:189. [PMID: 36510287 DOI: 10.1186/s13098-022-00949-z] [Reference Citation Analysis]
154 Bharadwaj P, Mazumder A, Das S, Singh H, Nashra, Dhasmana S. A Critical Analysis of Relationship and Management of Sweet Bones in Insulin-Dependent Diabetes Mellitus. PCI- Approved-IJPSN 2022;15:6245-6257. [DOI: 10.37285/ijpsn.2022.15.6.7] [Reference Citation Analysis]
155 Bassi M, Strati MF, Andreottola V, Calevo MG, d'Annunzio G, Maghnie M, Minuto N. To sleep or not to sleep: An Italian Control-IQ-uestion. Front Endocrinol (Lausanne) 2022;13:996453. [PMID: 36578959 DOI: 10.3389/fendo.2022.996453] [Reference Citation Analysis]
156 Tinkir Kayitmazbatir E, Bitirgen G, Şatirtav G, Kilinc İ, Kulaksizoğlu M, Savut B, Kerimoğlu H. Short-term impact of glycaemic control and intravitreal ranibizumab treatment on serum cytokine levels and diabetic macular edema in patients with unregulated blood glucose. Genel Tıp Dergisi 2022. [DOI: 10.54005/geneltip.1191169] [Reference Citation Analysis]
157 Fleischer J, Hansen TK, Cichosz SL. Hypoglycemia event prediction from CGM using ensemble learning. Front Clin Diabetes Healthc 2022;3. [DOI: 10.3389/fcdhc.2022.1066744] [Reference Citation Analysis]
158 Kang SL, Hwang YN, Kwon JY, Kim SM. Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis. Diabetol Metab Syndr 2022;14:187. [PMID: 36494830 DOI: 10.1186/s13098-022-00962-2] [Reference Citation Analysis]
159 Stefanowicz-Bielska A, Słomion M, Rąpała M. Knowledge of School Nurses on the Basic Principles of Type 1 Diabetes Mellitus Self-Control and Treatment in Children. Int J Environ Res Public Health 2022;19. [PMID: 36554455 DOI: 10.3390/ijerph192416576] [Reference Citation Analysis]
160 Rodriguez E, Villamizar R. Artificial Pancreas: A Review of Meal Detection and Carbohydrates Counting Techniques. Review of Diabetic Studies 2022;18:171-180. [DOI: 10.1900/rds.2022.18.171] [Reference Citation Analysis]
161 Pavlicek V. HbA1c und mikrovaskuläre Komplikationen bei Typ-1-Diabetes. Diabetologie 2022. [DOI: 10.1007/s11428-022-00982-6] [Reference Citation Analysis]
162 Hoshiyama K, Hirano T, Hirabayashi K, Wakabayashi M, Tokimitsu M, Murata T. Morphological Changes in the Foveal Avascular Zone after Panretinal Photocoagulation for Diabetic Retinopathy Using OCTA: A Study Focusing on Macular Ischemia. Medicina (Kaunas) 2022;58. [PMID: 36556999 DOI: 10.3390/medicina58121797] [Reference Citation Analysis]
163 Quigley M, Earnest A, Andrikopoulos S, Wischer N, Green S, Zoungas S. ANDA-Evaluating Facilitated Feedback Enhancement - a Cluster randomised Trial (ANDA-EFFECT): protocol for a cluster randomised trial of audit feedback augmented with education and support, compared to feedback alone, on acceptability, utility and health outcomes in diabetes centres in Australia. Trials 2022;23:976. [PMID: 36471424 DOI: 10.1186/s13063-022-06910-9] [Reference Citation Analysis]
164 Silveira AOSM, Gomides MDA, Sadoyama G. Analysis of the impact of a diabetes education program on glycemic control and prevalence of chronic complications. Archives of Endocrinology and Metabolism 2022. [DOI: 10.20945/2359-3997000000541] [Reference Citation Analysis]
165 Sigal RJ, Yardley JE, Perkins BA, Riddell MC, Goldfield GS, Donovan L, Malcolm J, Hadjiyannakis S, Edwards AL, Gougeon R, Wells GA, Pacaud D, Woo V, Ford GT, Coyle D, Phillips P, Doucette S, Khandwala F, Kenny GP. The Resistance Exercise in Already Active Diabetic Individuals (READI) Randomised Clinical Trial. J Clin Endocrinol Metab 2022:dgac682. [PMID: 36459469 DOI: 10.1210/clinem/dgac682] [Reference Citation Analysis]
166 Matalqah LM, Yehya A, Radaideh KM. PHARMACIST-LEAD SCREENING FOR DIABETIC PERIPHERAL NEUROPATHY USING MICHIGAN NEUROPATHY SCREENING INSTRUMENT (MNSI). International Journal of Neuroscience 2022. [DOI: 10.1080/00207454.2022.2154671] [Reference Citation Analysis]
167 Welters A, Tittel SR, Reinehr T, Weghuber D, Wiegand S, Karges W, Freiberg C, Meissner T, Schloot NC, Holl RW. Clinical characteristics and cardiovascular risk profile in children and adolescents with latent autoimmune diabetes: Results from the German/Austrian prospective diabetes follow-up registry. Pediatr Diabetes 2022;23:1602-12. [PMID: 36334008 DOI: 10.1111/pedi.13450] [Reference Citation Analysis]
168 de Bock M, Codner E, Craig ME, Huynh T, Maahs DM, Mahmud FH, Marcovecchio L, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes 2022;23:1270-6. [PMID: 36537523 DOI: 10.1111/pedi.13455] [Reference Citation Analysis]
169 Kang M, Li W. Time-in-range: a promising glycemic control metric for bariatric surgery. Surg Obes Relat Dis 2022;18:1416-23. [PMID: 36089462 DOI: 10.1016/j.soard.2022.08.002] [Reference Citation Analysis]
170 Timmons JG, Littlejohn L, Boyle JG, Petrie JR. Recent developments in adjunct therapies for type 1 diabetes. Expert Opin Investig Drugs 2022;31:1311-20. [PMID: 36655950 DOI: 10.1080/13543784.2022.2159806] [Reference Citation Analysis]
171 Griggs S, Blanchette JE, Hickman RL Jr, Magny-Normilus C, Baskin RG, Margevicius S, Hatipoglu B. Racial and Ethnic Cardiometabolic Risk Disparities in the Type 1 Diabetes Exchange Clinic Registry Cohort. Endocr Pract 2022;28:1237-43. [PMID: 36280025 DOI: 10.1016/j.eprac.2022.10.003] [Reference Citation Analysis]
172 Bjornstad P, Dart A, Donaghue KC, Dost A, Feldman EL, Tan GS, Wadwa RP, Zabeen B, Marcovecchio ML. ISPAD Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes 2022;23:1432-50. [PMID: 36537531 DOI: 10.1111/pedi.13444] [Reference Citation Analysis]
173 Ugamura D, Hosojima M, Kabasawa H, Tanabe N, Yoshizawa Y, Suzuki Y, Saito A, Narita I. An exploratory clinical trial on the efficacy and safety of glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes on maintenance hemodialysis. Ren Replace Ther 2022;8. [DOI: 10.1186/s41100-022-00409-4] [Reference Citation Analysis]
174 Sherr JL, Heinemann L, Fleming GA, Bergenstal RM, Bruttomesso D, Hanaire H, Holl RW, Petrie JR, Peters AL, Evans M. Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association. Diabetes Care 2022;45:3058-74. [PMID: 36202061 DOI: 10.2337/dci22-0018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
175 Tauschmann M, Forlenza G, Hood K, Cardona-Hernandez R, Giani E, Hendrieckx C, DeSalvo DJ, Laffel LM, Saboo B, Wheeler BJ, Laptev DN, Yarhere I, DiMeglio LA. ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring. Pediatr Diabetes 2022;23:1390-405. [PMID: 36537528 DOI: 10.1111/pedi.13451] [Reference Citation Analysis]
176 Demarsilis A, Reddy N, Boutari C, Filippaios A, Sternthal E, Katsiki N, Mantzoros C. Pharmacotherapy of type 2 diabetes: An update and future directions. Metabolism 2022;137:155332. [DOI: 10.1016/j.metabol.2022.155332] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
177 Fröhlich-Reiterer E, Elbarbary NS, Simmons K, Buckingham B, Humayun KN, Johannsen J, Holl RW, Betz S, Mahmud FH. ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 2022;23:1451-67. [PMID: 36537532 DOI: 10.1111/pedi.13445] [Reference Citation Analysis]
178 Pauley ME, Tommerdahl KL, Snell-Bergeon JK, Forlenza GP. Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits. Curr Cardiol Rep 2022;24:2043-56. [PMID: 36279036 DOI: 10.1007/s11886-022-01799-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Cameron FJ, Arnold M, Gregory JW. Adolescent ambivalence about diabetes technology-The Janus faces of automated care. Pediatr Diabetes 2022;23:1717-24. [PMID: 36183170 DOI: 10.1111/pedi.13423] [Reference Citation Analysis]
180 Chen Z, Shao L, Jiang M, Ma R, Ping H, Wang Z, Ba X, Ma B, Zhou T. Identification of a rare compound heterozygous hemoglobin variant β0-thal [β17(A14) Lys>Stop, HBB: c.52A>T] and Hb J-Lome [β59(E3) Lys>Asn, HBB: c.180G>C]. Hematology 2022;27:946-50. [PMID: 36004523 DOI: 10.1080/16078454.2022.2114672] [Reference Citation Analysis]
181 Perkins BA, Bebu I, de Boer IH, Molitch M, Zinman B, Bantle J, Lorenzi GM, Nathan DM, Lachin JM. Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes. Diabetes Care 2022;45:2943-9. [PMID: 36321737 DOI: 10.2337/dc22-1420] [Reference Citation Analysis]
182 Arya P, Kumar P. Diosgenin: An ingress towards solving puzzle for diabetes treatment. J Food Biochem 2022;46:e14390. [PMID: 36106684 DOI: 10.1111/jfbc.14390] [Reference Citation Analysis]
183 Xu M, Li X. Comment on Allen et al. Thirty-Year Time Trends in Diabetic Retinopathy and Macular Edema in Youth With Type 1 Diabetes. Diabetes Care 2022;45:2247-2254. Diabetes Care 2022;45:e184. [PMID: 36455122 DOI: 10.2337/dc22-1398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Kim YK, Ning X, Munir KM, Davis SN. Emerging drugs for the treatment of diabetic nephropathy. Expert Opin Emerg Drugs 2022;27:417-30. [PMID: 36472144 DOI: 10.1080/14728214.2022.2155632] [Reference Citation Analysis]
185 Virmani A, Brink SJ, Middlehurst A, Mohsin F, Giraudo F, Sarda A, Ajmal S, von Oettingen JE, Pillay K, Likitmaskul S, Calliari LE, Craig ME. ISPAD Clinical Practice Consensus Guidelines 2022: Management of the child, adolescent, and young adult with diabetes in limited resource settings. Pediatr Diabetes 2022;23:1529-51. [PMID: 36537524 DOI: 10.1111/pedi.13456] [Reference Citation Analysis]
186 Patel D, Ananthakrishnan A, Lin T, Channa R, Liu TYA, Wolf RM. Social Determinants of Health and Impact on Screening, Prevalence, and Management of Diabetic Retinopathy in Adults: A Narrative Review. J Clin Med 2022;11. [PMID: 36498694 DOI: 10.3390/jcm11237120] [Reference Citation Analysis]
187 Wu Z, Yu S, Zhang H, Guo Z, Zheng Y, Xu Z, Li Z, Liu X, Li X, Chen S, Zhang J, Tao L, Guo X. Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes. Cardiovasc Diabetol 2022;21:262. [PMID: 36443820 DOI: 10.1186/s12933-022-01696-1] [Reference Citation Analysis]
188 Bawazeer NM, Alshehri LH, Alharbi NM, Alhazmi NA, Alrubaysh AF, Alkasser AR, Aburisheh KH. Evaluation of carbohydrate counting knowledge among individuals with type 1 diabetes mellitus in Saudi Arabia: a cross-sectional study. BMJ Nutr Prev Health 2022;5:344-51. [PMID: 36619333 DOI: 10.1136/bmjnph-2022-000553] [Reference Citation Analysis]
189 Pleus S, Baumstark A, Schauer S, Kölle J, Jendrike N, Mende J, Haug C, Freckmann G. User Performance Evaluation and System Accuracy Assessment of Four Blood Glucose Monitoring Systems With Color Coding of Measurement Results. J Diabetes Sci Technol 2022. [DOI: 10.1177/19322968221141926] [Reference Citation Analysis]
190 Li Y, Wu Y, Shu Y, Li S, Pei J, Chen H, Liu S, Xiang G, Wang W, Shan P, Su H, Wu X, Yan D, Li W. Blood glucose may be another index to initiate insulin treatment besides glycated hemoglobin A1c after oral antidiabetic medications failure for glycemic control: A real-world survey. Front Endocrinol (Lausanne) 2022;13:998210. [PMID: 36506049 DOI: 10.3389/fendo.2022.998210] [Reference Citation Analysis]
191 Rodríguez-sarmiento DL, León-vargas F, García-jaramillo M. Artificial pancreas systems: experiences from concept to commercialisation. Expert Review of Medical Devices 2022. [DOI: 10.1080/17434440.2022.2150546] [Reference Citation Analysis]
192 Sayed TS, Maayah ZH, Zeidan HA, Agouni A, Korashy HM. Insight into the physiological and pathological roles of the aryl hydrocarbon receptor pathway in glucose homeostasis, insulin resistance, and diabetes development. Cell Mol Biol Lett 2022;27:103. [PMID: 36418969 DOI: 10.1186/s11658-022-00397-7] [Reference Citation Analysis]
193 Faro Barros J, Sahraoui PF, Kalia YN, Lapteva M. Devices for Active Targeted Delivery: A Way to Control the Rate and Extent of Drug Administration. Targeted Drug Delivery 2022. [DOI: 10.1002/9783527827855.ch14] [Reference Citation Analysis]
194 Novak K, Kovacs L, Drexler DA, Eigner G. Glycemic control metrics for in silico testing of artificial pancreas systems. 2022 IEEE 22nd International Symposium on Computational Intelligence and Informatics and 8th IEEE International Conference on Recent Achievements in Mechatronics, Automation, Computer Science and Robotics (CINTI-MACRo) 2022. [DOI: 10.1109/cinti-macro57952.2022.10029513] [Reference Citation Analysis]
195 Petria I, Albuquerque S, Varoquaux G, Vie JJ, Venteclef N, Mohammedi K, Roussel R, Camoin M, Perseghin G, Velho G, Potier L. Body-weight variability and risk of cardiovascular outcomes in patients with type 1 diabetes: a retrospective observational analysis of data from the DCCT/EDIC population. Cardiovasc Diabetol 2022;21:247. [PMID: 36397092 DOI: 10.1186/s12933-022-01689-0] [Reference Citation Analysis]
196 Alzughbi N, Oraibi OH, Alzuhairi NM. Prevalence and determinants of metabolic syndrome among patients with type 1 diabetes mellitus attending the Diabetes Center of King Khalid University Hospital, Riyadh, Saudi Arabia.. [DOI: 10.21203/rs.3.rs-2216110/v1] [Reference Citation Analysis]
197 Zhou YY, Zhou TC, Chen N, Zhou GZ, Zhou HJ, Li XD, Wang JR, Bai CF, Long R, Xiong YX, Yang Y. Risk factor analysis and clinical decision tree model construction for diabetic retinopathy in Western China. World J Diabetes 2022; 13(11): 986-1000 [DOI: 10.4239/wjd.v13.i11.986] [Reference Citation Analysis]
198 Gohda T, Murakoshi M. Sodium-Glucose Cotransporter-2 Inhibitors-Miracle Drugs for the Treatment of Chronic Kidney Disease Irrespective of the Diabetes Status: Lessons from the Dedicated Kidney Disease-Focused CREDENCE and DAPA-CKD Trials. Int J Mol Sci 2022;23. [PMID: 36430228 DOI: 10.3390/ijms232213749] [Reference Citation Analysis]
199 Patel J, Gonzalvo JD, Eckert GJ, Schmelz AN, Bhatwadekar AD. Pharmacist-Managed Diabetic Retinopathy in Hispanic/LatinX Population. Journal of Pharmacy Practice 2022. [DOI: 10.1177/08971900221136897] [Reference Citation Analysis]
200 Selea Zivojinovic A. Blood Glucose Monitoring. Basics of Hypoglycemia 2022. [DOI: 10.5772/intechopen.105605] [Reference Citation Analysis]
201 Novak LM, Lavin-tompkins J. Summary Report of the ADCES 2021 Insulin Initiation and Titration Survey. ADCES in Practice 2022;10:28-34. [DOI: 10.1177/2633559x221122823] [Reference Citation Analysis]
202 Ang L, Mizokami-stout K, Eid SA, Elafros M, Callaghan B, Feldman EL, Pop-busui R. The conundrum of diabetic neuropathies—Past, present, and future. Journal of Diabetes and its Complications 2022;36:108334. [DOI: 10.1016/j.jdiacomp.2022.108334] [Reference Citation Analysis]
203 Kim JA, Park MJ, Song E, Roh E, Park SY, Lee DY, Kim J, Yu JH, Seo JA, Choi KM, Baik SH, Yoo HJ, Kim NH. Comparison of Laser and Conventional Lancing Devices for Blood Glucose Measurement Conformance and Patient Satisfaction in Diabetes Mellitus. Diabetes Metab J 2022;46:936-40. [PMID: 35350088 DOI: 10.4093/dmj.2021.0293] [Reference Citation Analysis]
204 von Sengbusch S, Schneidewind J, Bokelmann J, Scheffler N, Bertram B, Frielitz FS, Hiort O, Lange K. Monthly video consultation for children and adolescents with type 1 diabetes mellitus during the COVID-19 pandemic. Diabetes Res Clin Pract 2022;193:110135. [PMID: 36374788 DOI: 10.1016/j.diabres.2022.110135] [Reference Citation Analysis]
205 Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int 2022;102:S1-S127. [PMID: 36272764 DOI: 10.1016/j.kint.2022.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
206 Pease AJ, Zoungas S, Callander E, Jones TW, Johnson SR, Holmes-Walker DJ, Bloom DE, Davis EA, Zomer E. Nationally Subsidized Continuous Glucose Monitoring: A Cost-effectiveness Analysis. Diabetes Care 2022;45:2611-9. [PMID: 36162008 DOI: 10.2337/dc22-0951] [Reference Citation Analysis]
207 Kato A, Yoshiuchi K, Hashimoto H, Suzuki R, Yamauchi T, Kadowaki T. Feasibility, acceptability, and effects of a self-stigma reduction pilot program for Japanese individuals with type 2 diabetes. PEC Innovation 2022. [DOI: 10.1016/j.pecinn.2022.100112] [Reference Citation Analysis]
208 Okubo N, Miki K, Yamanouchi M, Ikuma D, Mizuno H, Oba Y, Sekine A, Hasegawa E, Suwabe T, Hoshino J, Yokoyama T, Ishii Y, Kono K, Kinowaki K, Ohashi K, Yamaguchi Y, Sawa N, Nakamura Y, Ubara Y. Kidney Transplantation From a Diabetic Donor to a Nondiabetic Recipient: A Case Report. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2022.09.024] [Reference Citation Analysis]
209 TODAY Study Group, TODAY Study Group. Long-term Outcomes Among Young Adults With Type 2 Diabetes Based on Durability of Glycemic Control: Results From the TODAY Cohort Study. Diabetes Care 2022;45:2689-97. [PMID: 36190810 DOI: 10.2337/dc22-0784] [Reference Citation Analysis]
210 White NH, Pan Q, Knowler WC, Schroeder EB, Dabelea D, Chew EY, Blodi B, Goldberg RB, Pi-Sunyer X, Darwin C, Schlögl M, Nathan DM; Diabetes Prevention Program Outcome Study (DPPOS) Research Group. Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience. Diabetes Care 2022;45:2653-61. [PMID: 36098658 DOI: 10.2337/dc22-0860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
211 Limonte CP, Kretzler M, Pennathur S, Pop-busui R, de Boer IH. Present and future directions in diabetic kidney disease. Journal of Diabetes and its Complications 2022. [DOI: 10.1016/j.jdiacomp.2022.108357] [Reference Citation Analysis]
212 Arnqvist HJ, Westerlund MC, Fredrikson M, Ludvigsson J, Nordwall M. Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study. Diabetes Care 2022;45:2675-82. [PMID: 36094113 DOI: 10.2337/dc22-0239] [Reference Citation Analysis]
213 Burguera-couce E, Milinovich A, Ji X, Kattan MW, Griebeler ML, Pantalone KM. Type 1 diabetes, overweight and obesity: The overlooked epidemic. Obesity Medicine 2022. [DOI: 10.1016/j.obmed.2022.100468] [Reference Citation Analysis]
214 Bao Y, Zhu D; Chinese Diabetes Society. Clinical application guidelines for blood glucose monitoring in China (2022 edition). Diabetes Metab Res Rev 2022;38:e3581. [PMID: 36251516 DOI: 10.1002/dmrr.3581] [Reference Citation Analysis]
215 Gu Hong WC, Ferri J, Ampudia-blasco FJ, Martín-brufau R, Peiró M, Benito E, Martinez-hervas S, Sanz MJ, Real JT. Effect of personality on blood glucose control in patients with type 1 diabetes. Endocrinología, Diabetes y Nutrición (English ed ) 2022;69:677-685. [DOI: 10.1016/j.endien.2021.11.034] [Reference Citation Analysis]
216 Dos Santos TJ, Chobot A, Piona C, Dovc K, Biester T, Gajewska KA, de Beaufort C, Sumnik Z, Petruzelkova L. Proceedings of 21st ISPAD science school for physicians 2022. Pediatr Diabetes 2022;23:903-11. [PMID: 36250646 DOI: 10.1111/pedi.13412] [Reference Citation Analysis]
217 Sinclair SH, Miller E, Talekar KS, Schwartz SS. Diabetes mellitus associated neurovascular lesions in the retina and brain: A review. Front Ophthalmol 2022;2. [DOI: 10.3389/fopht.2022.1012804] [Reference Citation Analysis]
218 Raghav A, Singh M, Jeong G, Giri R, Agarwal S, Kala S. New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational prospective review. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1036220] [Reference Citation Analysis]
219 Westall SJ, Watmough S, Narayanan RP, Irving G, Hardy K. Psychometric and biomedical outcomes of glycated haemoglobin target-setting in adults with type 1 and type 2 diabetes: Protocol for a mixed-methods parallel-group randomised feasibility study. PLoS One 2022;17:e0275980. [PMID: 36302049 DOI: 10.1371/journal.pone.0275980] [Reference Citation Analysis]
220 Zhang J, Zhang J, Zhang C, Zhang J, Gu L, Luo D, Qiu Q. Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications. Cells 2022;11:3362. [DOI: 10.3390/cells11213362] [Reference Citation Analysis]
221 Trujillo C, Ferrari G, Ngoga G, McLaughlin A, Davies J, Tucker A, Randolph C, Cook R, Park PH, Bukhman G, Adler AJ, Pierre J. Evaluating implementation of Diabetes Self-Management Education in Maryland County, Liberia: protocol for a pilot prospective cohort study. BMJ Open 2022;12:e060592. [PMID: 36253048 DOI: 10.1136/bmjopen-2021-060592] [Reference Citation Analysis]
222 Montone RA, Pitocco D, Gurgoglione FL, Rinaldi R, Del Buono MG, Camilli M, Rizzi A, Tartaglione L, Rizzo GE, Di Leo M, Flex A, Russo M, Liuzzo G, Magnani G, Bonadonna RC, Ardissino D, Crea F, Niccoli G. Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 2022;21:211. [PMID: 36243750 DOI: 10.1186/s12933-022-01637-y] [Reference Citation Analysis]
223 Renke G, Gapanowicz DP, Pereira MB, Mattos F, Ribeiro-Alves M, Assad M, Moreira ASB. Long-Term Association between Intensive Medical Treatment and the Incidence of Cardiovascular Outcomes in Patients with Dyslipidemia: an Observational Study. Cardiol Ther 2022. [PMID: 36223067 DOI: 10.1007/s40119-022-00282-6] [Reference Citation Analysis]
224 Alka K, Mohammad G, Kowluru RA. Regulation of serine palmitoyl-transferase and Rac1-Nox2 signaling in diabetic retinopathy. Sci Rep 2022;12:16740. [PMID: 36202842 DOI: 10.1038/s41598-022-20243-2] [Reference Citation Analysis]
225 Horiguchi M, Tsurudome Y, Ushijima K. AMFR and DCTN2 genes cause transplantation resistance of adipose-derived mesenchymal stem cells in type 1 diabetes mellitus. Front Pharmacol 2022;13:1005293. [DOI: 10.3389/fphar.2022.1005293] [Reference Citation Analysis]
226 Souza ABCD, Correa-giannella MLC, Gomes MB, Negrato CA, Nery M. Epidemiology and risk factors of hypoglycemia in subjects with type 1 diabetes in Brazil: a cross-sectional, multicenter study. Archives of Endocrinology and Metabolism 2022. [DOI: 10.20945/2359-3997000000523] [Reference Citation Analysis]
227 Kim H, Jung DY, Lee SH, Cho JH, Yim HW, Kim HS. Long-Term Changes in HbA1c According to Blood Glucose Control Status During the First 3 Months After Visiting a Tertiary University Hospital. J Korean Med Sci 2022;37:e281. [PMID: 36193638 DOI: 10.3346/jkms.2022.37.e281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Fezzi C, Refahi H, Albuisson E, Feigerlova E. User-centered approach in the development of an eHealth tool for self-management skills in functional insulin therapy to prevent complications of diabetes. Preventive Medicine Reports 2022;29:101968. [DOI: 10.1016/j.pmedr.2022.101968] [Reference Citation Analysis]
229 Messer LH, Buckingham BA, Cogen F, Daniels M, Forlenza G, Jafri RZ, Mauras N, Muir A, Wadwa RP, White PC, Russell SJ, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro CA, Li Z, Marak MC, Calhoun P, Beck RW. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial. Diabetes Technol Ther 2022;24:712-25. [PMID: 36173237 DOI: 10.1089/dia.2022.0201.pub] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Lynch J, Kanapka LG, Russell SJ, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro C, Calhoun P, Beck RW. The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes. Diabetes Technol Ther 2022;24:726-36. [PMID: 36173238 DOI: 10.1089/dia.2022.0341] [Reference Citation Analysis]
231 Sarma S, Richardson L, Neary J. One hundred years of solitude-underrepresentation of Indigenous and minority groups in diabetes trials. Lancet Glob Health 2022;10:e1383-4. [PMID: 36113518 DOI: 10.1016/S2214-109X(22)00356-4] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
232 González EY, Medina JA, Murillo JG. High sensitivity photonic crystal sensor based on transition between photonic bands. Laser Phys 2022;32:106202. [DOI: 10.1088/1555-6611/ac9526] [Reference Citation Analysis]
233 Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, Chandrasekaran S, DeFronzo RA, Einhorn D, Galindo RJ, Gardner TW, Garg R, Garvey WT, Hirsch IB, Hurley DL, Izuora K, Kosiborod M, Olson D, Patel SB, Pop-Busui R, Sadhu AR, Samson SL, Stec C, Tamborlane WV Jr, Tuttle KR, Twining C, Vella A, Vellanki P, Weber SL. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. Endocr Pract 2022;28:923-1049. [PMID: 35963508 DOI: 10.1016/j.eprac.2022.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
234 So WZ, Qi Wong NS, Tan HC, Yu Lin MT, Yu Lee IX, Mehta JS, Liu YC. Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy. Neural Regen Res 2022;17:2172-8. [PMID: 35259825 DOI: 10.4103/1673-5374.327364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
235 Gu C, He G, Lin C. EVALUATION OF HIGH LEVELS OF SPORTS ACTIVITY AND THE BENEFICIAL EFFECT ON POSTPRANDIAL BLOOD GLUCOSE PROFILES. Rev Bras Med Esporte 2022;28:465-8. [DOI: 10.1590/1517-8692202228052022_127] [Reference Citation Analysis]
236 Williams S, Raheim SA, Khan MI, Rubab U, Kanagala P, Zhao SS, Marshall A, Brown E, Alam U. Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.09.002] [Reference Citation Analysis]
237 Ola MS. Attenuation of reactive oxygen species (ROS) generation in the cultured retinal cells under high glucose conditions. Journal of King Saud University - Science 2022;34:102227. [DOI: 10.1016/j.jksus.2022.102227] [Reference Citation Analysis]
238 Beck RW, Russell SJ, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro C, Li Z, Calhoun P. A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes. Diabetes Technol Ther 2022;24:681-96. [PMID: 36173235 DOI: 10.1089/dia.2022.0167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
239 Kruger D, Kass A, Lonier J, Pettus J, Raskin P, Salam M, Trikudanathan S, Zhou K, Russell SJ, Damiano ER, El-Khatib FH, Ruedy KJ, Balliro C, Li Z, Marak MC, Calhoun P, Beck RW. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes. Diabetes Technol Ther 2022;24:697-711. [PMID: 36173236 DOI: 10.1089/dia.2022.0200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
240 Smith F, Sabri AH, Heppel M, Fonseca I, Chowdhury F, Cheung K, Willmor S, Rawson F, Marlow M. The clinical and translational prospects of microneedle devices, with a focus on insulin therapy for diabetes mellitus as a case study. Int J Pharm 2022;:122234. [PMID: 36191817 DOI: 10.1016/j.ijpharm.2022.122234] [Reference Citation Analysis]
241 Jian Q, Wu Y, Zhang F. Metabolomics in Diabetic Retinopathy: From Potential Biomarkers to Molecular Basis of Oxidative Stress. Cells 2022;11:3005. [DOI: 10.3390/cells11193005] [Reference Citation Analysis]
242 Zhou F, Deng J, Banfield L, Thabane L, Sadeghirad B, Samaan MC. Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials. BMJ Open 2022;12:e065287. [PMID: 36167361 DOI: 10.1136/bmjopen-2022-065287] [Reference Citation Analysis]
243 Dekamin A, Wahab MIM, Keshavjee K, Guergachi A. High cardiovascular disease risk-associated with the incidence of Type 2 diabetes among prediabetics. Eur J Intern Med 2022:S0953-6205(22)00320-X. [PMID: 36156254 DOI: 10.1016/j.ejim.2022.09.005] [Reference Citation Analysis]
244 Teigen IA, Riaz M, Åm MK, Christiansen SC, Carlsen SM. Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices. Front Bioeng Biotechnol 2022;10:986858. [DOI: 10.3389/fbioe.2022.986858] [Reference Citation Analysis]
245 Doyle EA, Weinzimer SA, Tamborlane W. DKA Prevention and Insulin Pumps: Lessons Learned From a Large Pediatric Pump Practice. Sci Diabetes Self Manag Care 2022;:26350106221125699. [PMID: 36129121 DOI: 10.1177/26350106221125699] [Reference Citation Analysis]
246 Navarro J, Sanchez A, Ba Aqeel SH, Ye M, Rehman MZ, Wysocki J, Rademaker A, Molitch ME, Batlle D. Urinary Angiotensinogen in Patients With Type 1 Diabetes With Microalbuminuria: Gender Differences and Effect of Intensive Insulin Therapy. Kidney Int Rep 2022;7:2657-67. [PMID: 36506234 DOI: 10.1016/j.ekir.2022.09.010] [Reference Citation Analysis]
247 Sladić Rimac D, Bilić Ćurčić I, Prpić Križevac I, Schonberger E, Centner MG, Barišić M, Canecki Varžić S. The Association of Personality Traits and Parameters of Glycemic Regulation in Type 1 Diabetes Mellitus Patients Using isCGM. Healthcare (Basel) 2022;10. [PMID: 36141404 DOI: 10.3390/healthcare10091792] [Reference Citation Analysis]
248 Blevins TC, Raiter Y, Sun B, Donnelly C, Shapiro R, Chullikana A, Rao A, Vashishta L, Ranganna G, Barve A. Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog®) in Patients with Type 1 Diabetes After 24 Weeks: A Randomized Open-Label Study. BioDrugs. [DOI: 10.1007/s40259-022-00554-6] [Reference Citation Analysis]
249 Huang W, Chen YY, Li ZQ, He FF, Zhang C. Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases. Int J Mol Sci 2022;23:10882. [PMID: 36142794 DOI: 10.3390/ijms231810882] [Reference Citation Analysis]
250 S. Kapare H, Department of Pharmaceutics, Dr. D. Y. Patil Unitech Society’s Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune - 411 018, Maharashtra, India, S. Chitlange S, S. Aher K, H. Nagore D. CHRONIC KIDNEY DISEASES: AN OVERVIEW OF MANAGEMENT AND TREATMENT STRATEGIES. IND DRU 2022;59:7-20. [DOI: 10.53879/id.59.08.12991] [Reference Citation Analysis]
251 Salvatore T, Galiero R, Caturano A, Vetrano E, Loffredo G, Rinaldi L, Catalini C, Gjeloshi K, Albanese G, Di Martino A, Docimo G, Sardu C, Marfella R, Sasso FC. Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options. Biomedicines 2022;10:2274. [DOI: 10.3390/biomedicines10092274] [Reference Citation Analysis]
252 Al-Qahtani SM, Shati AA, Alqahtani YA, AlAsmari AA, Almahdi MA, Al Hassan AA, Alhassany AM, Shathan RA, Aldosari RM, AlQahtani AS, Khalil SN. Factors Affecting Glycemic Control among Saudi Children with Type 1 Diabetes Mellitus in Aseer Region, Southwestern Saudi Arabia. Int J Environ Res Public Health 2022;19. [PMID: 36141857 DOI: 10.3390/ijerph191811558] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Muley PA, Muley PP, Sambre AD, Ambad RS. A Cross-Sectional Study of Electrophysiological Changes Occurring in Type II Diabetes Mellitus. Cureus 2022. [DOI: 10.7759/cureus.28994] [Reference Citation Analysis]
254 Larocque JC, Gardy S, Sammut M, Mcbey DP, Melling CWJ. Sexual dimorphism in response to repetitive bouts of acute aerobic exercise in rodents with type 1 diabetes mellitus. PLoS ONE 2022;17:e0273701. [DOI: 10.1371/journal.pone.0273701] [Reference Citation Analysis]
255 You Y, Hua Z, Dong F. Generalized mixed prediction chain model and its application in forecasting chronic complications. Journal of the Operational Research Society. [DOI: 10.1080/01605682.2022.2118630] [Reference Citation Analysis]
256 Calikoglu F, Bagdemir E, Celik S, Idiz C, Ozsarı H, Issever H, Satman I. Telemedicine as a Motivational Tool to Optimize Metabolic Control in Patients with Diabetes in Turkey: A Prospective, Randomized, Controlled TeleDiab Trial. Telemed J E Health 2022. [PMID: 36067018 DOI: 10.1089/tmj.2022.0028] [Reference Citation Analysis]
257 Lee BY, Ordovás JM, Parks EJ, Anderson CAM, Barabási AL, Clinton SK, de la Haye K, Duffy VB, Franks PW, Ginexi EM, Hammond KJ, Hanlon EC, Hittle M, Ho E, Horn AL, Isaacson RS, Mabry PL, Malone S, Martin CK, Mattei J, Meydani SN, Nelson LM, Neuhouser ML, Parent B, Pronk NP, Roche HM, Saria S, Scheer FAJL, Segal E, Sevick MA, Spector TD, Van Horn L, Varady KA, Voruganti VS, Martinez MF. Research gaps and opportunities in precision nutrition: an NIH workshop report. Am J Clin Nutr 2022;116:1877-900. [PMID: 36055772 DOI: 10.1093/ajcn/nqac237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 He X, Gao X, Xie P, Liu Y, Bai W, Liu Y, Shi A. Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects. DDDT 2022;Volume 16:2967-2980. [DOI: 10.2147/dddt.s372575] [Reference Citation Analysis]
259 Pramanik S, Banerjee K, Mondal LK, Zhong Q. The Amelioration of Detrimental Biochemical Anomalies by Supplementing B, C, and E Vitamins in Subjects with Type 2 Diabetes Mellitus May Reduce the Rate of Development of Diabetic Retinopathy. Journal of Diabetes Research 2022;2022:1-8. [DOI: 10.1155/2022/3886710] [Reference Citation Analysis]
260 Renard E, Nevoret C, Borot S, Delemer B, Mohammedi K, Sultan A, Bahloul A, Benkhelil A, Detournay B, Penfornis A. Prise en charge du diabète de type 1 chez les adultes en France : l’étude SAGE. Médecine des Maladies Métaboliques 2022. [DOI: 10.1016/j.mmm.2022.09.001] [Reference Citation Analysis]
261 Rajendran S, Mishra S, Madhavanpillai M, G V. Association of hemoglobin glycation index with cardiovascular risk factors in non-diabetic adults: A cross-sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022;16:102592. [DOI: 10.1016/j.dsx.2022.102592] [Reference Citation Analysis]
262 Markova L, Cvetko E, Ugwoke CK, Horvat S, Umek N, Stopar Pintarič T. The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model. Pharmaceutics 2022;14:1824. [DOI: 10.3390/pharmaceutics14091824] [Reference Citation Analysis]
263 Di Mario C, Genovese S, Lanza GA, Mannucci E, Marenzi G, Sciatti E, Pitocco D; Expert Panel Group. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus. Cardiovasc Diabetol 2022;21:164. [PMID: 36030229 DOI: 10.1186/s12933-022-01598-2] [Reference Citation Analysis]
264 Lee JH, Khin PP, Lee G, Lim OK, Jun H. Effect of BBT-877, a novel inhibitor of ATX, on a mouse model of type 1 diabetic nephropathy. Aging. [DOI: 10.18632/aging.204249] [Reference Citation Analysis]
265 Rescalli A, Varoni EM, Cellesi F, Cerveri P. Analytical Challenges in Diabetes Management: Towards Glycated Albumin Point-of-Care Detection. Biosensors 2022;12:687. [DOI: 10.3390/bios12090687] [Reference Citation Analysis]
266 Patel MV, Patel MM, Patel KB, Chhayani PV, Mittwede M, Scheidbach D, Gupta SN. A randomized placebo-compared study on the efficacy of classical ayurvedic pharmaceutical form versus aqueous alcoholic extracts of Phyllanthus niruri Linn. Plus Sida cordifolia Linn. In patients of diabetic sensory polyneuropathy. J Ayurveda Integr Med 2022;13:100619. [PMID: 36027804 DOI: 10.1016/j.jaim.2022.100619] [Reference Citation Analysis]
267 Yu W, Wang T, Wu F, Zhang Y, Shang J, Zhao Z. Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease. Front Pharmacol 2022;13:931282. [DOI: 10.3389/fphar.2022.931282] [Reference Citation Analysis]
268 Jones J, James S, Brown F, O'Neal D, I Ekinci E. Dead in Bed - A systematic review of overnight deaths in type 1 diabetes. Diabetes Res Clin Pract 2022;:110042. [PMID: 36007797 DOI: 10.1016/j.diabres.2022.110042] [Reference Citation Analysis]
269 Yeh ST, Ooi SW, Chang YH, Li CY, Chen HF. Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes. Medicine (Baltimore) 2022;101:e29942. [PMID: 35984136 DOI: 10.1097/MD.0000000000029942] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
270 Vanderniet JA, Jenkins AJ, Donaghue KC. Epidemiology of Type 1 Diabetes. Curr Cardiol Rep 2022. [PMID: 35976602 DOI: 10.1007/s11886-022-01762-w] [Reference Citation Analysis]
271 Liu Y, Yamagishi R, Honjo M, Kurano M, Yatomi Y, Igarashi K, Aihara M. Role of Autotaxin in High Glucose-Induced Human ARPE-19 Cells. IJMS 2022;23:9181. [DOI: 10.3390/ijms23169181] [Reference Citation Analysis]
272 He J, Qin Z, Chen X, He W, Li D, Zhang L, Le Y, Xiong Q, Zhang B, Wang H, Ahmad S. HIF-1α Ameliorates Diabetic Neuropathic Pain via Parkin-Mediated Mitophagy in a Mouse Model. BioMed Research International 2022;2022:1-18. [DOI: 10.1155/2022/5274375] [Reference Citation Analysis]
273 Flekač M. Time in range: new parameter to evaluate blood glucose control. Vnitr Lek 2022;68:315-323. [DOI: 10.36290/vnl.2022.066] [Reference Citation Analysis]
274 Muntean C, Starcea IM, Banescu C. Diabetic kidney disease in pediatric patients: A current review. World J Diabetes 2022; 13(8): 587-599 [DOI: 10.4239/wjd.v13.i8.587] [Reference Citation Analysis]
275 Vellapandian C, R R, Ramachandram DS. Renoprotective activity of anethole- rich fraction from aromatic herbs on junk food induced diabetic nephropathy in rats. J Diabetes Metab Disord. [DOI: 10.1007/s40200-022-01101-4] [Reference Citation Analysis]
276 Morrison AE, Chong K, Senior PA, Lam A. A scoping review of Do-It-Yourself Automated Insulin Delivery system (DIY AID) use in people with type 1 diabetes. PLoS ONE 2022;17:e0271096. [DOI: 10.1371/journal.pone.0271096] [Reference Citation Analysis]
277 Papachristoforou E, Kountouri A, Maratou E, Kouretas D, Skaperda Z, Tsoumani M, Efentakis P, Ikonomidis I, Lambadiari V, Makrilakis K. Association of Hypoglycemia with Biomarkers of Oxidative Stress and Antioxidants: An Observational Study. Healthcare 2022;10:1509. [DOI: 10.3390/healthcare10081509] [Reference Citation Analysis]
278 Moreno-Fernandez J, Chico A, Martínez-Brocca MA, Beato-Víbora PI, Vidal M, Piedra M, Quirós C, Muñoz-Rodriguez JR. Continuous subcutaneous insulin infusion in type 1 diabetes mellitus patients: results from the Spanish national registry. Diabetes Technol Ther 2022. [PMID: 35947087 DOI: 10.1089/dia.2022.0207] [Reference Citation Analysis]
279 Paul J, Jani R, Jones M, Davoren P, Knight-Agarwal C. Association between a low carbohydrate diet, glycemic control, and quality of life in Australian adults living with type 1 diabetes: a pilot study. Endocr Pract 2022:S1530-891X(22)00578-X. [PMID: 35963507 DOI: 10.1016/j.eprac.2022.08.003] [Reference Citation Analysis]
280 Hermanns C, da Silva Filho OP, Vaithilingam V, van Apeldoorn A. The Potential of Cell Sheet Technology for Beta Cell Replacement Therapy. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00371-4] [Reference Citation Analysis]
281 Oshima H, Takamura Y, Hirano T, Shimura M, Sugimoto M, Kida T, Matsumura T, Gozawa M, Yamada Y, Morioka M, Inatani M. Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema. J Clin Med 2022;11. [PMID: 36012896 DOI: 10.3390/jcm11164659] [Reference Citation Analysis]
282 Zhang C, Yu J, Tu Q, Yan F, Hu Z, Zhang Y, Song C. Antioxidant Capacities and Enzymatic Inhibitory Effects of Different Solvent Fractions and Major Flavones from Celery Seeds Produced in Different Geographic Areas in China. Antioxidants 2022;11:1542. [DOI: 10.3390/antiox11081542] [Reference Citation Analysis]
283 Hasnani D, Saboo B, Chaturvedi A, Sikdar M, Shankar A, Choudhury R, Saboo B, Singh NM, Jha S, Chavda V. Current insulinization trends in India. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-022-01123-x] [Reference Citation Analysis]
284 Cleemen C, Müller N, Lehmann T, Voigt UA, Meller D, Kloos C, Wolf G, Müller UA, Voigt M. Prevalence of Impairment of Visual Acuity and Severity of Retinopathy in Patients with Diabetes Mellitus. Exp Clin Endocrinol Diabetes 2022. [PMID: 35940177 DOI: 10.1055/a-1752-0024] [Reference Citation Analysis]
285 Alburno H, Schneider F, de Vries H, Al Mohannadi D, Mercken L. Determinants of adherence to insulin and blood glucose monitoring among adolescents and young adults with type 1 diabetes in Qatar: a qualitative study. F1000Res 2022;11:907. [DOI: 10.12688/f1000research.123468.1] [Reference Citation Analysis]
286 Peyton KJ, Behnammanesh G, Durante GL, Durante W. Canagliflozin Inhibits Human Endothelial Cell Inflammation through the Induction of Heme Oxygenase-1. Int J Mol Sci 2022;23. [PMID: 35955910 DOI: 10.3390/ijms23158777] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
287 Ólafsdóttir AF, Andelin M, Saeed A, Sofizadeh S, Hamoodi H, Jansson PA, Lind M. Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease. World J Clin Cases 2022; 10(22): 7794-7807 [DOI: 10.12998/wjcc.v10.i22.7794] [Reference Citation Analysis]
288 Chen C, Houng J, Ko T, Juan S, Chou H. Sigesbeckia orientalis Extract Ameliorates the Experimental Diabetic Nephropathy by Downregulating the Inflammatory and Oxidative Stress Signaling Pathways. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-13. [DOI: 10.1155/2022/3323745] [Reference Citation Analysis]
289 Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Prevention and Management Strategies for Diabetic Neuropathy. Life (Basel) 2022;12:1185. [PMID: 36013364 DOI: 10.3390/life12081185] [Reference Citation Analysis]
290 Ojha A, Vidwans H, Watve M. Does sugar control arrest complications in type 2 diabetes? Examining rigor in statistical and causal inference in clinical trials.. [DOI: 10.1101/2022.08.02.22278347] [Reference Citation Analysis]
291 Sastre J, Pinés PJ, del Val F, Moreno-fernandez J, Gonzalez López J, Quiroga I, Herranz S, López Gallardo G, Calderón D, López López J. Control metabólico y pautas de tratamiento en pacientes con diabetes tipo 1 en Castilla-La Mancha, 10 años después. Estudio DIACAM1 2020. Endocrinología, Diabetes y Nutrición 2022;69:483-492. [DOI: 10.1016/j.endinu.2021.10.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Zaharieva DP, Bishop FK, Maahs DM; 4T study research team. Advancements and future directions in the teamwork, targets, technology, and tight control-the 4T study: improving clinical outcomes in newly diagnosed pediatric type 1 diabetes. Curr Opin Pediatr 2022;34:423-9. [PMID: 35836400 DOI: 10.1097/MOP.0000000000001140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
293 Mastrandrea LD, Quattrin T. Preventing type 1 diabetes development and preserving beta-cell function. Curr Opin Endocrinol Diabetes Obes 2022;29:386-91. [PMID: 35799459 DOI: 10.1097/MED.0000000000000746] [Reference Citation Analysis]
294 Sala-mira I, Garcia P, Díez J, Bondia J. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems. Computer Methods and Programs in Biomedicine 2022. [DOI: 10.1016/j.cmpb.2022.107061] [Reference Citation Analysis]
295 Benedict Á, Hankosky ER, Marczell K, Chen J, Klein DJ, Caro JJ, Bae JP, Benneyworth BD. A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes. Pharmacoeconomics 2022;40:743-50. [PMID: 35668248 DOI: 10.1007/s40273-022-01148-4] [Reference Citation Analysis]
296 Pujante Alarcón P, Alonso Felgueroso C, Ares Blanco J, Morales Sánchez P, Lambert Goitia C, Rodríguez Escobedo R, Rodríguez Rodero S, Delgado Alvarez E, Menéndez Torre EL. Correlación entre parámetros glucométricos de la monitorización continua flash y la hemoglobina glucosilada. Experiencia en vida real en Asturias. Endocrinología, Diabetes y Nutrición 2022;69:493-499. [DOI: 10.1016/j.endinu.2021.10.008] [Reference Citation Analysis]
297 Shah N, Perkovic V, Kotwal S. Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria. Expert Rev Clin Pharmacol 2022. [PMID: 35912871 DOI: 10.1080/17512433.2022.2108402] [Reference Citation Analysis]
298 Pujante Alarcón P, Alonso Felgueroso C, Ares Blanco J, Morales Sánchez P, Lambert Goitia C, Rodríguez Escobedo R, Rodríguez Rodero S, Delgado Alvarez E, Menéndez Torre EL. Correlation between glucose measurement parameters of continuous flash monitoring and HbA1c. Real life experience in Asturias. Endocrinología, Diabetes y Nutrición (English ed ) 2022;69:493-499. [DOI: 10.1016/j.endien.2022.08.001] [Reference Citation Analysis]
299 Alharthi S, Alrajeh A, Alyusuf E, Alguwaihes AM, Jammah A, Al-sofiani ME. “Pre-Ramadan” telemedicine: Effect on fasting experience and glycemic control during ramadan in people with type 1 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022;16:102567. [DOI: 10.1016/j.dsx.2022.102567] [Reference Citation Analysis]
300 Starikova S, Castelvecchi A, Corboy A. Evaluation of Diabetes Mellitus Type 2 Control in Home-Based Primary Care Patients Managed by Clinical Pharmacy Specialists. sr care pharm 2022;37:366-373. [DOI: 10.4140/tcp.n.2022.366] [Reference Citation Analysis]
301 Das N, Ray N, Patil AR, Saini SS, Waghmode B, Ghosh C, Patil SB, Patil SB, Mote CS, Saini S, Saraswat BL, Sircar D, Roy P. Inhibitory effect of selected Indian honey on colon cancer cell growth by inducing apoptosis and targeting the β-catenin/Wnt pathway. Food Funct 2022;13:8283-303. [PMID: 35834215 DOI: 10.1039/d1fo03727g] [Reference Citation Analysis]
302 Sastre J, Pinés PJ, del Val F, Moreno-fernandez J, Gonzalez López J, Quiroga I, Herranz S, López Gallardo G, Calderón D, López López J. Metabolic control and treatment regimens in patients with type 1 diabetes in Castilla-La Mancha, 10 years later: The 2020 DIACAM1 study. Endocrinología, Diabetes y Nutrición (English ed ) 2022;69:483-492. [DOI: 10.1016/j.endien.2022.07.006] [Reference Citation Analysis]
303 Taherpour A, Hosseini-Khah Z, Zargari M, Ehsan Enderami S. The microenvironment of silk/gelatin nanofibrous scaffold improves proliferation and differentiation of Wharton's jelly-derived mesenchymal cells into islet-like cells. Gene 2022;833:146586. [PMID: 35597530 DOI: 10.1016/j.gene.2022.146586] [Reference Citation Analysis]
304 Kostourou D, Milonas D, Polychronopoulos G, Sofogianni A, Tziomalos K. The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy. JPM 2022;12:1253. [DOI: 10.3390/jpm12081253] [Reference Citation Analysis]
305 Freckmann G, Schauer S, Beltzer A, Waldenmaier D, Buck S, Baumstark A, Jendrike N, Link M, Zschornack E, Haug C, Pleus S. Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions. J Diabetes Sci Technol. [DOI: 10.1177/19322968221113341] [Reference Citation Analysis]
306 Zhang X, Nie Y, Gong Z, Zhu M, Qiu B, Wang Q. Plasma Apolipoproteins Predicting the Occurrence and Severity of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus. Front Endocrinol 2022;13:915575. [DOI: 10.3389/fendo.2022.915575] [Reference Citation Analysis]
307 Barana L, Colleluori G, Sulpizi MT, Ortenzi K, Farano L, Fanelli CG, Calafiore R, Dalla Ragione L, Pampanelli S. Efficacy of the holistic, psychonutritional approach of Centro DAI e Obesità di Città della Pieve in the management of type 2 diabetes among patients with obesity and dysfunctional eating. J Diabetes Metab Disord. [DOI: 10.1007/s40200-022-01085-1] [Reference Citation Analysis]
308 Allela O, Salih HM, Haji Ahmed I. Adherence to medication and glucose control in diabetic patients in Duhok, Iraq. PHAR 2022;69:673-679. [DOI: 10.3897/pharmacia.69.e86649] [Reference Citation Analysis]
309 Vergmann AS, Stokholm L, Rubin KH, Thykjær A, Möller S, Laugesen CS, Heegaard S, Højlund K, Kawasaki R, Schielke KC, Grauslund J. Investigation of the correlation between diabetic retinopathy and prevalent and incident migraine in a national cohort study. Sci Rep 2022;12:12443. [PMID: 35859157 DOI: 10.1038/s41598-022-16793-0] [Reference Citation Analysis]
310 Lombardo F, Bombaci B, Alibrandi A, Visalli G, Salzano G, Passanisi S. The Impact of Insulin-Induced Lipodystrophy on Glycemic Variability in Pediatric Patients with Type 1 Diabetes. Children 2022;9:1087. [DOI: 10.3390/children9071087] [Reference Citation Analysis]
311 Zaghloul H, Malik RA. COVID-19 and the hidden threat of diabetic microvascular complications. Ther Adv Endocrinol Metab 2022;13:20420188221110708. [PMID: 35847423 DOI: 10.1177/20420188221110708] [Reference Citation Analysis]
312 Bolli GB, Cheng AYY, Owens DR. Insulin: evolution of insulin formulations and their application in clinical practice over 100 years. Acta Diabetol 2022. [PMID: 35854185 DOI: 10.1007/s00592-022-01938-4] [Reference Citation Analysis]
313 Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes. Life (Basel) 2022;12:1074. [PMID: 35888162 DOI: 10.3390/life12071074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Elrakaybi A, Laubner K, Zhou Q, Hug MJ, Seufert J. Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role? Mol Metab 2022;:101549. [PMID: 35863639 DOI: 10.1016/j.molmet.2022.101549] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
315 Yongpeng Z, Yaxing W, Jinqiong Z, Qian W, Yanni Y, Xuan Y, Jingyan Y, Wenjia Z, Ping W, Chang S, Ming Y, Yanan L, Jinyuan W, Shouling W, Shuohua C, Haiwei W, Lijian F, Qianqian W, Jingyuan Z, Zihan N, Yuning C, Ying X, Jonas JB, Wenbin W. The Association Between Diabetic Retinopathy and the Prevalence of Age-Related Macular Degeneration—The Kailuan Eye Study. Front Public Health 2022;10:922289. [DOI: 10.3389/fpubh.2022.922289] [Reference Citation Analysis]
316 Choi SH, Yoon GS, Lee MJ, Park SD, Ko YG, Ahn CM, Yu CW, Chun WJ, Jang WJ, Kim HJ, Kim BS, Bae JW, Lee SY, Kwon SU, Kim JS, Lee WS, Jeong JO, Lim SH, Cho S, Yang JH, Gwon HC. Prognostic Impact of Plasma Glucose on Patients With Cardiogenic Shock With or Without Diabetes Mellitus from the SMART RESCUE Trial. Am J Cardiol 2022;175:145-51. [PMID: 35550823 DOI: 10.1016/j.amjcard.2022.04.008] [Reference Citation Analysis]
317 Ma Y, Lin C, Cai X, Hu S, Zhu X, Lv F, Yang W, Ji L. The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysis. Expert Rev Clin Pharmacol 2022. [PMID: 35839519 DOI: 10.1080/17512433.2022.2102973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
318 Kaiserman KB, Christiansen M, Bhavsar S, Ulloa J, Santogatta B, Hanna J, Bailey TS. Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage. J Diabetes Sci Technol 2022;:19322968221110622. [PMID: 35833638 DOI: 10.1177/19322968221110622] [Reference Citation Analysis]
319 Afarid M, Sadeghi E, Johari M, Namvar E, Sanie-jahromi F, Sabiu S. Evaluation of the Effect of Garlic Tablet as a Complementary Treatment for Patients with Diabetic Retinopathy. Journal of Diabetes Research 2022;2022:1-7. [DOI: 10.1155/2022/6620661] [Reference Citation Analysis]
320 Nitta A, Imai S, Kajiayama S, Matsuda M, Miyawaki T, Matsumoto S, Kajiyama S, Hashimoto Y, Ozasa N, Fukui M. Impact of Dietitian-Led Nutrition Therapy of Food Order on 5-Year Glycemic Control in Outpatients with Type 2 Diabetes at Primary Care Clinic: Retrospective Cohort Study. Nutrients 2022;14. [PMID: 35889820 DOI: 10.3390/nu14142865] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
321 Ito K, Satoh S, Kondo Y, Tamura H, Hasebe M, Terauchi Y. Effect of dulaglutide and long-acting insulin combination therapy in patients with type 2 diabetes: a retrospective observational study. Diabetol Int 2023;14:51-7. [PMID: 36636162 DOI: 10.1007/s13340-022-00592-z] [Reference Citation Analysis]
322 Momenzadeh A, Shamsa A, Meyer JG. Bias or biology? Importance of model interpretation in machine learning studies from electronic health records. JAMIA Open 2022;5. [DOI: 10.1093/jamiaopen/ooac063] [Reference Citation Analysis]
323 Hettiarachchi C, Malagutti N, Nolan C, Daskalaki E, Suominen H. A Reinforcement Learning Based System for Blood Glucose Control without Carbohydrate Estimation in Type 1 Diabetes: In Silico Validation. 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2022. [DOI: 10.1109/embc48229.2022.9871054] [Reference Citation Analysis]
324 Grassi BA, Caramés B, Plaza-Plaza JC, Onetto MT, Moreno S, Sandoval T, Tapia N, Mena F, Revello A. Insulin settings and their association with time in range in patients with type 1 diabetes users of predictive low glucose suspend (PLGS) augmented insulin pumps in Santiago, Chile. J Diabetes Complications 2022;:108262. [PMID: 35842304 DOI: 10.1016/j.jdiacomp.2022.108262] [Reference Citation Analysis]
325 Mahoney ALG, Nassif NT, O’brien BA, Simpson AM. Pancreatic Transdifferentiation Using β-Cell Transcription Factors for Type 1 Diabetes Treatment. Cells 2022;11:2145. [DOI: 10.3390/cells11142145] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 Gómez AM, Henao C DC, Rebolledo M, Jaramillo P PE, Muñoz V OM, Niño G LM, Yepes C CA. Determination of Time in Range Associated With HbA1c ≤7% in a Prospective Cohort of Patients With Type 1 Diabetes Using CGM for Three Months. J Diabetes Sci Technol 2022;:19322968221108424. [PMID: 35791440 DOI: 10.1177/19322968221108424] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
327 Hassanein M, Akbar MAJ, Al-Shamiri M, Amir A, Amod A, Chudleigh R, Elhadd T, Heshmat H, Jibani M, Al Saleh YM. Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies. Diabetes Ther 2022;13:1253-80. [PMID: 35679010 DOI: 10.1007/s13300-022-01282-4] [Reference Citation Analysis]
328 Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapie des Typ-1-Diabetes. Diabetologie 2022;18:612-622. [DOI: 10.1007/s11428-022-00920-6] [Reference Citation Analysis]
329 Chittooru CS, Gorantla Ananda K, Panati DD, Chaudhuri S, Prahalad H. Self-care practices and its determinants among diabetic population in rural Andhra Pradesh, India: A cross-sectional study. Clinical Epidemiology and Global Health 2022;16:101102. [DOI: 10.1016/j.cegh.2022.101102] [Reference Citation Analysis]
330 Jansson Sigfrids F, Groop PH, Harjutsalo V. Incidence rate patterns, cumulative incidence, and time trends for moderate and severe albuminuria in individuals diagnosed with type 1 diabetes aged 0-14 years: a population-based retrospective cohort study. Lancet Diabetes Endocrinol 2022;10:489-98. [PMID: 35489369 DOI: 10.1016/S2213-8587(22)00099-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
331 Gilmore L, Freeman S, Amarasekara S, Maza A, Setji T. Evaluation of the Efficacy of a Hypoglycemia Protocol to Treat Severe Hypoglycemia. Clin Nurse Spec 2022;36:196-203. [PMID: 35714322 DOI: 10.1097/NUR.0000000000000678] [Reference Citation Analysis]
332 Semenchuk J, Sullivan K, Moineddin R, Mahmud F, Dart A, Wicklow B, Xiao F, Medeiros T, Scholey J, Burger D. Urinary interleukin-9 in youth with type 1 diabetes mellitus. Acta Diabetol 2022;59:939-47. [PMID: 35445345 DOI: 10.1007/s00592-022-01873-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
333 Schiaffini R, Deodati A, Nicoletti MC, Carducci C, Ciampalini P, Lorubbio A, Matteoli MC, Pampanini V, Patera IP, Rapini N, Cianfarani S. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study. Acta Diabetol 2022;59:959-64. [PMID: 35451679 DOI: 10.1007/s00592-022-01886-z] [Reference Citation Analysis]
334 Ozaslan B, Levy CJ, Kudva YC, Pinsker JE, O'Malley G, Kaur RJ, Castorino K, Levister C, Trinidad MC, Desjardins D, Church MM, Plesser M, McCrady-Spitzer S, Ogyaadu S, Nelson K, Reid C, Deshpande S, Kremers WK, Doyle FJ , III, Rosenn B, Dassau E. Feasibility of Closed-Loop Insulin Delivery with a Pregnancy-Specific Zone Model Predictive Control Algorithm. Diabetes Technol Ther 2022;24:471-80. [PMID: 35230138 DOI: 10.1089/dia.2021.0521] [Reference Citation Analysis]
335 Przezak A, Bielka W, Molęda P. Fear of hypoglycemia-An underestimated problem. Brain Behav 2022;12:e2633. [PMID: 35620854 DOI: 10.1002/brb3.2633] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
336 Neves ALD, Martins LEG, Gabbay MAL, Cavicchioli G, Tenorio FS, Cunha TS. Insulin Pump-Associated Adverse Events in a Brazilian Reference Center for the Treatment of Diabetes Mellitus: Proposal for a Taxonomy of Device Failures in Adults, Adolescents, and Children. J Diabetes Sci Technol 2022;:19322968221106196. [PMID: 35771027 DOI: 10.1177/19322968221106196] [Reference Citation Analysis]
337 Wang Y, Zou C, Na H, Zeng W, Li X. Effect of Different Glucose Monitoring Methods on Bold Glucose Control: A Systematic Review and Meta-Analysis. Comput Math Methods Med 2022;2022:2851572. [PMID: 35761839 DOI: 10.1155/2022/2851572] [Reference Citation Analysis]
338 Cheung YM, Hughes M, Harrod J, Files J, Kirkner G, Buckley L, Lin NU, Tolaney SM, McDonnell ME, Min L. The Effects of Diabetes and Glycemic Control on Cancer Outcomes in Individuals With Metastatic Breast Cancer. J Clin Endocrinol Metab 2022;107:2511-21. [PMID: 35766387 DOI: 10.1210/clinem/dgac375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
339 Çetiner İ, Barsal Çetiner E, Bircan İ. Glycemic Controls of Patients with Type 1 Diabetes, Affecting Factors and Relationship Between Type 1 Diabetes and Infection Frequency. Türkiye Çocuk Hast Derg 2022. [DOI: 10.12956/tchd.925713] [Reference Citation Analysis]
340 Jacobsen L, Bocchino L, Lum J, Kollman C, Barnes-Lomen V, Sulik M, Haller M, Bode B, Cernich J, Killeen A, Garg U, Lilenquist DR, Adams J, Clements M, Gabrielson D, Johnson T, Clements MA, Beck RW. Accuracy of Three Commercial Home-Use HbA1c Tests. Diabetes Technol Ther 2022. [PMID: 35763337 DOI: 10.1089/dia.2022.0187] [Reference Citation Analysis]
341 Paterson K. Animal and Human Insulins. Diabetes Drug Notes 2022. [DOI: 10.1002/9781119785033.ch7] [Reference Citation Analysis]
342 Timmons and J, Boyle J. Metformin. Diabetes Drug Notes 2022. [DOI: 10.1002/9781119785033.ch2] [Reference Citation Analysis]
343 Quester W. Effects of Diabetes on Fitness to Drive. Handbook of Forensic Medicine 2022. [DOI: 10.1002/9781119648628.ch57] [Reference Citation Analysis]
344 Li Z, Deng X, Zhou L, Lu T, Lan Y, Jin C. Nomogram-based prediction of clinically significant macular edema in diabetes mellitus patients. Acta Diabetol 2022. [PMID: 35739321 DOI: 10.1007/s00592-022-01901-3] [Reference Citation Analysis]
345 Ishibashi F, Kosaka A, Tavakoli M. Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study. Front Endocrinol 2022;13:864332. [DOI: 10.3389/fendo.2022.864332] [Reference Citation Analysis]
346 Johnson C, D'eramo Melkus G, Reagan L, Pan W, Amarasekara S, Pereira K, Hassell N, Nowlin S, Vorderstrasse A. Learning in a Virtual Environment to Improve Type 2 Diabetes Outcomes: A Randomized Controlled Trial (Preprint).. [DOI: 10.2196/preprints.40359] [Reference Citation Analysis]
347 Kumar M, Thompson PD. Should Hemoglobin A1c Targets Be Re-Evaluated? Am J Cardiol 2022;173:141-2. [PMID: 35317932 DOI: 10.1016/j.amjcard.2022.02.017] [Reference Citation Analysis]
348 Echouffo-Tcheugui JB, Ndumele CE, Zhang S, Florido R, Matsushita K, Coresh J, Skali H, Shah AM, Selvin E. Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study. J Am Coll Cardiol 2022;79:2285-93. [PMID: 35680178 DOI: 10.1016/j.jacc.2022.03.378] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
349 de Sá JR, Rangel EB, Canani LH, Bauer AC, Escott GM, Zelmanovitz T, Bertoluci MC, Silveiro SP. The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD. Diabetol Metab Syndr 2022;14:81. [PMID: 35690830 DOI: 10.1186/s13098-022-00843-8] [Reference Citation Analysis]
350 Groenendijk WN, Griffin TP, Islam MN, Blake L, Wall D, Bell M, O'Shea PM. Remote capillary blood collection for HbA1c measurement during the COVID-19 pandemic: A laboratory and patient perspective. Diabet Med 2022;:e14897. [PMID: 35686665 DOI: 10.1111/dme.14897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
351 Hermanns N, Ehrmann D, Heinemann L, Freckmann G, Waldenmaier D, Calhoun P. Real-Time Continuous Glucose Monitoring Can Predict Severe Hypoglycemia in People with Type 1 Diabetes: Combined Analysis of the HypoDE and DIAMOND Trials. Diabetes Technol Ther 2022. [PMID: 35604794 DOI: 10.1089/dia.2022.0130] [Reference Citation Analysis]
352 Nyström T, Schwarz E, Dahlqvist S, Wijkman M, Ekelund M, Holmer H, Bolinder J, Hellman J, Imberg H, Hirsch IB, Lind M. Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With MDI: An Analysis Based on the GOLD Randomized Trial (GOLD 8). J Diabetes Sci Technol 2022;:19322968221101916. [PMID: 35677967 DOI: 10.1177/19322968221101916] [Reference Citation Analysis]
353 Xu A, Chen W, Xu M, Xie W, Ji L. Identification of Hemoglobin Variants Prevalent in China and Their Effects on Hemoglobin A1c Measurements. Am J Clin Pathol 2022;157:852-7. [PMID: 34871348 DOI: 10.1093/ajcp/aqab196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
354 Hamamoto Y, Ouhara K, Miyagawa T, Shintani T, Komatsu N, Kajiya M, Matsuda S, Fujita T, Sasaki S, Iwata T, Ohno H, Yoneda M, Mizuno N, Kurihara H. Masticatory dysfunction in patients with diabetic neuropathy: A cross-sectional study. PLoS ONE 2022;17:e0269594. [DOI: 10.1371/journal.pone.0269594] [Reference Citation Analysis]
355 Templer S. Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions. Front Endocrinol 2022;13:919942. [DOI: 10.3389/fendo.2022.919942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
356 Sarkar S, Sadhukhan P, Das D, Basyach P, Das J, Das MR, Saikia L, Wann SB, Kalita J, Sil PC, Manna P. Glucose-Sensitive Delivery of Vitamin K by Using Surface-Functionalized, Dextran-Capped Mesoporous Silica Nanoparticles To Alleviate Hyperglycemia. ACS Appl Mater Interfaces 2022;14:26489-500. [DOI: 10.1021/acsami.2c05974] [Reference Citation Analysis]
357 Tremblay ES, Liu E, Laffel LM. Health Disparities Likely Emerge Early in the Course of Type-1 Diabetes in Youth. J Diabetes Sci Technol 2022;:19322968221082646. [PMID: 35658634 DOI: 10.1177/19322968221082646] [Reference Citation Analysis]
358 Tucker AP, Erdman AG, Schreiner PJ, Ma S, Chow LS. Neural Networks With Gated Recurrent Units Reduce Glucose Forecasting Error due to Changes in Sensor Location. J Diabetes Sci Technol 2022;:19322968221100839. [PMID: 35658633 DOI: 10.1177/19322968221100839] [Reference Citation Analysis]
359 Maunder RG, Hunter JJ. Attachment Relationships as Determinants of Physical Health. Psychodyn Psychiatry 2022;50:360-79. [PMID: 35653525 DOI: 10.1521/pdps.2022.50.2.360] [Reference Citation Analysis]
360 Kimura M, Toyoda M, Saito N, Takahashi M, Isozumi K, Kato E, Kawanami D, Fukagawa M. The Importance of Patient and Family Engagement, the Needs for Self-Monitoring of Blood Glucose (SMBG) - Our Perspectives Learned Through a Story of SMBG Assistive Devices Made by a Husband of the Patient with Diabetes. Diabetes Metab Syndr Obes 2022;15:1627-38. [PMID: 35642182 DOI: 10.2147/DMSO.S363762] [Reference Citation Analysis]
361 Mao Y, Zhong W. HbA1c Variability as an Independent Risk Factor for Microvascular Complications in Type 1 Diabetes. J Diabetes Sci Technol 2022;:19322968221100833. [PMID: 35652692 DOI: 10.1177/19322968221100833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Miller KM, Kanapka LG, Rickels MR, Ahmann AJ, Aleppo G, Ang L, Bhargava A, Bode BW, Carlson A, Chaytor NS, Gannon G, Goland R, Hirsch IB, Kiblinger L, Kruger D, Kudva YC, Levy CJ, McGill JB, O'Malley G, Peters AL, Philipson LH, Philis-Tsimikas A, Pop-Busui R, Salam M, Shah VN, Thompson MJ, Vendrame F, Verdejo A, Weinstock RS, Young L, Pratley R. Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes. Diabetes Technol Ther 2022;24:424-34. [PMID: 35294272 DOI: 10.1089/dia.2021.0503] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
363 Ratiner K, Shapiro H, Goldenberg K, Elinav E. Time-limited diets and the gut microbiota in cardiometabolic disease. J Diabetes 2022;14:377-93. [PMID: 35698246 DOI: 10.1111/1753-0407.13288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
364 Kramer JR, Natarajan Y, Dai J, Yu X, Li L, El-Serag HB, Kanwal F. Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. Hepatology 2022;75:1420-8. [PMID: 34779535 DOI: 10.1002/hep.32244] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 28.0] [Reference Citation Analysis]
365 Veiby NCBB, Simeunovic A, Heier M, Brunborg C, Saddique N, Moe MC, Dahl-Jørgensen K, Petrovski G, Margeirsdottir HD. Retinal venular oxygen saturation is associated with non-proliferative diabetic retinopathy in young patients with type 1 diabetes. Acta Ophthalmol 2022;100:388-94. [PMID: 34668632 DOI: 10.1111/aos.15018] [Reference Citation Analysis]
366 Staimez LR, Kipling LM, Nina Ham J, Legvold BT, Jackson SL, Wilson PWF, Rhee MK, Phillips LS. Potential Misclassification of Diabetes and Prediabetes in the U.S.:Mismatched HbA1c and glucose in NHANES 2005-2016. Diabetes Res Clin Pract 2022;:109935. [PMID: 35662612 DOI: 10.1016/j.diabres.2022.109935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
367 Evans M, Welsh Z, Seibold A. Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies. Diabetes Ther 2022;13:1175-85. [PMID: 35476279 DOI: 10.1007/s13300-022-01253-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
368 Seyed Ahmadi S, Pivodic A, Svensson AM, Wedel H, Rathsman B, Nyström T, Ludvigsson J, Lind M. Risk factors for nephropathy in persons with type 1 diabetes: a population-based study. Acta Diabetol 2022;59:761-72. [PMID: 35201418 DOI: 10.1007/s00592-022-01863-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
369 Tak S, Jain A. Severe hypoglycemia and cardiovascular disease. Current Opinion in Endocrine and Metabolic Research 2022;24:100357. [DOI: 10.1016/j.coemr.2022.100357] [Reference Citation Analysis]
370 Yoshiji S, Minamino H, Tanaka D, Yamane S, Harada N, Inagaki N. Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: A meta-analysis and meta-regression analysis. Diabetes Obes Metab 2022;24:1029-37. [PMID: 35137511 DOI: 10.1111/dom.14666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
371 Monnier L, Colette C, Owens D. Below Which Threshold of Glycemic Variability Is There a Minimal Risk of Hypoglycemia in People with Type 2 Diabetes? Diabetes Technol Ther 2022;24:453-4. [PMID: 35230157 DOI: 10.1089/dia.2022.0006] [Reference Citation Analysis]
372 Campbell MD, West DJ, O'Mahoney LL, Pearson S, Kietsiriroje N, Holmes M, Ajjan RA. The relative contribution of diurnal and nocturnal glucose exposures to HbA1c in type 1 diabetes males: a pooled analysis. J Diabetes Metab Disord 2022;21:573-81. [PMID: 35673512 DOI: 10.1007/s40200-022-01015-1] [Reference Citation Analysis]
373 Anjana RM, Unnikrishnan R, Deepa M, Venkatesan U, Pradeepa R, Joshi S, Saboo B, Das AK, Bajaj S, Bhansali A, Madhu SV, Dhandhania VK, Jabbar PK, Jain SM, Gupta A, Chowdhury S, Ali MK, Nirmal E, Subashini R, Kaur T, Dhaliwal RS, Tandon N, Mohan V; ICMR-INDIAB collaborators. Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study. Lancet Diabetes Endocrinol 2022;10:430-41. [PMID: 35461575 DOI: 10.1016/S2213-8587(22)00072-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 8.0] [Reference Citation Analysis]
374 Moreno-fernandez J, Garcia-seco JA, Virlaboa-cebrian R, Seco AM, Muñoz-rodriguez JR, Gomez-romero FJ. Faster-acting insulin aspart reduces glycaemic variability in sensor-augmented pump treated type 1 diabetes patients. Endocrinología, Diabetes y Nutrición 2022. [DOI: 10.1016/j.endinu.2021.12.011] [Reference Citation Analysis]
375 Alharbi MY, Albunyan A, Al Nahari A, Al Azmi F, Alenazi B, Al Harbi T, Al Malki M, Al Ahmadi H. Measuring the Impact of Flash Glucose Monitoring in a Pediatric Population in Saudi Arabia: A Retrospective Cohort Study. Diabetes Ther 2022;13:1139-46. [PMID: 35441933 DOI: 10.1007/s13300-022-01224-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
376 Rasoulinejad SA, Meftah N, Maniati MS, Maniati M. High levels of FBS and HbA1c and their association with diabetic retinopathy: a study in the north of Iran. J Diabetes Metab Disord 2022;21:399-406. [PMID: 35673440 DOI: 10.1007/s40200-022-00986-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
377 Farooq MD, Tak FA, Ara F, Rashid S, Mir IA. Vitamin B12 Deficiency and Clinical Neuropathy with Metformin Use in Type 2 Diabetes. J Xenobiot 2022;12:122-30. [PMID: 35736024 DOI: 10.3390/jox12020011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
378 Cyrino FVR, Cardillo JA, Roque EMDST. Diabetes e retinopatia: conhecimento dos profissionais da Estratégia Saúde da Família. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/saude/diabetes-e-retinopatia] [Reference Citation Analysis]
379 Jang K, Westbay JH, Asher SA. DNA-Crosslinked 2D Photonic Crystal Hydrogels for Detection of Adenosine Actuated by an Adenosine-Binding Aptamer. ACS Sens 2022. [PMID: 35623053 DOI: 10.1021/acssensors.1c02424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
380 Huang YM, Chen WM, Chen M, Shia BC, Wu SY. Sarcopenia Is an Independent Risk Factor for Severe Diabetic Nephropathy in Type 2 Diabetes: A Long-Term Follow-Up Propensity Score-Matched Diabetes Cohort Study. J Clin Med 2022;11. [PMID: 35683381 DOI: 10.3390/jcm11112992] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
381 Hemavathy V, Jegatha C. Effectiveness of health education on knowledge on diabetic care among rural adult diabetic patients – a pilot analysis. CM 2022. [DOI: 10.18137/cardiometry.2022.22.527533] [Reference Citation Analysis]
382 Foppa L, Alessi J, Nemetz B, de Matos R, Telo GH, Schaan BD. Quality of care in patients with type 1 diabetes during the COVID-19 pandemic: a cohort study from Southern Brazil. Diabetol Metab Syndr 2022;14:75. [PMID: 35598019 DOI: 10.1186/s13098-022-00845-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
383 Russell-Jones D, Bawlchhim Z. Discovery of insulin 100 years on. Postgrad Med J 2022:postgradmedj-2022-141651. [PMID: 35595268 DOI: 10.1136/postgradmedj-2022-141651] [Reference Citation Analysis]
384 Tao X, Koguma R, Nagai Y, Kohzuma T. Analytical performances of a glycated albumin assay that is traceable to standard reference materials and reference range determination. J Clin Lab Anal 2022;:e24509. [PMID: 35595963 DOI: 10.1002/jcla.24509] [Reference Citation Analysis]
385 Heise T, Piras de Oliveira C, Juneja R, Ribeiro A, Chigutsa F, Blevins T. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro. Diabetes Obes Metab 2022. [PMID: 35593434 DOI: 10.1111/dom.14773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 Yin X, Zhu W, Liu C, Yao H, You J, Chen Y, Ying X, Li L. Association of continuous glucose monitoring-derived time in range with major amputation risk in diabetic foot osteomyelitis patients undergoing amputation. Therapeutic Advances in Endocrinology 2022;13:204201882210993. [DOI: 10.1177/20420188221099337] [Reference Citation Analysis]
387 Martens TW, Parkin CG. How use of continuous glucose monitoring can address therapeutic inertia in primary care. Postgrad Med 2022. [PMID: 35584802 DOI: 10.1080/00325481.2022.2080419] [Reference Citation Analysis]
388 Shi W, Zhang J, Chen D, Chen X, Duan W, Zhang H, Algalil FA. Heart Rate Variability and Chronic Kidney Disease in Patients with Type 2 Diabetes. Applied Bionics and Biomechanics 2022;2022:1-7. [DOI: 10.1155/2022/2475750] [Reference Citation Analysis]
389 Gilor C, Fleeman LM. One hundred years of insulin: Is it time for smart? J Small Anim Pract 2022. [PMID: 35560042 DOI: 10.1111/jsap.13507] [Reference Citation Analysis]
390 Chen Y, Coorey NJ, Zhang M, Zeng S, Madigan MC, Zhang X, Gillies MC, Zhu L, Zhang T. Metabolism Dysregulation in Retinal Diseases and Related Therapies. Antioxidants 2022;11:942. [DOI: 10.3390/antiox11050942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Lu C, Tseng C, Liao KC, Yang H, Chen P, Perng M. The Behavior of Self-Monitoring of Blood Glucose and Glycemic Control in Taiwanese Population. Endocrines 2022;3:214-22. [DOI: 10.3390/endocrines3020019] [Reference Citation Analysis]
392 Cobry EC, Karami AJ, Meltzer LJ. Friend or Foe: a Narrative Review of the Impact of Diabetes Technology on Sleep. Curr Diab Rep 2022. [PMID: 35522354 DOI: 10.1007/s11892-022-01468-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
393 Block TJ, Batu D, Cooper ME. Recent advances in the pharmacotherapeutic management of diabetic kidney disease. Expert Opin Pharmacother 2022;:1-13. [PMID: 35522659 DOI: 10.1080/14656566.2022.2054699] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
394 Amara D, Hansen KS, Kupiec-Weglinski SA, Braun HJ, Hirose R, Hilton JF, Rickels MR, Odorico JS, Stock PG. Pancreas Transplantation for Type 2 Diabetes: A Systematic Review, Critical Gaps in the Literature, and a Path Forward. Transplantation 2022. [PMID: 35576270 DOI: 10.1097/TP.0000000000004113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Nakamura A. Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function. Int J Mol Sci 2022;23:5104. [PMID: 35563495 DOI: 10.3390/ijms23095104] [Reference Citation Analysis]
396 Al-Harbi MY, Albunyan A, Alnahari A, Kao K, Brandner L, El Jammal M, Dunn TC. Frequency of flash glucose monitoring and glucose metrics: real-world observational data from Saudi Arabia. Diabetol Metab Syndr 2022;14:66. [PMID: 35501880 DOI: 10.1186/s13098-022-00831-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Ogata K, Moriyama M, Matsumura-kawashima M, Kawado T, Yano A, Nakamura S. The Therapeutic Potential of Secreted Factors from Dental Pulp Stem Cells for Various Diseases. Biomedicines 2022;10:1049. [DOI: 10.3390/biomedicines10051049] [Reference Citation Analysis]
398 Aggarwal S, Pepper AR, Al Jahdhami N. Augmenting engraftment of beta cell replacement therapies for T1DM. Journal of Immunology and Regenerative Medicine 2022;16:100058. [DOI: 10.1016/j.regen.2021.100058] [Reference Citation Analysis]
399 Pleus S, Freckmann G, Schauer S, Heinemann L, Ziegler R, Ji L, Mohan V, Calliari LE, Hinzmann R. Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus. Diabetes Ther 2022;13:829-46. [PMID: 35416589 DOI: 10.1007/s13300-022-01254-8] [Reference Citation Analysis]
400 Felfeli T, Katsnelson G, Kiss A, Plumptre L, Paterson JM, Ballios BG, Mandelcorn ED, Glazier RH, Brent MH, Wong DT. Prevalence and predictors for being unscreened for diabetic retinopathy: a population-based study over a decade. Canadian Journal of Ophthalmology 2022. [DOI: 10.1016/j.jcjo.2022.04.002] [Reference Citation Analysis]
401 Scanlon PH. Improving the screening of risk factors in diabetic retinopathy. Expert Rev Endocrinol Metab 2022;17:235-43. [PMID: 35730170 DOI: 10.1080/17446651.2022.2078305] [Reference Citation Analysis]
402 Vlasenko IO, Babileva AA, Kurashvili RB, Davtian LL. COMPARATIVE PHARMACOECONOMIC ANALYSIS OF SELF-CONTROL OF DIABETES MELLITUS USING GLUCOMETERS. Wiad Lek 2022;75:1105-1110. [DOI: 10.36740/wlek202205110] [Reference Citation Analysis]
403 Bichuette LD, Lottenberg MP, Cardozo FAM, Calderaro D. Atherosclerosis risk factor management - what's new for the neurologist? Arq Neuro-Psiquiatr 2022;80:88-93. [DOI: 10.1590/0004-282x-anp-2022-s102] [Reference Citation Analysis]
404 Gentile G, Mckinney K, Reboldi G. Tight Blood Pressure Control in Chronic Kidney Disease. JCDD 2022;9:139. [DOI: 10.3390/jcdd9050139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
405 Gupta M, Rao IR, Nagaraju SP, Bhandary SV, Gupta J, Babu GTC, Scholze A. Diabetic Retinopathy Is a Predictor of Progression of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis. International Journal of Nephrology 2022;2022:1-11. [DOI: 10.1155/2022/3922398] [Reference Citation Analysis]
406 Nah EH, Cho S, Park H, Noh D, Kwon E, Cho HI. The Reproducibility and Usefulness of Estimated Average Glucose for Hyperglycemia Management during Health Checkups: A Retrospective Cross-Sectional Study. Healthcare (Basel) 2022;10. [PMID: 35627961 DOI: 10.3390/healthcare10050824] [Reference Citation Analysis]
407 Kimura T, Kagami K, Sato A, Osaki A, Ito K, Horii S, Toya T, Masaki N, Yasuda R, Nagatomo Y, Adachi T. Sarco/Endoplasmic Reticulum Ca2+ ATPase 2 Activator Ameliorates Endothelial Dysfunction; Insulin Resistance in Diabetic Mice. Cells 2022;11:1488. [DOI: 10.3390/cells11091488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
408 Di Molfetta S, Patruno P, Cormio S, Cignarelli A, Paleari R, Mosca A, Lamacchia O, De Cosmo S, Massa M, Natalicchio A, Perrini S, Laviola L, Giorgino F. A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial. J Endocrinol Invest 2022. [PMID: 35476320 DOI: 10.1007/s40618-022-01802-w] [Reference Citation Analysis]
409 Schultz ANØ, Christensen R, Bollig G, Kidholm K, Brandt F. Effectiveness of video consultations in type 1 diabetes patients treated with insulin pumps in the outpatient clinic: protocol for a randomised controlled trial. BMJ Open 2022;12:e058728. [PMID: 35477877 DOI: 10.1136/bmjopen-2021-058728] [Reference Citation Analysis]
410 Norman GJ, Paudel ML, Parkin CG, Bancroft T, Lynch PM. Association between Real-Time Continuous Glucose Monitor Use and Diabetes-Related Medical Costs for Patients with Type 2 Diabetes. Diabetes Technol Ther 2022. [PMID: 35230158 DOI: 10.1089/dia.2021.0525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
411 Edward JA, Josey K, Bahn G, Caplan L, Reusch JEB, Reaven P, Ghosh D, Raghavan S. Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis. Cardiovasc Diabetol 2022;21:58. [PMID: 35477454 DOI: 10.1186/s12933-022-01496-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
412 Bellido V, Aguilera E, Cardona-Hernandez R, Diaz-Soto G, González Pérez de Villar N, Picón-César MJ, Ampudia-Blasco FJ. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes. J Diabetes Sci Technol 2022;:19322968221088601. [PMID: 35470692 DOI: 10.1177/19322968221088601] [Reference Citation Analysis]
413 Oriot P, Viry C, Vandelaer A, Grigioni S, Roy M, Philips JC, Prévost G. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease. J Diabetes Sci Technol 2022;:19322968221092050. [PMID: 35466719 DOI: 10.1177/19322968221092050] [Reference Citation Analysis]
414 Chellan N, Muller CJF. Running with Type 1 Diabetes: A Case Report on the Benefit of Sensor Technology. Diabetology 2022;3:310-314. [DOI: 10.3390/diabetology3020021] [Reference Citation Analysis]
415 Olçomendy L, Cassany L, Pirog A, Franco R, Puginier E, Jaffredo M, Gucik-derigny D, Ríos H, Ferreira de Loza A, Gaitan J, Raoux M, Bornat Y, Catargi B, Lang J, Henry D, Renaud S, Cieslak J. Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes. Front Endocrinol 2022;13:795225. [DOI: 10.3389/fendo.2022.795225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
416 Ling J, Ng JKC, Chan JCN, Chow E. Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease. Front Endocrinol 2022;13:869899. [DOI: 10.3389/fendo.2022.869899] [Reference Citation Analysis]
417 Ju DT, Van Thao D, Lu CY, Ali A, Shibu MA, Chen RJ, Day CH, Shih TC, Tsai CY, Kuo CH, Huang CY. Protective effects of CHIP overexpression and Wharton's jelly mesenchymal-derived stem cell treatment against streptozotocin-induced neurotoxicity in rats. Environ Toxicol 2022. [PMID: 35442559 DOI: 10.1002/tox.23544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Padugupati S, Ramamoorthy S, Thangavelu K, Sarma DVHS, Jamadar D. Effect of berberine in comparison to metformin on the biophysical and biochemical parameters in diabetic albino Wistar rats. ijhs 2022. [DOI: 10.53730/ijhs.v6ns2.6256] [Reference Citation Analysis]
419 Alam U, Ponirakis G, Asghar O, Petropoulos IN, Azmi S, Jeziorska M, Marshall A, Boulton AJM, Efron N, Malik RA. Corneal Confocal Microscopy Identifies People with Type 1 Diabetes with More Rapid Corneal Nerve Fibre Loss and Progression of Neuropathy. J Clin Med 2022;11:2249. [PMID: 35456342 DOI: 10.3390/jcm11082249] [Reference Citation Analysis]
420 Sabeti F, Carle CF, Nolan CJ, Jenkins AJ, James AC, Baker L, Coombes CE, Cheung V, Chiou M, Maddess T. Multifocal pupillographic objective perimetry for assessment of early diabetic retinopathy and generalised diabetes-related tissue injury in persons with type 1 diabetes. BMC Ophthalmol 2022;22:166. [PMID: 35418088 DOI: 10.1186/s12886-022-02382-2] [Reference Citation Analysis]
421 Tian K, Li Chang AA, Choudhary P, Xin X, Bee YM, Yen GS, Teh MM. High incidence of undetected low sensor glucose events among elderly patients with type 2 diabetes more than a decade on after the ACCORD study. Curr Med Res Opin 2022;:1-8. [PMID: 35414299 DOI: 10.1080/03007995.2022.2065143] [Reference Citation Analysis]
422 Ortiz JT. Rigoroso controllo glicemico: una revisione della letteratura. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/salute/rigoroso-controllo-glicemico] [Reference Citation Analysis]
423 Ortiz JT. Control estricto de la glucemia: una revisión de la literatura. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/salud/control-estricto-de-la-glucemia] [Reference Citation Analysis]
424 Ehrmann D, Eichinger V, Vesper I, Kober J, Kraus M, Schäfer V, Hermanns N, Kulzer B, Silbermann S. Health care effects and medical benefits of a smartphone-based diabetes self-management application: study protocol for a randomized controlled trial. Trials 2022;23. [DOI: 10.1186/s13063-022-06248-2] [Reference Citation Analysis]
425 Ortiz JT. Contrôle glycémique strict : une revue de la littérature. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/sante/controle-glycemique-strict] [Reference Citation Analysis]
426 Ortiz JT. Strenge glykämische Kontrolle: eine Literaturübersicht. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/gesundheit/strenge-glykaemische-kontrolle] [Reference Citation Analysis]
427 Ortiz JT. Строгий гликемический контроль: обзор литературы. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/ru/114890] [Reference Citation Analysis]
428 Ortiz JT. O controle glicêmico rigoroso: uma revisão de literatura. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/saude/controle-glicemico-rigoroso] [Reference Citation Analysis]
429 Ortiz JT. Strict glycemic control: a literature review. Revista Científica Multidisciplinar Núcleo do Conhecimento 2022. [DOI: 10.32749/nucleodoconhecimento.com.br/health/strict-glycemic-control] [Reference Citation Analysis]
430 De Block CEM, Van Cauwenberghe J, Bochanen N, Dirinck E. Rapid-acting insulin analogues: Theory and best clinical practice in type 1 and type 2 diabetes. Diabetes Obes Metab 2022. [PMID: 35403348 DOI: 10.1111/dom.14713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
431 Di Molfetta S, Rossi A, Assaloni R, Cherubini V, Consoli A, Di Bartolo P, Guardasole V, Laurenzi A, Lombardo F, Maffeis C, Scaramuzza A, Irace C; Working group of Diabetes, Technology AMD-SID-SIEDP. A guide for the use of LibreView digital diabetes platform in clinical practice: Expert paper of the Italian Working Group for Diabetes and Technology. Diabetes Res Clin Pract 2022;:109867. [PMID: 35405166 DOI: 10.1016/j.diabres.2022.109867] [Reference Citation Analysis]
432 Hoffmann AP, Honigberg MC. Glycated Hemoglobin as an Integrator of Cardiovascular Risk in Individuals Without Diabetes: Lessons from Recent Epidemiologic Studies. Curr Atheroscler Rep 2022. [PMID: 35386092 DOI: 10.1007/s11883-022-01024-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
433 Bhatti JS, Sehrawat A, Mishra J, Sidhu IS, Navik U, Khullar N, Kumar S, Bhatti GK, Reddy PH. Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives. Free Radic Biol Med 2022:S0891-5849(22)00122-8. [PMID: 35398495 DOI: 10.1016/j.freeradbiomed.2022.03.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 37.0] [Reference Citation Analysis]
434 Wang M, Li Y, Li S, Lv J. Endothelial Dysfunction and Diabetic Cardiomyopathy. Front Endocrinol 2022;13:851941. [DOI: 10.3389/fendo.2022.851941] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
435 Panov A, Mayorov VI, Dikalov S. Metabolic Syndrome and β-Oxidation of Long-Chain Fatty Acids in the Brain, Heart, and Kidney Mitochondria. Int J Mol Sci 2022;23:4047. [PMID: 35409406 DOI: 10.3390/ijms23074047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
436 Pramanik S, Kanta Mondal L, Chowdhury S, Bose C, Bera D, Bhattacharjee K. Role of Lipid, Protein-Derived Toxic Molecules, and Deficiency of Antioxidants behind the Pathogenesis of Diabetic Retinopathy (DR) in Type 2 Diabetes Mellitus. Diabetic Eye Disease - From Therapeutic Pipeline to the Real World 2022. [DOI: 10.5772/intechopen.99904] [Reference Citation Analysis]
437 Ndubuisi Okonkwo O, Akanbi T, Thelma Agweye C. Current Management of Diabetic Macular Edema. Diabetic Eye Disease - From Therapeutic Pipeline to the Real World 2022. [DOI: 10.5772/intechopen.100157] [Reference Citation Analysis]
438 Crespo-Masip M, Perez-Gomez A, Garcia-Carrasco A, Jover R, Guzmán C, Dolcet X, Ibarz M, Martínez C, Eritja À, Diaz-Tocados JM, Valdivielso JM. Elimination of Vitamin D Signaling Causes Increased Mortality in a Model of Overactivation of the Insulin Receptor: Role of Lipid Metabolism. Nutrients 2022;14:1516. [PMID: 35406129 DOI: 10.3390/nu14071516] [Reference Citation Analysis]
439 Barengo NC, Apolinar LM, Estrada Cruz NA, Fernández Garate JE, Correa González RA, Diaz Valencia PA, Gonzalez CAC, Rodriguez JAG, González NC, Arellano Flores ML, Ledesma Muñoz ME, Gonzalez Sotelo DA, Davila Maldonado OM, Gomez Garcia JG, Laureano Hernandez FJ, Jimenez JEZ, Pulido Garcia BA, Vazquez HR, Ramirez Dorantes AA, Gonzalez Fierro LA, Hernandez Hernandez JC, Perez JZ; On behalf of the SANENT Study Group. Development of an information system and mobile application for the care of type 2 diabetes patients at the primary care level for the health sector in Mexico: study protocol for a randomized controlled, open-label trial. Trials 2022;23. [DOI: 10.1186/s13063-022-06177-0] [Reference Citation Analysis]
440 Inkeri J, Adeshara K, Harjutsalo V, Forsblom C, Liebkind R, Tatlisumak T, Thorn LM, Groop PH, Shams S, Martola J, Putaala J, Gordin D; FinnDiane Study Group. Glycemic control is not related to cerebral small vessel disease in neurologically asymptomatic individuals with type 1 diabetes. Acta Diabetol 2022;59:481-90. [PMID: 34778921 DOI: 10.1007/s00592-021-01821-8] [Reference Citation Analysis]
441 Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapy of Type 1 Diabetes. Exp Clin Endocrinol Diabetes 2022. [PMID: 35373309 DOI: 10.1055/a-1624-3340] [Reference Citation Analysis]
442 Kirthi V, Nderitu P, Alam U, Evans JR, Nevitt S, Malik RA, Hopkins D, Jackson TL. The prevalence of retinopathy in prediabetes: A systematic review. Survey of Ophthalmology 2022. [DOI: 10.1016/j.survophthal.2022.04.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
443 Nettleton J, Burton A, Povey R. “No-one realises what we go through as Type 1s”: A qualitative photo-elicitation study on coping with diabetes. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109876] [Reference Citation Analysis]
444 Mounié M, Costa N, Gourdy P, Latorre C, Schirr-Bonnans S, Lagarrigue JM, Roussel H, Martini J, Buisson JC, Chauchard MC, Delaunay J, Taoui S, Poncet MF, Cosma V, Lablanche S, Coustols-Valat M, Chaillous L, Thivolet C, Sanz C, Penfornis A, Lepage B, Colineaux H, Hanaire H, Molinier L, Turnin MC; Educ@dom Study Group. Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study. Diabetes Ther 2022;13:693-708. [PMID: 35133640 DOI: 10.1007/s13300-022-01207-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
445 Teo E, Hassan N, Tam W, Koh S. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis. Diabetologia 2022;65:604-19. [PMID: 35141761 DOI: 10.1007/s00125-021-05648-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
446 Reiff S, Fava S. Does optimal HbA1c in diabetes differ according to drug treatment? An evaluation of national electronic database in Malta. Diabetes Metab Syndr 2022;16:102475. [PMID: 35367912 DOI: 10.1016/j.dsx.2022.102475] [Reference Citation Analysis]
447 Karin A, Jon E, Martin A, Lena B, Martin L, Naveed S, Marcus L, Maria Å, Annika R. Body mass index in adolescence, risk of type 2 diabetes and associated complications: A nationwide cohort study of men. EClinicalMedicine 2022;46:101356. [PMID: 35330801 DOI: 10.1016/j.eclinm.2022.101356] [Reference Citation Analysis]
448 Boroojeny AB, Nunney I, Dhatariya KK. The Association Between Glycaemic Control, Renal Function and Post-operative Ophthalmic Complications in People With Diabetes Undergoing Cataract Surgery-A Single-Centre Retrospective Analysis. Diabetes Ther 2022;13:723-32. [PMID: 35278194 DOI: 10.1007/s13300-022-01241-z] [Reference Citation Analysis]
449 Serné EH, Roze S, Buompensiere MI, Valentine WJ, De Portu S, de Valk HW. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands. Adv Ther 2022;39:1844-56. [PMID: 35226346 DOI: 10.1007/s12325-022-02058-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
450 Elhabashy SA, Sherif EMM, Salah NY, Elkader MAEA, Youssef DAH. Uncontrolled type 1 diabetes among Egyptian adolescents; risk determinants and clinical outcomes. Diabetes Epidemiology and Management 2022;6:100051. [DOI: 10.1016/j.deman.2022.100051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
451 Steigmann L, Miller R, Trapani VR, Giannobile WV, Braffett BH, Pop-Busui R, Lorenzi G, Herman WH, Sarma AV; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J Diabetes Complications 2022;36:108120. [PMID: 35000860 DOI: 10.1016/j.jdiacomp.2021.108120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
452 Mazin I, Chernomordik F, Fefer P, Matetzky S, Beigel R. The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients. J Clin Med 2022;11:1904. [PMID: 35407513 DOI: 10.3390/jcm11071904] [Reference Citation Analysis]
453 Yang X, Yang Y. Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications. Front Endocrinol 2022;13:853822. [DOI: 10.3389/fendo.2022.853822] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
454 Zhu BT. Biochemical mechanism underlying the pathogenesis of diabetic retinopathy and other diabetic complications in humans: the methanol-formaldehyde-formic acid hypothesis. Acta Biochim Biophys Sin (Shanghai) 2022;54:415-51. [PMID: 35607958 DOI: 10.3724/abbs.2022012] [Reference Citation Analysis]
455 Wang CS, Pai YW, Lin CH, Lee IT, Chang MH. Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study. Sci Rep 2022;12:5240. [PMID: 35347201 DOI: 10.1038/s41598-022-09333-3] [Reference Citation Analysis]
456 Butler AM, Hilliard ME, Fegan-Bohm K, Minard C, Anderson BJ. Peer-support intervention for African American and Latino parents to improve the glycemic control trajectory among school-aged children with type 1 diabetes: A pilot and feasibility protocol. Contemp Clin Trials 2022;116:106739. [PMID: 35341991 DOI: 10.1016/j.cct.2022.106739] [Reference Citation Analysis]
457 Nimri R, Tirosh A, Muller I, Shtrit Y, Kraljević I, Alonso MM, Milicic T, Saboo B, Deeb A, Christoforidis A, den Brinker M, Bozzetto L, Bolla AM, Krcma M, Rabini RA, Tabba S, Vazeou-Gerasimidi A, Maltoni G, Giani E, Dotan I, Liberty IF, Toledano Y, Kordonouri O, Bratina N, Dovc K, Biester T, Atlas E, Phillip M. Comparison of Insulin Dose Adjustments Made by Artificial Intelligence based Decision Support System and by Physicians in People with Type 1 Diabetes using Multiple Daily Injections Therapy. Diabetes Technol Ther 2022. [PMID: 35325567 DOI: 10.1089/dia.2021.0566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
458 Sperling MA, Laffel LM. Current Management of Glycemia in Children with Type 1 Diabetes Mellitus. N Engl J Med 2022;386:1155-64. [PMID: 35320645 DOI: 10.1056/NEJMcp2112175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
459 Fung TH, Patel B, Wilmot EG, Amoaku WM. Diabetic retinopathy for the non-ophthalmologist. Clin Med (Lond) 2022;22:112-6. [PMID: 35304370 DOI: 10.7861/clinmed.2021-0792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
460 Podoláková K, Lobotková D, Jančová E, Podracká Ľ, Barák Ľ, Staník J. Postinitial remission in children with type 1 diabetes mellitus. Czech-Slovak Pediatrics 2022;77:72-77. [DOI: 10.55095/cspediatrie2022/009] [Reference Citation Analysis]
461 Chang Y, Chang JT, Lee MY, Huang MZ, Chao YCC, Shih YL, Hwang YR. Does Far-Infrared Therapy Improve Peritoneal Function and Reduce Recurrent Peritonitis in Peritoneal Dialysis Patients? J Clin Med 2022;11. [PMID: 35329948 DOI: 10.3390/jcm11061624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
462 M Richardson J, Shaginian R. Hypoglycemia Detection in Diabetes. Basics of Hypoglycemia [Working Title] 2022. [DOI: 10.5772/intechopen.103137] [Reference Citation Analysis]
463 Momenzadeh A, Shamsa A, Meyer JG. Clinical interpretation of machine learning models for prediction of diabetic complications using electronic health records.. [DOI: 10.1101/2022.03.11.22272039] [Reference Citation Analysis]
464 Vidya Kr, Balaji S, Rm S, Lohit K. Self-Care Practices Among Of Diabetic Patients in a Rural Area of Karnataka. Natl J Community Med 2022;12:148-152. [DOI: 10.5455/njcm.20210619120028] [Reference Citation Analysis]
465 Wang WM, Ou HT, Wen MJ, Su PF, Yang CY, Kuo TH, Wang MC, Lin WH. Association of retinopathy severity with cardiovascular and renal outcomes in patients with type 1 diabetes: a multi-state modeling analysis. Sci Rep 2022;12:4177. [PMID: 35264740 DOI: 10.1038/s41598-022-08166-4] [Reference Citation Analysis]
466 Drozd I, Weiskorn J, Lange K, Kordonouri O. Typ-1-Diabetes und kardiovaskuläre Risikofaktoren bei Kindern und Jugendlichen. Diabetologie und Stoffwechsel. [DOI: 10.1055/a-1713-2438] [Reference Citation Analysis]
467 Mendivil CO, Amaya-Montoya M, Hernández-Vargas JA, Ramírez-García N, Romero-Díaz C, Pérez-Londoño A, Guatibonza-García V, Acuña-Merchán L. Achievement of treatment goals among adults with diabetes in Colombia, 2015-2019: Results from a national registry. Diabetes Res Clin Pract 2022;:109823. [PMID: 35271878 DOI: 10.1016/j.diabres.2022.109823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
468 Li S, Huang B, Liu M, Cui X, Cao Y, Gao Z. The Association Between Leucine and Diabetic Retinopathy in Different Genders: A Cross-Sectional Study in Chinese Patients With Type 2 Diabetes. Front Endocrinol 2022;13:806807. [DOI: 10.3389/fendo.2022.806807] [Reference Citation Analysis]
469 Malyuzhinskaya NV, Shishimorov IN, Magnitskaya OV, Stepanenko KV, Polyakova OV, Klitochenko GV, Petrova IV, Emelyanova SA, Skiba AP. PHARMACOTHERAPY POSSIBILITIES OF CARDIOVASCULAR AUTONOMOUS NEUROPATHY IN CHILDREN WITH TYPE 1 DIABETES MELLITUS AT THE PRECLINICAL STAGE. Farm farmakol (Pâtigorsk) 2022;10:93-103. [DOI: 10.19163/2307-9266-2022-10-1-93-103] [Reference Citation Analysis]
470 El Fathi A, Fabris C, Breton MD. Titration of Long-Acting Insulin Using Continuous Glucose Monitoring and Smart Insulin Pens in Type 1 Diabetes: A Model-Based Carbohydrate-Free Approach. Front Endocrinol (Lausanne) 2021;12:795895. [PMID: 35082757 DOI: 10.3389/fendo.2021.795895] [Reference Citation Analysis]
471 Zhang P, Fonnesbeck C, Schmidt DC, White J, Kleinberg S, Mulvaney SA. Using Momentary Assessment and Machine Learning to Identify Barriers to Self-management in Type 1 Diabetes: Observational Study. JMIR Mhealth Uhealth 2022;10:e21959. [DOI: 10.2196/21959] [Reference Citation Analysis]
472 Pereda P, Boarati V, Guidetti B, Duran AC. Direct and Indirect Costs of Diabetes in Brazil in 2016. Annals of Global Health 2022;88:14. [DOI: 10.5334/aogh.3000] [Reference Citation Analysis]
473 Garner K, Boggiss A, Jefferies C, Serlachius A. Digital health interventions for improving mental health outcomes and wellbeing for youth with type 1 diabetes: A systematic review. Pediatr Diabetes 2022;23:258-69. [PMID: 34913548 DOI: 10.1111/pedi.13304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
474 Sarray S, Lamine LB, Dallel M, Jairajpuri D, Turki A, Sellami N, Ezzidi I, Abdelhadi M, Brock R, Ghorbel M, Mahjoub T. Association of MMP-2 genes variants with diabetic retinopathy in Tunisian population with type 2 diabetes. Journal of Diabetes and its Complications 2022. [DOI: 10.1016/j.jdiacomp.2022.108182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
475 Jung CY, Yoo TH. Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease. Diabetes Metab J 2022;46:181-97. [PMID: 35385633 DOI: 10.4093/dmj.2021.0329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
476 Coppin B, Hamood N, Tan F, Scholar M, Goss P. Survey of Australian general paediatricians regarding insulin initiation practices in children with new onset of type 1 diabetes. J Paediatr Child Health 2022;58:463-7. [PMID: 34623008 DOI: 10.1111/jpc.15742] [Reference Citation Analysis]
477 Scanlon PH, Nevill CR, Stratton IM, Maruti SS, Massó-González EL, Sivaprasad S, Bailey C, Ehrlich M, Chong V. Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire. Acta Ophthalmol 2022;100:e560-70. [PMID: 34180581 DOI: 10.1111/aos.14927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
478 Dhawan P, Vasishta S, Balakrishnan A, Joshi MB. Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
479 Quinn LM, Thayakaran R, Thomas N, Nirantharakumar K, Narendran P. Comment on Lachin et al. The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes. Diabetes Care 2021;44:2225-2230. Diabetes Care 2022;45:e70-1. [PMID: 35245356 DOI: 10.2337/dc21-2372] [Reference Citation Analysis]
480 Thagaard MS, Vergmann AS, Grauslund J. Topical treatment of diabetic retinopathy: a systematic review. Acta Ophthalmol 2022;100:136-47. [PMID: 34096180 DOI: 10.1111/aos.14912] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
481 Langberg J, Mueller A, Rodriguez de la Vega P, Castro G, Varella M. The Association of Hemoglobin A1c Levels and Depression Among Adults With Diabetes in the United States. Cureus. [DOI: 10.7759/cureus.22688] [Reference Citation Analysis]
482 Inácio I, Azevedo T, Martins JL, Balsa AMM, Dantas R, Alves M, Albuquerque I, Guimarães J. Cardiovascular Risk Prediction by the American Diabetes Association Risk-Assessment Tool and Novel and Traditional Cardiovascular Risk Factors in Young Adults With Type 1 Diabetes. Cureus 2022. [DOI: 10.7759/cureus.22574] [Reference Citation Analysis]
483 Mouhammad ZA, Vohra R, Horwitz A, Thein A, Rovelt J, Cvenkel B, Williams PA, Azuara-blanco A, Kolko M. Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma? Front Neurosci 2022;16:824054. [DOI: 10.3389/fnins.2022.824054] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
484 Reis RMDF, Azulay RSS, Tavares MDG, Nascimento GC, Damianse SDSP, Rocha VCC, Almeida AG, Lago DCF, Rodrigues V, Magalhães M, Sobral CS, Parente C, França J, Ribeiro J, Ferraz PCD, Junior CAA, Silva DA, Gomes MB, Faria MDS. Early Markers of Cardiovascular Disease Associated with Clinical Data and Autosomal Ancestry in Patients with Type 1 Diabetes: A Cross-Sectional Study in an Admixed Brazilian Population. Genes (Basel) 2022;13:389. [PMID: 35205433 DOI: 10.3390/genes13020389] [Reference Citation Analysis]
485 Sriwimol W, Choosongsang P, Choosongsang P, Petkliang W, Treerut P. Associations between HbA1c-derived estimated average glucose and fasting plasma glucose in patients with normal and abnormal hemoglobin patterns. Scand J Clin Lab Invest 2022;:1-7. [PMID: 35175156 DOI: 10.1080/00365513.2022.2040051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
486 Rajan R, Kshatriya M, Banfield L, Athale U, Thabane L, Samaan MC. Impact of virtual care on health-related quality of life in children with diabetes mellitus: a systematic review protocol. BMJ Open 2022;12:e053642. [PMID: 35173001 DOI: 10.1136/bmjopen-2021-053642] [Reference Citation Analysis]
487 Cristello Sarteau A, Mayer-Davis E. Too Much Dietary Flexibility May Hinder, Not Help: Could More Specific Targets for Daily Food Intake Distribution Promote Glycemic Management among Youth with Type 1 Diabetes? Nutrients 2022;14:824. [PMID: 35215477 DOI: 10.3390/nu14040824] [Reference Citation Analysis]
488 Crossen SS, Bruggeman BS, Haller MJ, Raymond JK. Challenges and Opportunities in Using Telehealth for Diabetes Care. Diabetes Spectr 2022;35:33-42. [PMID: 35308158 DOI: 10.2337/dsi21-0018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
489 Pramanik S, Saha C, Chowdhury S, Bose C, Bhattacharyya NP, Mondal LK. Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus. Diabetes Metab Syndr Obes 2022;15:345-58. [PMID: 35153496 DOI: 10.2147/DMSO.S346097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
490 Brink SJ. Insulin Past, Present, and Future: 100 Years from Leonard Thompson. Diabetology 2022;3:117-158. [DOI: 10.3390/diabetology3010010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Oliveira LM, Belfort GP, Padilha PC, Rosado EL, Silva LBGD, Fagherazzi S, Zajdenverg L, Zagury RL, Saunders C. Impact of Carbohydrate Counting Method during Pregnancy in Women with Pregestational Diabetes Mellitus: A Controlled Clinical Trial. Rev Bras Ginecol Obstet 2022. [PMID: 35139572 DOI: 10.1055/s-0042-1742291] [Reference Citation Analysis]
492 Rathod S. Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes. Diabetology 2022;3:79-96. [DOI: 10.3390/diabetology3010007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
493 Yang L, Wu T, Tang C, Peng T. Efficacy and immunogenicity of insulin biosimilar compared to their reference products: a systematic review and meta-analysis. BMC Endocr Disord 2022;22. [DOI: 10.1186/s12902-022-00944-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
494 Davidson MB. Historical Review of the Diagnosis of Prediabetes/Intermediate Hyperglycemia: Case for the International Criteria. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109219] [Reference Citation Analysis]
495 Jahn LA, Logan B, Love KM, Horton WB, Eichner NZ, Hartline LM, Weltman AL, Barrett EJ. Nitric oxide-dependent micro- and macrovascular dysfunction occurs early in adolescents with type 1 diabetes. Am J Physiol Endocrinol Metab 2022;322:E101-8. [PMID: 34894721 DOI: 10.1152/ajpendo.00267.2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 Mima A. Mitochondria-targeted drugs for diabetic kidney disease. Heliyon 2022;8:e08878. [DOI: 10.1016/j.heliyon.2022.e08878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
497 Kieu A, King J, Govender RD, Östlundh L. The Benefits of Utilizing Continuous Glucose Monitoring of Diabetes Mellitus in Primary Care: A Systematic Review. J Diabetes Sci Technol. [DOI: 10.1177/19322968211070855] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
498 Palmer T, Jennings HM, Shannon G, Salustri F, Grewal G, Chelagat W, Sarker M, Pelletier N, Haghparast-Bidgoli H, Skordis J. Improving access to diabetes care for children: An evaluation of the changing diabetes in children project in Kenya and Bangladesh. Pediatr Diabetes 2022;23:19-32. [PMID: 34713540 DOI: 10.1111/pedi.13277] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
499 Levine SR, Sapieha P, Dutta S, Sun JK, Gardner TW. It is time for a moonshot to find “Cures” for diabetic retinal disease. Progress in Retinal and Eye Research 2022. [DOI: 10.1016/j.preteyeres.2022.101051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
500 Alyusuf EY, Alharthi S, Alguwaihes AM, Jammah AA, Alfadda AA, Al-Sofiani ME. Predictors of use and improvement in glycemic indices after initiating continuous glucose monitoring in real world: Data from Saudi Arabia. Diabetes Metab Syndr 2022;16:102416. [PMID: 35150962 DOI: 10.1016/j.dsx.2022.102416] [Reference Citation Analysis]
501 Lautsch D, Boggs R, Wang T, Gonzalez C, Milligan G, Rajpathak S, Malkani S, McLeod E, Carroll J, Higgins V. Individualized HbA1c Goals, and Patient Awareness and Attainment of Goals in Type 2 Diabetes Mellitus: A Real-World Multinational Survey. Adv Ther 2022;39:1016-32. [PMID: 34951678 DOI: 10.1007/s12325-021-01985-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
502 Harmer MJ, Everitt LH, Parker L, Davis N, Connett G, Nagra A. Structured transition is associated with improved outcomes in diabetes. Practical Diabetes 2022;39:18. [DOI: 10.1002/pdi.2375] [Reference Citation Analysis]
503 Saikia D, Kumar S. Low glucose metabolizing capacity and not insulin resistance is primary etiology of Type 2 Diabetes Mellitus: A hypothesis. Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110804] [Reference Citation Analysis]
504 Hafidh K, Abdella NA. Glycemic control of adult patients with type 1 diabetes mellitus in Arabian Gulf Countries; PREDICT. BMC Endocr Disord 2022;22:32. [PMID: 35101023 DOI: 10.1186/s12902-022-00946-3] [Reference Citation Analysis]
505 Wallace AS, Chang AR, Shin JI, Reider J, Echouffo-Tcheugui JB, Grams ME, Selvin E. Obesity and Chronic Kidney Disease in US Adults With Type 1 and Type 2 Diabetes Mellitus. J Clin Endocrinol Metab 2022;107:1247-56. [PMID: 35080610 DOI: 10.1210/clinem/dgab927] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
506 Dagdelen S, Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, Yilmaz T. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice. Front Endocrinol 2022;12:663222. [DOI: 10.3389/fendo.2021.663222] [Reference Citation Analysis]
507 Hopper W, Fox J, Dimucci-Ward J. Assessment of Glycemic Control at St. Luke's Free Medical Clinic: Retrospective Chart Review. Interact J Med Res 2022;11:e31123. [PMID: 35072636 DOI: 10.2196/31123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Kent de Grey RG, Berg CA, Campbell MS, Munion AK, Luyckx K, Raymaekers K, Litchman ML, Wiebe DJ. Diabetes support from romantic partners during early emerging adulthood. J Behav Med. [DOI: 10.1007/s10865-021-00271-5] [Reference Citation Analysis]
509 Khadilkar A, Oza C. Glycaemic Control in Youth and Young Adults: Challenges and Solutions. Diabetes Metab Syndr Obes 2022;15:121-9. [PMID: 35046683 DOI: 10.2147/DMSO.S304347] [Reference Citation Analysis]
510 Rizvi AA, Abbas M, Verma S, Verma S, Khan A, Raza ST, Mahdi F. Determinants in Tailoring Antidiabetic Therapies: A Personalized Approach. Glob Med Genet. [DOI: 10.1055/s-0041-1741109] [Reference Citation Analysis]
511 Gill A, Gothard MD, Briggs Early K. Glycemic outcomes among rural patients in the type 1 diabetes T1D Exchange registry, January 2016-March 2018: a cross-sectional cohort study. BMJ Open Diabetes Res Care 2022;10:e002564. [PMID: 35042753 DOI: 10.1136/bmjdrc-2021-002564] [Reference Citation Analysis]
512 Altzoumailis A, Kytopoulos VN. Qualitative and Quantitative Determination of Montmorillonite Using Infrared Spectrometry. International Journal of Materials 2022;8:105-108. [DOI: 10.46300/91018.2021.8.14] [Reference Citation Analysis]
513 Bassi M, Teliti M, Lezzi M, Iosca A, Strati MF, Carmisciano L, d’Annunzio G, Minuto N, Maggi D. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes. Front Endocrinol 2022;12:802419. [DOI: 10.3389/fendo.2021.802419] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
514 Xu M, Huang J, Jiang S, He J, Wang Z, Qin H, Guan YQ. Glucose sensitive konjac glucomannan/concanavalin A nanoparticles as oral insulin delivery system. Int J Biol Macromol 2022:S0141-8130(22)00057-5. [PMID: 35038475 DOI: 10.1016/j.ijbiomac.2022.01.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
515 Rasoulinejad SA. Evaluating the Risk Factors of Development and Progression of Diabetic Retinopathy: A Review Study. Shiraz E-Med J 2022;23. [DOI: 10.5812/semj.117171] [Reference Citation Analysis]
516 Sakran N, Graham Y, Pintar T, Yang W, Kassir R, Willigendael EM, Singhal R, Kooreman ZE, Ramnarain D, Mahawar K, Parmar C, Madhok B, Pouwels S. The many faces of diabetes. Is there a need for re-classification? A narrative review. BMC Endocr Disord 2022;22:9. [PMID: 34991585 DOI: 10.1186/s12902-021-00927-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
517 Kobayati A, Haidar A, Tsoukas MA. Glucagon-like peptide-1 receptor agonists as adjunctive treatment for type 1 diabetes: Renewed opportunities through tailored approaches? Diabetes Obes Metab 2022;24:769-87. [PMID: 34989070 DOI: 10.1111/dom.14637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
518 Gomez-Peralta F, Choudhary P, Cosson E, Irace C, Rami-Merhar B, Seibold A. Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin. Diabetes Obes Metab 2022;24:599-608. [PMID: 34984825 DOI: 10.1111/dom.14638] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
519 Planalp EM, Kliems H, Chewning BA, Palta M, LeCaire TJ, Young LA, Cox ED. Development and validation of the self-management Barriers and Supports Evaluation for working-aged adults with type 1 diabetes mellitus. BMJ Open Diabetes Res Care 2022;10:e002583. [PMID: 34980593 DOI: 10.1136/bmjdrc-2021-002583] [Reference Citation Analysis]
520 Montenegro AC, Griz L, Bandeira F. The Diabetic Neuropathies. Endocrinology and Diabetes 2022. [DOI: 10.1007/978-3-030-90684-9_36] [Reference Citation Analysis]
521 Menon D, Bril V. Electrodiagnostic evaluation in diabetic neuropathy. Diabetic Neuropathy 2022. [DOI: 10.1016/b978-0-12-820669-0.00005-0] [Reference Citation Analysis]
522 Metri K, Nagaratna R, Singh A. Role of Yoga in Prevention and Management of Type 2 Diabetes Mellitus (T2DM) and Its Complications. The Principles and Practice of Yoga in Cardiovascular Medicine 2022. [DOI: 10.1007/978-981-16-6913-2_16] [Reference Citation Analysis]
523 Abazari A, Ghazi NG, Karcioglu ZA. Diabetic Retinopathy. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_17] [Reference Citation Analysis]
524 Davalos L, Stino AM, Selvarajah D, Sakowski SA, Tesfaye S, Feldman EL. Precision Medicine for Diabetic Neuropathy. Precision Medicine in Diabetes 2022. [DOI: 10.1007/978-3-030-98927-9_8] [Reference Citation Analysis]
525 Sun JK, Aiello LP. Diabetic Macular Edema. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_25] [Reference Citation Analysis]
526 Elliott WJ. Antihypertensive Therapies. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_23] [Reference Citation Analysis]
527 Yamada S, Inaba M. Diabetes and Bone. Osteoporotic Fracture and Systemic Skeletal Disorders 2022. [DOI: 10.1007/978-981-16-5613-2_18] [Reference Citation Analysis]
528 Howarth BS, Bourgeois JA, Kates N. Consultation-Liaison Psychiatry and Collaborative Care Models of the Patient with Renal Disease. Psychonephrology 2022. [DOI: 10.1007/978-3-030-84740-1_9] [Reference Citation Analysis]
529 . Endokrines System und Immunmodulation. Arzneimitteltherapie in der Palliativmedizin 2022. [DOI: 10.1016/b978-3-437-23673-0.00008-2] [Reference Citation Analysis]
530 American Diabetes Association Professional Practice Committee. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S83-96. [PMID: 34964868 DOI: 10.2337/dc22-S006] [Cited by in Crossref: 166] [Cited by in F6Publishing: 137] [Article Influence: 166.0] [Reference Citation Analysis]
531 Liu Z, Zhou Y, Qu X, Xu L, Zou Y, Shan Y, Shao J, Wang C, Liu Y, Xue J, Jiang D, Fan Y, Li Z, Ye H. A Self-Powered Optogenetic System for Implantable Blood Glucose Control. Research (Wash D C) 2022;2022:9864734. [PMID: 35935133 DOI: 10.34133/2022/9864734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
532 Speight S, Morriss-roberts C. What is the Lived Experience of the ‘Three Great Pathologies’ of Diabetic Foot Disease? An Interpretative Phenomenological Analysis of the Independent Thinking of Podiatrists in Diabetes Secondary Care. INQUIRY 2022;59:004695802210886. [DOI: 10.1177/00469580221088622] [Reference Citation Analysis]
533 宗景 匡. Can we provide healthcare away from patients? Iryou kikigaku (The Japanese journal of medical instrumentation) 2022;92:348-354. [DOI: 10.4286/jjmi.92.348] [Reference Citation Analysis]
534 Hare MJL, Topliss DJ. Classification and Laboratory Diagnosis of Diabetes Mellitus. Endocrinology and Diabetes 2022. [DOI: 10.1007/978-3-030-90684-9_28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
535 El Asmar N, Arafah BM, Smith CK. Diabetes Mellitus. Family Medicine 2022. [DOI: 10.1007/978-3-030-54441-6_186] [Reference Citation Analysis]
536 刘 丽. Current Situation and New Progress of the Prevention and Treatment of Diabetic Macular Oedema. MD 2022;12:72-83. [DOI: 10.12677/md.2022.121012] [Reference Citation Analysis]
537 Gu X, Ge L, Ren B, Fang Y, Li Y, Wang Y, Xu H. Glucocorticoids Promote Extracellular Matrix Component Remodeling by Activating YAP in Human Retinal Capillary Endothelial Cells. Front Cell Dev Biol 2021;9:738341. [PMID: 34970541 DOI: 10.3389/fcell.2021.738341] [Reference Citation Analysis]
538 Lee J, Lee WJ. Understanding Diabetes for Reconstruction. Diabetic Foot Reconstruction 2022. [DOI: 10.1007/978-981-16-9816-3_1] [Reference Citation Analysis]
539 Sturiale A, Fabiani B, Porzio FC, Brusciano L, Menconi C, Naldini G. Anorectal Physiology Assessment in Patients with Anal Fistula: When Necessary. Anal Fistula and Abscess 2022. [DOI: 10.1007/978-3-030-76670-2_11] [Reference Citation Analysis]
540 Bhattacharjee H, Barman M, Garg M. Diabetic Retinopathy and Diabetic Macular Edema: Fighting the Emerging Global Burden. Diabetic Macular Edema 2022. [DOI: 10.1007/978-981-19-7307-9_20] [Reference Citation Analysis]
541 Sukhorukikh O, Bessonova T, Fedina E, Omelyanovskiy V. Economic evaluation of providing patients with test strips for blood glucose level monitoring with a frequency indicated in clinical guidelines in the Russian Federation. Med Tech Asses and Choice 2022. [DOI: 10.17116/medtech20224401142] [Reference Citation Analysis]
542 Peltier AC. Treatment of diabetic polyneuropathy. Diabetic Neuropathy 2022. [DOI: 10.1016/b978-0-12-820669-0.00021-9] [Reference Citation Analysis]
543 Yagihashi S. Pathologic basis for diabetic neuropathy in humans. Diabetic Neuropathy 2022. [DOI: 10.1016/b978-0-12-820669-0.00003-7] [Reference Citation Analysis]
544 Lovre D, Thethi TK. Natural Course (Stages/Evidence-Based Discussion). Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_4] [Reference Citation Analysis]
545 Fonseca V, Bhatnagar A, Chamarthi GD. Historical Background of Diabetic Kidney Disease. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_1] [Reference Citation Analysis]
546 da Conceição Chaves de Lemos M. Carbohydrate Counting. Endocrinology and Diabetes 2022. [DOI: 10.1007/978-3-030-90684-9_40] [Reference Citation Analysis]
547 Ishikawa Y, Lewis RD, Laing EM, Anderson AK, Zhang D, Quyyumi AA, Dunbar SB, Trivedi-kapoor R, L. P. Sattler E. Prevalence and Trends of Type 2 Diabetes Mellitus and Prediabetes among Community-Dwelling Heart Failure Patients in the United States. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
548 Müller-wieland D, Marx N. Herz und Diabetes. Klinische Kardiologie 2022. [DOI: 10.1007/978-3-662-62939-0_12-1] [Reference Citation Analysis]
549 Conway B, Goddard J, Jaap A, Patrick A. Management of Diabetic Nephropathy. Primer on Nephrology 2022. [DOI: 10.1007/978-3-030-76419-7_38] [Reference Citation Analysis]
550 Gluba-brzózka A, Rysz J, Franczyk B, Banach M. Dyslipidemia and Diabetes. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_15] [Reference Citation Analysis]
551 Michnik K, Mularczyk M, Stępień-słodkowska M. Anthropometric measures and biomarkers for cardiovascular disease risk factors: evidence from a study of Polish adults participating in the cardiovascular disease prevention program (CHUK). Anthropological Review 2022;84:431-41. [DOI: 10.2478/anre-2021-0025] [Reference Citation Analysis]
552 Ralbovsky NM, Lednev IK. Infrared and Raman Spectroscopy Assisted Diagnosis of Diabetics. Springer Series on Bio- and Neurosystems 2022. [DOI: 10.1007/978-3-030-99728-1_7] [Reference Citation Analysis]
553 Krikorian AA, Calimag APP. Glycemic Control. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_21] [Reference Citation Analysis]
554 Romeo GR, Silva PS, Cavallerano J. Diabetes Mellitus. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_294] [Reference Citation Analysis]
555 Nsubuga MJ, Pierre-jerome C. The surgical approach and follow-up of the complicated Charcot foot: general considerations. The Essentials of Charcot Neuroarthropathy 2022. [DOI: 10.1016/b978-0-323-99352-4.00019-x] [Reference Citation Analysis]
556 Geitung JT, Borthne AS, Pierre-jerome C. Epidemiology and socioeconomic impact of diabetes and Charcot neuroarthropathy. The Essentials of Charcot Neuroarthropathy 2022. [DOI: 10.1016/b978-0-323-99352-4.00001-2] [Reference Citation Analysis]
557 Hendrieckx C, de Wit M, Gray SM, van Duinkerken E, Snoek FJ. Diabetes Mellitus: A Biopsychosocial Perspective. Comprehensive Clinical Psychology 2022. [DOI: 10.1016/b978-0-12-818697-8.00206-5] [Reference Citation Analysis]
558 Braune K, Lal RA, Petruželková L, Scheiner G, Winterdijk P, Schmidt S, Raimond L, Hood KK, Riddell MC, Skinner TC, Raile K, Hussain S; OPEN International Healthcare Professional Network and OPEN Legal Advisory Group. Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals. Lancet Diabetes Endocrinol 2022;10:58-74. [PMID: 34785000 DOI: 10.1016/S2213-8587(21)00267-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 28.0] [Reference Citation Analysis]
559 American Diabetes Association Professional Practice Committee. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S97-S112. [PMID: 34964871 DOI: 10.2337/dc22-S007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 74.0] [Reference Citation Analysis]
560 Sharma A, Parachuri N, Kumar N, Saboo B, Tripathi HN, Kuppermann BD, Bandello F. Semaglutide and the risk of diabetic retinopathy-current perspective. Eye (Lond) 2022;36:10-1. [PMID: 34373613 DOI: 10.1038/s41433-021-01741-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
561 Suda N, Lee HJ. Initial Diagnosis and Management of Type 2 Diabetes Mellitus. A Case-Based Guide to Clinical Endocrinology 2022. [DOI: 10.1007/978-3-030-84367-0_39] [Reference Citation Analysis]
562 Das T, Nandy S, Mukherjee A, Nongdam P, Dey A. Plant Essential Oils for Combating Antimicrobial Resistance via Re-potentiating the Fading Antibiotic Arsenal. Antimicrobial Resistance 2022. [DOI: 10.1007/978-981-16-3120-7_15] [Reference Citation Analysis]
563 Eng E, Quaggin S. Putting it All Together: Practical Approach to the Patient with Diabetic Kidney Disease. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_29] [Reference Citation Analysis]
564 Røikjer J, Ejskjaer N. The conundrum and enigma of painful and painless neuropathy. Diabetic Neuropathy 2022. [DOI: 10.1016/b978-0-12-820669-0.00012-8] [Reference Citation Analysis]
565 Hettiarachchi C, Malagutti N, Nolan CJ, Suominen H, Daskalaki E. Non-linear Continuous Action Spaces for Reinforcement Learning in Type 1 Diabetes. AI 2022: Advances in Artificial Intelligence 2022. [DOI: 10.1007/978-3-031-22695-3_39] [Reference Citation Analysis]
566 Barbosa GC, Silva AG, Susanna BN, Mazzeo TM, Bermudes FH, Machado CG, Gomes AV. Pain Perception of Patients Undergoing Laser Panretinal Photocoagulation: Comparison of Single-Spot Versus Multispot Techniques. Ophthalmic Surg Lasers Imaging Retina 2022;53:40-5. [PMID: 34982007 DOI: 10.3928/23258160-20211223-01] [Reference Citation Analysis]
567 Tschiedel B, Puñales M. Insulin Therapy. Endocrinology and Diabetes 2022. [DOI: 10.1007/978-3-030-90684-9_32] [Reference Citation Analysis]
568 Akil H, Burgess J, Nevitt S, Harding SP, Alam U, Burgess P. Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review. Diabetes Ther 2022;13:1-23. [PMID: 34928488 DOI: 10.1007/s13300-021-01190-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
569 American Diabetes Association Professional Practice Committee. 12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S185-94. [PMID: 34964887 DOI: 10.2337/dc22-S012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 40.0] [Reference Citation Analysis]
570 Borot S. Cent ans après la découverte de l’insuline : une nouvelle révolution pour les patients vivant avec un diabète de type 1 ? Biologie Aujourd’hui 2022;216:29-35. [DOI: 10.1051/jbio/2022005] [Reference Citation Analysis]
571 Purohit B, Kumar A, Mahato K, Chandra P. Continuous Glucose Monitoring for Diabetes Management Based on Miniaturized Biosensors. Miniaturized Biosensing Devices 2022. [DOI: 10.1007/978-981-16-9897-2_7] [Reference Citation Analysis]
572 Williams ME, Stanton RC. Nutritional and metabolic management of the diabetic patient with chronic kidney disease and chronic renal failure. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00006-9] [Reference Citation Analysis]
573 Mao Y, Zhong W. Changes of insulin resistance status and development of complications in type 1 diabetes mellitus: Analysis of DCCT/EDIC study. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
574 American Diabetes Association Professional Practice Committee. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S46-59. [PMID: 34964869 DOI: 10.2337/dc22-S004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 45.0] [Reference Citation Analysis]
575 Lopez LN, Wang W, Loomba L, Afkarian M, Butani L. Diabetic kidney disease in children and adolescents: an update. Pediatr Nephrol 2022;37:2583-97. [PMID: 34913986 DOI: 10.1007/s00467-021-05347-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
576 Tuazon J, Cho J. Screening, Early Diagnosis, Genetic Markers and Predictors of Progression. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_8] [Reference Citation Analysis]
577 Mustonen J, Rautiainen P, Lamidi ML, Lavikainen P, Martikainen J, Laatikainen T. Marked Improvement in A1C Levels After Initiation of Intermittently Scanned Continuous Glucose Monitoring Is Maintained Over 4 Years in Patients With Type 1 Diabetes. Diabetes Spectr 2022;35:469-75. [PMID: 36545258 DOI: 10.2337/ds21-0087] [Reference Citation Analysis]
578 Shan J, Ma CJ, Sun CQ. Neovascular Glaucoma in Proliferative Diabetic Retinopathy. Essentials in Ophthalmology 2022. [DOI: 10.1007/978-3-031-11720-6_6] [Reference Citation Analysis]
579 Fouque D. Dietary interventions to slow the progression of chronic kidney disease and improve metabolic control of uremia. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00023-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
580 Boettcher C, Tittel SR, Meissner T, Gohlke B, Stachow R, Dost A, Wunderlich S, Lowak I, Lanzinger S. Sex differences over time for glycemic control, pump use and insulin dose in patients aged 10-40 years with type 1 diabetes: a diabetes registry study. BMJ Open Diabetes Res Care 2021;9:e002494. [PMID: 34969693 DOI: 10.1136/bmjdrc-2021-002494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
581 Vujčić S, Stefanović T, Zeljković A, Mihajlović M, Vekić J. Biomarkers of dyslipidemia in patients with diabetic foot. Arhiv za farmaciju 2022;72:184-192. [DOI: 10.5937/arhfarm72-36296] [Reference Citation Analysis]
582 Sheer R, Nair R, Pasquale MK, Evers T, Cockrell M, Gay A, Singh R, Schmedt N. Predictive Risk Models to Identify Patients at High-Risk for Severe Clinical Outcomes With Chronic Kidney Disease and Type 2 Diabetes. J Prim Care Community Health 2022;13:21501319211063726. [PMID: 35068244 DOI: 10.1177/21501319211063726] [Reference Citation Analysis]
583 Tsai JC, Wand M. Neovascular Glaucoma. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_157] [Reference Citation Analysis]
584 Shirazian S, Maesaka JK, Imbriano LJ, Mattana J. Computerized Clinical Decision Support. Diabetes and Kidney Disease 2022. [DOI: 10.1007/978-3-030-86020-2_22] [Reference Citation Analysis]
585 Gu Hong WC, Ferri J, Ampudia-blasco FJ, Martín-brufau R, Peiró M, Benito E, Martinez-hervas S, Sanz MJ, Real JT. Effect of personality on blood glucose control in patients with type 1 diabetes. Endocrinología, Diabetes y Nutrición 2022. [DOI: 10.1016/j.endinu.2021.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
586 Caramori ML, Rossing P. Diabetic Kidney Disease: Identification, Prevention, and Treatment. Precision Medicine in Diabetes 2022. [DOI: 10.1007/978-3-030-98927-9_7] [Reference Citation Analysis]
587 Ceriello A, Prattichizzo F, Phillip M, Hirsch IB, Mathieu C, Battelino T. Glycaemic management in diabetes: old and new approaches. Lancet Diabetes Endocrinol 2022;10:75-84. [PMID: 34793722 DOI: 10.1016/S2213-8587(21)00245-X] [Cited by in Crossref: 26] [Cited by in F6Publishing: 7] [Article Influence: 26.0] [Reference Citation Analysis]
588 Freichel M, Klinge A. Diabetes mellitus. Arzneiverordnungs-Report 2022 2022. [DOI: 10.1007/978-3-662-66303-5_10] [Reference Citation Analysis]
589 Sun JK, Aiello LP. Nonproliferative and Proliferative Diabetic Retinopathy. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_24] [Reference Citation Analysis]
590 Reindl-schwaighofer R, Oberbauer R. Niereninsuffizienz und Nierenersatztherapie. Die Urologie 2022. [DOI: 10.1007/978-3-642-41168-7_62-2] [Reference Citation Analysis]
591 Pierre-jerome C. The nervous system: innervations of the skeleton; bone homeostasis; and peripheral neuropathies (Baxter’s neuropathy, tarsal tunnel syndrome, and peroneal neuropathy). The Essentials of Charcot Neuroarthropathy 2022. [DOI: 10.1016/b978-0-323-99352-4.00009-7] [Reference Citation Analysis]
592 Bassam BA, Bertorini TE. Neuromuscular Manifestations of Acquired Metabolic, Endocrine, and Nutritional Disorders. Neuromuscular Disorders 2022. [DOI: 10.1016/b978-0-323-71317-7.00021-4] [Reference Citation Analysis]
593 Aswin M, Mohan V. Diabetes and Hypertension: What Is the Connection? Hypertension and Cardiovascular Disease in Asia 2022. [DOI: 10.1007/978-3-030-95734-6_12] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
594 Chan W, Sobrin L. Epidemiology and Genetics of Diabetic Retinopathy. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_35] [Reference Citation Analysis]
595 Conti G, Postelmans L, Dorchy H. Screening for diabetic retinopathy with fluorescein angiography in patients with type 1 diabetes from adolescence to adult life. A retrospective study of the past 30 years of clinical practice in a tertiary Belgian centre. Endocrino Diabet & Metabol 2022;5. [DOI: 10.1002/edm2.304] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
596 Türe M, Akın A, Unal E, Kan A, Savaş S. Electrocardiographic data of children with type 1 diabetes mellitus. Cardiol Young 2022;32:106-10. [PMID: 34724995 DOI: 10.1017/S1047951121004376] [Reference Citation Analysis]
597 John J, Naik GT, Rashmi SC, Zille SV, Iyer SS, Neeralagi M, M.k A. Correlation of Serum Bilirubin Levels in Type 2 Diabetes Mellitus Patients with and without Diabetic Retinopathy. jemds 2021;10:4013-4018. [DOI: 10.14260/jemds/2021/810] [Reference Citation Analysis]
598 Montevirgen R, Mendoza KB, Lopez LK. The Impact of the Filipino Plate Method versus Standard Nutrition Education on Food Group Proportions and 2-hour Postprandial Blood Glucose for Type 2 Diabetes. J ASEAN Fed Endocr Soc 2021;36:142-8. [PMID: 34966197 DOI: 10.15605/jafes.036.02.03] [Reference Citation Analysis]
599 Vella A. Choosing Medications for Type 2 Diabetes – What Weighting Should Be Given to Cardiovascular Risk Reduction? Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch14] [Reference Citation Analysis]
600 Gonzales K, Smith SA. Does HbA1c Remain the Most Important Therapeutic Target in Outpatient Management of Diabetes? Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch8] [Reference Citation Analysis]
601 Ahmed S, Tirumalasetty S, Fonseca V. Screening Patients with Prediabetes and Diabetes for Cardiovascular Disease. Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch13] [Reference Citation Analysis]
602 Barkmeier AJ, Astafurov K. Diagnosis and Management of Ophthalmic Complications of Diabetes. Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch21] [Reference Citation Analysis]
603 Almokayyad R, Cuddihy R. What Is the Role of Self‐Monitoring in Diabetes? Is There a Role for Postprandial Glucose Monitoring? How Does Continuous Glucose Monitoring Integrate into Clinical Practice? Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch7] [Reference Citation Analysis]
604 Sharma S, Gillespie P, Hobbins A, Dinneen SF. Estimating the cost of type 1 diabetes in Ireland. Diabet Med 2021;:e14779. [PMID: 34958713 DOI: 10.1111/dme.14779] [Reference Citation Analysis]
605 McIllhatton A, Lanting S, Lambkin D, Leigh L, Casey S, Chuter V. Reliability of recommended non-invasive chairside screening tests for diabetes-related peripheral neuropathy: a systematic review with meta-analyses. BMJ Open Diabetes Res Care 2021;9:e002528. [PMID: 34952841 DOI: 10.1136/bmjdrc-2021-002528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
606 Gemelas J, Marino M, Valenzuela S, Schmidt T, Suchocki A, Huguet N. Changes in diabetes prescription patterns following Affordable Care Act Medicaid expansion. BMJ Open Diabetes Res Care 2021;9:e002135. [PMID: 34933870 DOI: 10.1136/bmjdrc-2021-002135] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
607 Rivera PA, Rodríguez-Zúñiga MJM, Caballero-Alvarado J, Fiestas F. Glycated hemoglobin as a surrogate for evaluating the effectiveness of drugs in diabetes mellitus trials: a systematic review and trial-level meta-analysis. Int J Technol Assess Health Care 2021;38:e12. [PMID: 34933703 DOI: 10.1017/S0266462321001689] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
608 Ipp E. Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness. Front Endocrinol (Lausanne) 2021;12:734360. [PMID: 34912295 DOI: 10.3389/fendo.2021.734360] [Reference Citation Analysis]
609 Mohamed IAA, Talaat IM, Alghamdi HA, Allam G. Role of free style Libre-Flash Glucose Monitoring: Glycemic control of Type-1 Diabetes. Pak J Med Sci 2021;37:1883-9. [PMID: 34912412 DOI: 10.12669/pjms.37.7.4114] [Reference Citation Analysis]
610 Allen LA, Dayan CM. Immunotherapy for type 1 diabetes. Br Med Bull 2021;140:76-90. [PMID: 34893820 DOI: 10.1093/bmb/ldab027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
611 Rouf S, Ezzerrouqi A, Benyakhlef S, Abda N, Latrech H. Flexible insulin therapy improves metabolic control and decreases the risk of hypoglycemia in type 1 diabetic patients. Pan Afr Med J 2021;40:100. [PMID: 34909088 DOI: 10.11604/pamj.2021.40.100.18097] [Reference Citation Analysis]
612 Ramallo-Fariña Y, Rivero-Santana A, García-Pérez L, García-Bello MA, Wägner AM, Gonzalez-Pacheco H, Rodríguez-Rodríguez L, Kaiser-Girardot S, Monzón-Monzón G, Guerra-Marrero C, Daranas-Aguilar C, Roldán-Ruano M, Carmona M, Serrano-Aguilar PG; INDICA Team. Patient-reported outcome measures for knowledge transfer and behaviour modification interventions in type 2 diabetes-the INDICA study: a multiarm cluster randomised controlled trial. BMJ Open 2021;11:e050804. [PMID: 34911711 DOI: 10.1136/bmjopen-2021-050804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
613 Batalha APDB, Ponciano IC, Chaves G, Felício DC, Britto RR, da Silva LP. Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c. J Diabetes Metab Disord 2021;20:1815-36. [PMID: 34900827 DOI: 10.1007/s40200-021-00846-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
614 Madani S, Setudeh A, Aghayan HR, Alavi-Moghadam S, Rouhifard M, Rezaei N, Rostami P, Mohsenipour R, Amirkashani D, Bandarian F, Arjmand B, Larijani B. Placenta derived Mesenchymal Stem Cells transplantation in Type 1 diabetes: preliminary report of phase 1 clinical trial. J Diabetes Metab Disord 2021;20:1179-89. [PMID: 34900770 DOI: 10.1007/s40200-021-00837-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
615 Elbarbary N, Moser O, Al Yaarubi S, Alsaffar H, Al Shaikh A, Ajjan RA, Deeb A. Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes. Diab Vasc Dis Res 2021;18:14791641211062155. [PMID: 34898300 DOI: 10.1177/14791641211062155] [Reference Citation Analysis]
616 Lin T, Gubitosi-Klug RA, Channa R, Wolf RM. Pediatric Diabetic Retinopathy: Updates in Prevalence, Risk Factors, Screening, and Management. Curr Diab Rep 2021;21:56. [PMID: 34902076 DOI: 10.1007/s11892-021-01436-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
617 Rodríguez-Gutiérrez R, Millan-Alanis JM, Barrera FJ, McCoy RG. Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes. Curr Diab Rep 2021;21:63. [PMID: 34902079 DOI: 10.1007/s11892-021-01433-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
618 Alimova IL. Clinical guidelines «Children with diabetes mellitus type 1, 2020”: what a pediatrician needs to know. Ross vestn perinatol pediatr 2021;66:109-117. [DOI: 10.21508/1027-4065-2021-66-5-109-117] [Reference Citation Analysis]
619 Burgess J, Petropoulos I, Gad H, Nevitt SJ, Ponirakis G, Ferdousi M, Kalteniece A, Azmi S, Kaye S, Malik RA, Alam U. Corneal confocal microscopy for the diagnosis of diabetic sensorimotor polyneuropathy in people with type 1 and 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2021;2021. [DOI: 10.1002/14651858.cd014675] [Reference Citation Analysis]
620 Zhang X, Yang X, Sun B, Zhu C. Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review. Commun Biol 2021;4:1366. [PMID: 34876671 DOI: 10.1038/s42003-021-02896-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
621 Wilhelm-Benartzi CS, Miller SE, Bruggraber S, Picton D, Wilson M, Gatley K, Chhabra A, Marcovecchio ML, Hendriks AEJ, Morobé H, Chmura PJ, Bond S, Aschemeier-Fuchs B, Knip M, Tree T, Overbergh L, Pall J, Arnaud O, Haller MJ, Nitsche A, Schulte AM, Mathieu C, Mander A, Dunger D. Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes. BMJ Open 2021;11:e053669. [PMID: 34876434 DOI: 10.1136/bmjopen-2021-053669] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
622 Rose S, Styles SE, Wiltshire EJ, Stanley J, Galland BC, de Bock MI, Tomlinson PA, Rayns JA, MacKenzie KE, Wheeler BJ. Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes-Extension phase outcomes following a 6-month randomized control trial. Diabet Med 2021;:e14756. [PMID: 34862661 DOI: 10.1111/dme.14756] [Reference Citation Analysis]
623 Nwanyanwu KMJH, Nunez-Smith M, Gardner TW, Desai MM. Awareness of Diabetic Retinopathy: Insight From the National Health and Nutrition Examination Survey. Am J Prev Med 2021;61:900-9. [PMID: 34426057 DOI: 10.1016/j.amepre.2021.05.018] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
624 Ulutas HG, Guclu M, Aslanci ME, Karatas G. The relationship between carotid intima-media thickness and microvascular changes in retinal zones and optic disc in patients with type 1 diabetes mellitus. Eur J Ophthalmol 2021;:11206721211064024. [PMID: 34851200 DOI: 10.1177/11206721211064024] [Reference Citation Analysis]
625 Kim JH, Shin CH, Yang SW. History of insulin treatment of pediatric patients with diabetes in Korea. Ann Pediatr Endocrinol Metab 2021;26:237-41. [PMID: 34991301 DOI: 10.6065/apem.2142242.121] [Reference Citation Analysis]
626 Aleppo G, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, Buse JB, McGill JB, Martens T, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Price D, Bergenstal RM; MOBILE Study Group, Type 2 Diabetes Basal Insulin Users: The Mobile Study (MOBILE) Study Group:. The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-37. [PMID: 34588210 DOI: 10.2337/dc21-1304] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
627 Şen S, Özalp Kızılay D, Taneli F, Özen Ç, Ertan P, Özunan İ, Yıldız R, Ersoy B. Urinary NGAL is a Potential Biomarker for Early Renal Injury in Insulin Resistant Obese Non-diabetic Children. J Clin Res Pediatr Endocrinol 2021;13:400-7. [PMID: 34013756 DOI: 10.4274/jcrpe.galenos.2021.2021.0020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
628 Sharma PK, Rajpal N, Upadhyay S, Shaha D, Deo N. Status of diabetes control and knowledge about diabetes in patients. Endocrinol Diabetes Nutr (Engl Ed) 2021;68:716-27. [PMID: 34924160 DOI: 10.1016/j.endien.2021.12.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
629 Mathieu C, Martens PJ, Vangoitsenhoven R. One hundred years of insulin therapy. Nat Rev Endocrinol 2021;17:715-25. [PMID: 34404937 DOI: 10.1038/s41574-021-00542-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
630 Riddell MC, Shakeri D, Scott SN. A Brief Review on the Evolution of Technology in Exercise and Sport in Type 1 Diabetes: Past, Present, and Future. Diabetes Technol Ther 2021. [PMID: 34809493 DOI: 10.1089/dia.2021.0427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
631 Palmer T, Waliaula C, Shannon G, Salustri F, Grewal G, Chelagat W, Jennings HM, Skordis J. Understanding the Lived Experience of Children With Type 1 Diabetes in Kenya: Daily Routines and Adaptation Over Time. Qual Health Res 2022;32:145-58. [PMID: 34841984 DOI: 10.1177/10497323211049775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
632 Falcetta P, Aragona M, Bertolotto A, Bianchi C, Campi F, Garofolo M, Del Prato S. Insulin discovery: A pivotal point in medical history. Metabolism 2021;127:154941. [PMID: 34838778 DOI: 10.1016/j.metabol.2021.154941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
633 Nicholl DDM, Whitelaw JP, Weir RV, Bissonnette MLZ, Gill JS, Landsberg DN. Case Report: Absence of Clinically Significant Recurrent Diabetic Kidney Disease on Postmortem Biopsy 32 Years After Kidney Transplantation for Type 1 Diabetes. Transplant Direct 2021;7:e790. [PMID: 34805492 DOI: 10.1097/TXD.0000000000001240] [Reference Citation Analysis]
634 Wysocka-Mincewicz M, Baszyńska-Wilk M, Mazur M, Byczyńska A, Nowacka-Gotowiec M. Thyroid Hormones, Peripheral White Blood Count, and Dose of Basal Insulin Are Associated with Changes in Nerve Conduction Studies in Adolescents with Type 1 Diabetes. Metabolites 2021;11:795. [PMID: 34822453 DOI: 10.3390/metabo11110795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
635 Jaffa MA, Gebregziabher M, Jaffa AA. Shared parameter and copula models for analysis of semicontinuous longitudinal data with nonrandom dropout and informative censoring. Stat Methods Med Res 2021;:9622802211060519. [PMID: 34806502 DOI: 10.1177/09622802211060519] [Reference Citation Analysis]
636 Pothen L, Balligand JL. Legacy in Cardiovascular Risk Factors Control: From Theory to Future Therapeutic Strategies? Antioxidants (Basel) 2021;10:1849. [PMID: 34829720 DOI: 10.3390/antiox10111849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
637 Krauss A. Assessing the Overall Validity of Randomised Controlled Trials. International Studies in the Philosophy of Science. [DOI: 10.1080/02698595.2021.2002676] [Reference Citation Analysis]
638 Riveline JP, Vergés B, Detournay B, Picard S, Benhamou PY, Bismuth E, Bordier L, Jeandidier N, Joubert M, Roussel R, Sola-Gazagnes A, Bonnefond A, Clavel S, Velayoudom FL, Beltrand J, Hanaire H, Fontaine P, Thivolet C, Servy H, Tubiana S, Lion S, Gautier JF, Larger E, Vicaut E, Sablone L, Fagherazzi G, Cosson E. Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT1 study. Diabetes Metab 2021;48:101306. [PMID: 34813929 DOI: 10.1016/j.diabet.2021.101306] [Reference Citation Analysis]
639 Xu J, Zuo C. The Fate Status of Stem Cells in Diabetes and its Role in the Occurrence of Diabetic Complications. Front Mol Biosci 2021;8:745035. [PMID: 34796200 DOI: 10.3389/fmolb.2021.745035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
640 Bell E, Binkowski S, Sanderson E, Keating B, Smith G, Harray AJ, Davis EA. Substantial Intra-Individual Variability in Post-Prandial Time to Peak in Controlled and Free-Living Conditions in Children with Type 1 Diabetes. Nutrients 2021;13:4154. [PMID: 34836409 DOI: 10.3390/nu13114154] [Reference Citation Analysis]
641 Bosetti R, Tabatabai L, Naufal G, Menser T, Kash B. Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review. PLoS One 2021;16:e0260139. [PMID: 34793562 DOI: 10.1371/journal.pone.0260139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
642 Simonsen M, Skipper L, Skipper N, Thingholm PR. Discontinuity in care: Practice closures among primary care providers and patient health care utilization. J Health Econ 2021;80:102551. [PMID: 34785433 DOI: 10.1016/j.jhealeco.2021.102551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Sharma MK, Chauhan J, Kumar M, Joshi CK, Sharma S, Lal C. Prospects of Aloe vera and its Bioactive Compounds in Diabetes: Critical Review. J Pure Appl Microbiol 2021;15:1781-97. [DOI: 10.22207/jpam.15.4.54] [Reference Citation Analysis]
644 Wołos-Kłosowicz K, Bandurska-Stankiewicz E. Effects of common weight loss plans on diabetes mellitus and cardiovascular risk factors. Prim Care Diabetes 2021:S1751-9918(21)00193-5. [PMID: 34802979 DOI: 10.1016/j.pcd.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
645 Nathan DM, Krause-Steinrauf H, Braffett BH, Arends VL, Younes N, McGee P, Lund C, Johnson M, Lorenzi G, Gao X, Steffes MW, Lachin JM; GRADE Research Group., DCCT/EDIC Research Group. Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies. PLoS One 2021;16:e0257154. [PMID: 34780485 DOI: 10.1371/journal.pone.0257154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
646 Otten J, Tavelin B, Söderberg S, Rolandsson O. Fasting C-peptide at type 2 diabetes diagnosis is an independent risk factor for total and cancer mortality. Diabetes Metab Res Rev 2021;:e3512. [PMID: 34780669 DOI: 10.1002/dmrr.3512] [Reference Citation Analysis]
647 Mustonen E, Hörhammer I, Patja K, Absetz P, Lammintakanen J, Talja M, Kuronen R, Linna M. Eight-year post-trial follow-up of morbidity and mortality of telephone health coaching. BMC Health Serv Res 2021;21:1237. [PMID: 34781936 DOI: 10.1186/s12913-021-07263-w] [Reference Citation Analysis]
648 Desimone ME, Sherwood J, Soltman SC, Moran A. Telemedicine in cystic fibrosis. J Clin Transl Endocrinol 2021;26:100270. [PMID: 34765457 DOI: 10.1016/j.jcte.2021.100270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
649 Cefalu WT, Andersen DK, Arreaza-Rubín G, Pin CL, Sato S, Verchere CB, Woo M, Rosenblum ND; symposium planning committee, moderators, and speakers. Heterogeneity of Diabetes: β-Cells, Phenotypes, and Precision Medicine: Proceedings of an International Symposium of the Canadian Institutes of Health Research's Institute of Nutrition, Metabolism and Diabetes and the U.S. National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases. Can J Diabetes 2021:S1499-2671(21)00396-8. [PMID: 34794897 DOI: 10.1016/j.jcjd.2021.09.126] [Reference Citation Analysis]
650 Mata-Moret L, Hernández-Bel L, Hernandez-Garfella ML, Castro-Navarro V, Chiarri-Toumit C, Cervera-Taulet E. Acute panendothelial retinal leakage in a patient with diabetes mellitus type 1 with a poor metabolic control. Arch Soc Esp Oftalmol (Engl Ed) 2021;96:598-601. [PMID: 34756282 DOI: 10.1016/j.oftale.2020.09.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
651 Nguyen TT, Nguyen TTD, Tran NM, Vo GV. Advances of microneedles in hormone delivery. Biomed Pharmacother 2021;145:112393. [PMID: 34773762 DOI: 10.1016/j.biopha.2021.112393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
652 Ünsal YA, Gül ÖÖ, Gürbüz B, Cander S, Aydemir E, Ersoy C. Effects of continuous subcutaneous insulin infusion on clinical parameters in patients with different sociodemographic and clinical characteristics. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-01025-4] [Reference Citation Analysis]
653 Lane WS, Weinrib SL, Lawrence MJ, Lane BC, Jarrett RT. Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial. Endocr Pract 2021:S1530-891X(21)01294-5. [PMID: 34763071 DOI: 10.1016/j.eprac.2021.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
654 Bolli GB, Porcellati F, Lucidi P, Fanelli CG, Owens DR. One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs. Metabolism 2021;126:154935. [PMID: 34762931 DOI: 10.1016/j.metabol.2021.154935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
655 Pintaudi B, Scatena A, Piscitelli G, Frison V, Corrao S, Manicardi V, Graziano G, Chiara Rossi M, Gallo M, Mannino D, Nicolucci A, Di Bartolo P. Clinical profiles and quality of care of adults with type 1 diabetes according to their cardiovascular Risk: A Multicenter, Observational, retrospective study. Diabetes Res Clin Pract 2021;182:109131. [PMID: 34762997 DOI: 10.1016/j.diabres.2021.109131] [Reference Citation Analysis]
656 Holt RIG, DeVries JH, Hess-Fischl A, Hirsch IB, Kirkman MS, Klupa T, Ludwig B, Nørgaard K, Pettus J, Renard E, Skyler JS, Snoek FJ, Weinstock RS, Peters AL. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2021;44:2589-625. [PMID: 34593612 DOI: 10.2337/dci21-0043] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 45.5] [Reference Citation Analysis]
657 González de Buitrago Amigo J, González García A, Díaz Fernández P, Fernández Llamas M, Tejado Bravo ML, de Nicolás Jiménez JM, Ferrer Lozano M. Impacto de faster aspart sobre el control glucémico en niños y adolescentes con diabetes tipo 1 en tratamiento con un sistema integrado. Anales de Pediatría 2021;95:321-329. [DOI: 10.1016/j.anpedi.2020.11.002] [Reference Citation Analysis]
658 Vartak T, Godson C, Brennan E. Therapeutic potential of pro-resolving mediators in diabetic kidney disease. Adv Drug Deliv Rev 2021;178:113965. [PMID: 34508793 DOI: 10.1016/j.addr.2021.113965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
659 Maffeis C, Olivieri F, Peverelli P, Cendon M, Tomasselli F, Tommasi M, Trandev T, Fornari E, Piona C, Morandi A, Maguolo A. Sex differences in cardiovascular risk factors of children and adolescents with type 1 diabetes mellitus: A role for diet? Nutrition, Metabolism and Cardiovascular Diseases 2021. [DOI: 10.1016/j.numecd.2021.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
660 Campochiaro PA. Retinal and Choroidal Vascular Diseases: Past, Present, and Future: The 2021 Proctor Lecture. Invest Ophthalmol Vis Sci 2021;62:26. [PMID: 34817536 DOI: 10.1167/iovs.62.14.26] [Reference Citation Analysis]
661 Heimbürger SMN, Hoe B, Nielsen CN, Bergmann NC, Hartmann B, Holst JJ, Vilsbøll T, Dejgaard TF, Christensen MB, Knop FK. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial. Diabetologia 2021;64:2425-31. [PMID: 34405256 DOI: 10.1007/s00125-021-05547-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
662 Gómez-Peralta F, Menéndez E, Conde S, Conget I, Novials A; investigators of the studies SED and SED1. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study. Endocrinol Diabetes Nutr (Engl Ed) 2021;68:642-53. [PMID: 34906345 DOI: 10.1016/j.endien.2021.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
663 Park H, Lee DY, Park SY, Min J, Shinn J, Lee DH, Kwon SH, Kim H, Kim NH. Development of a Predictive Model for Glycated Hemoglobin Values and Analysis of the Factors Affecting It. CPP 2021;3:106-114. [DOI: 10.36011/cpp.2021.3.e14] [Reference Citation Analysis]
664 Owens DR, Monnier L, Ceriello A, Bolli GB. Insulin Centennial: Milestones influencing the development of insulin preparations since 1922. Diabetes Obes Metab 2021. [PMID: 34708913 DOI: 10.1111/dom.14587] [Reference Citation Analysis]
665 Dena M, Svensson AM, Olofsson KE, Young L, Carlson A, Miller K, Grimsmann J, Welp R, Mader JK, Maahs DM, Holl RW, Lind M. Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1 Diabetes. Diabetes Ther 2021;12:3093-105. [PMID: 34697764 DOI: 10.1007/s13300-021-01169-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
666 Khan S. Wogonin and alleviation of hyperglycemia via inhibition of DAG mediated PKC expression. A brief insight. Protein Pept Lett 2021. [PMID: 34711151 DOI: 10.2174/0929866528666211027113349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
667 Amoabeng KA, Laurila S, Juárez-orozco LE, Marthinsen ABL, Moczulski D, Rebelos E, Dadson P. The utilization of positron emission tomography in the evaluation of renal health and disease. Clin Transl Imaging. [DOI: 10.1007/s40336-021-00469-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
668 Yeoh E, Png D, Koh PL, Sum CF, Lim SC, Tan HH, Ubeynarayana CU, Subramaniam T. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme. Diabet Med 2021;:e14733. [PMID: 34698420 DOI: 10.1111/dme.14733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
669 Janez A, Battelino T, Klupa T, Kocsis G, Kuricová M, Lalić N, Stoian AP, Prázný M, Rahelić D, Šoupal J, Tankova T, Zelinska N. Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe. Diabetes Ther 2021;12:3107-35. [PMID: 34694585 DOI: 10.1007/s13300-021-01160-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
670 Watha K, Davenport A, Tangvoraphonkchai K. Changes in blood glucose and lactate concentrations with hemodialysis. Artif Organs 2022;46:138-45. [PMID: 34695248 DOI: 10.1111/aor.14097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
671 Shi Q, Lin Y, Fonseca VA, Shi L. Optimizing treatment goals for long-term health outcomes among patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care 2021;9:e002396. [PMID: 34675042 DOI: 10.1136/bmjdrc-2021-002396] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
672 Xue T, Zhang X, Xing Y, Liu S, Zhang L, Wang X, Yu M. Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy. Front Pharmacol 2021;12:748193. [PMID: 34671261 DOI: 10.3389/fphar.2021.748193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
673 Tran PMH, Kim E, Tran LKH, Khaled BS, Hopkins D, Gardiner M, Bryant J, Bernard R, Morgan J, Bode B, Reed JC, She JX, Purohit S. T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications. Int J Environ Res Public Health 2021;18:11094. [PMID: 34769614 DOI: 10.3390/ijerph182111094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
674 Sun S, Hisland L, Grenet G, Gueyffier F, Cornu C, Jaafari N, Boussageon R. Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials. Therapie 2021:S0040-5957(21)00207-9. [PMID: 34782145 DOI: 10.1016/j.therap.2021.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
675 Khadanga S, Singh G, Pakhare AP, Joshi R. Diagnostic Accuracy of Point-of-Care Tests Measuring Glycosylated Haemoglobin (HbA1c) for Glycemic Control: A Field Study in India. Cureus 2021;13:e17920. [PMID: 34660113 DOI: 10.7759/cureus.17920] [Reference Citation Analysis]
676 Yu D, Dou X, Chen J, Lu Y, Ye B, Wu X, Wu Z, Li Q, Tian X, Zhou B, Deng Y, Li W, Hu X, Mou L, Pu Z. Two-field non-mydriatic fundus photography for diabetic retinopathy screening: a protocol for a systematic review and meta-analysis. BMJ Open 2021;11:e051761. [PMID: 34663665 DOI: 10.1136/bmjopen-2021-051761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
677 Trukhan DI. Relevance of self-control of blood glucose in the aspect of prevention of cardiovascular complications in patients with diabetes mellitus. Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-14-104-109] [Reference Citation Analysis]
678 Moreno-Fernandez J, Beato-Vibora P, Olvera P, Garcia-Seco JA, Gallego-Gamero F, Herrera MT, Muñoz-Rodriguez JR. Real-world outcomes of two different sensor-augmented insulin pumps with predictive low glucose suspend function in type 1 diabetes patients. Diabetes Res Clin Pract 2021;181:109093. [PMID: 34653567 DOI: 10.1016/j.diabres.2021.109093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
679 Yoshiji S, Minamino H, Tanaka D, Yamane S, Harada N, Inagaki N. Effects of Glucagon-like Peptide-1 Receptor Agonists on Cardiovascular and Renal Outcomes: A Meta-Analysis and Meta-Regression Analysis.. [DOI: 10.1101/2021.10.14.21264803] [Reference Citation Analysis]
680 González de Buitrago Amigo J, González García A, Díaz Fernández P, Fernández Llamas M, Tejado Bravo ML, de Nicolás Jiménez JM, Ferrer Lozano M. The impact of "faster aspart" on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump. An Pediatr (Engl Ed) 2021;95:321-9. [PMID: 34645579 DOI: 10.1016/j.anpede.2020.11.006] [Reference Citation Analysis]
681 Komatsu H, Qi M, Gonzalez N, Salgado M, Medrano L, Rawson J, Orr C, Omori K, Isenberg JS, Kandeel F, Mullen Y, Al-Abdullah IH. A Multiparametric Assessment of Human Islets Predicts Transplant Outcomes in Diabetic Mice. Cell Transplant 2021;30:9636897211052291. [PMID: 34628956 DOI: 10.1177/09636897211052291] [Reference Citation Analysis]
682 Franco L, Bozzetto L, Angelis R, Calabrese I, Cavagnuolo L, Gasparro T, Riccardi G, Rivellese AA, Annuzzi G. Beneficial effects on body weight of group vs individual care in adults with type 1 diabetes on advanced technologies. Health Sci Rep 2021;4:e385. [PMID: 34622019 DOI: 10.1002/hsr2.385] [Reference Citation Analysis]
683 Song C, Booth GL, Perkins BA, Weisman A. Impact of government-funded insulin pump programs on insulin pump use in Canada: a cross-sectional study using the National Diabetes Repository. BMJ Open Diabetes Res Care 2021;9:e002371. [PMID: 34615649 DOI: 10.1136/bmjdrc-2021-002371] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
684 Liu J, Wu YP, Qi JJ, Yue ZP, Hu CD. Effect of Statin Therapy on Diabetes Retinopathy in People With Type 2 Diabetes Mellitus: A Meta-Analysis. Clin Appl Thromb Hemost 2021;27:10760296211040109. [PMID: 34617462 DOI: 10.1177/10760296211040109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
685 Fort PE, Rajendiran TM, Soni T, Byun J, Shan Y, Looker HC, Nelson RG, Kretzler M, Michailidis G, Roger JE, Gardner TW, Abcouwer SF, Pennathur S, Afshinnia F. Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy. JCI Insight 2021;6:e152109. [PMID: 34437304 DOI: 10.1172/jci.insight.152109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
686 Ziegler AG, Danne T, Daniel C, Bonifacio E. 100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention. Med (N Y) 2021;2:1120-37. [PMID: 34993499 DOI: 10.1016/j.medj.2021.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
687 Stagi S, Papacciuoli V, Ciofi D, Piccini B, Farello G, Toni S, Ferrari M, Chiarelli F. Retrospective Evaluation on the Use of a New Polysaccharide Complex in Managing Paediatric Type 1 Diabetes with Metabolic Syndrome (MetS). Nutrients 2021;13:3517. [PMID: 34684518 DOI: 10.3390/nu13103517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
688 Muir R, Forbes S, Birch DJS, Vyshemirsky V, Rolinski OJ. Collagen Glycation Detected by Its Intrinsic Fluorescence. J Phys Chem B 2021;125:11058-66. [PMID: 34555903 DOI: 10.1021/acs.jpcb.1c05001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
689 Thomas RL. Delaying and preventing diabetic retinopathy. Pract Diab 2021;38:31-4. [DOI: 10.1002/pdi.2360] [Reference Citation Analysis]
690 Faulkner MS, Smart MJ. Sleep quality and heart rate variability in adolescents with type 1 or type 2 diabetes. J Diabetes Complications 2021;35:108049. [PMID: 34600825 DOI: 10.1016/j.jdiacomp.2021.108049] [Reference Citation Analysis]
691 Jendle J, Buompensiere MI, Holm AL, de Portu S, Malkin SJP, Cohen O. The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden. Diabetes Ther 2021;12:2977-91. [PMID: 34596879 DOI: 10.1007/s13300-021-01157-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
692 Piemonti L. Felix dies natalis, insulin… ceterum autem censeo "beta is better". Acta Diabetol 2021;58:1287-306. [PMID: 34027619 DOI: 10.1007/s00592-021-01737-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
693 Penfornis A, Joubert M. Place de la télésurveillance : données personnelles, données de l’expérience ETAPES et perspectives. Médecine des Maladies Métaboliques 2021;15:578-584. [DOI: 10.1016/j.mmm.2021.09.007] [Reference Citation Analysis]
694 Lee JM, Rusnak A, Garrity A, Hirschfeld E, Thomas IH, Wichorek M, Lee JE, Rioles NA, Ebekozien O, Corathers SD. Feasibility of Electronic Health Record Assessment of 6 Pediatric Type 1 Diabetes Self-management Habits and Their Association With Glycemic Outcomes. JAMA Netw Open 2021;4:e2131278. [PMID: 34709387 DOI: 10.1001/jamanetworkopen.2021.31278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
695 Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapie des Typ-1-Diabetes – Kurzfassung der S3-Leitlinie (AWMF-Registernummer: 057-013; 2. Auflage). Diabetologie und Stoffwechsel 2021;16:S142-S153. [DOI: 10.1055/a-1515-8682] [Reference Citation Analysis]
696 Schmidt S, Frandsen CS, Dejgaard TF, Vistisen D, Halldórsson T, Olsen SF, Jensen JB, Madsbad S, Andersen HU, Nørgaard K. Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump-treated type 1 diabetes. Diabetes Obes Metab 2021. [PMID: 34595827 DOI: 10.1111/dom.14567] [Reference Citation Analysis]
697 La Sala L, Pontiroli AE. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. Int J Mol Sci 2021;22:10643. [PMID: 34638984 DOI: 10.3390/ijms221910643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
698 Malhotra B, Hiteshi P, Rajput R, Bhansali A, Rastogi A. Prevalent vascular complications in people with diabetes: a multicentre observational cohort study. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-01010-x] [Reference Citation Analysis]
699 Xie P, Deng B, Zhang X, Li Y, Du C, Rui S, Deng W, Boey J, Armstrong DG, Ma Y, Deng W. Time in range in relation to amputation and all-cause mortality in hospitalised patients with diabetic foot ulcers. Diabetes Metab Res Rev 2021;:e3498. [PMID: 34587332 DOI: 10.1002/dmrr.3498] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
700 Tsoukas MA, Majdpour D, Yale JF, Fathi AE, Garfield N, Rutkowski J, Rene J, Legault L, Haidar A. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial. Lancet Digit Health 2021;3:e723-32. [PMID: 34580055 DOI: 10.1016/S2589-7500(21)00139-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
701 Kanclerz P, Tuuminen R, Khoramnia R. Imaging Modalities Employed in Diabetic Retinopathy Screening: A Review and Meta-Analysis. Diagnostics (Basel) 2021;11:1802. [PMID: 34679501 DOI: 10.3390/diagnostics11101802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
702 Sayeed MA, Banu A, Khanam PA, Begum T. Prevalence and incidence of micro- and macro-vascular complications in a diabetic population of Bangladesh: a retrospective cohort study. IMC Journal of Medical Science. [DOI: 10.55010/imcjms.16.002] [Reference Citation Analysis]
703 Breyton AE, Lambert-Porcheron S, Laville M, Vinoy S, Nazare JA. CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review. Front Endocrinol (Lausanne) 2021;12:666008. [PMID: 34566883 DOI: 10.3389/fendo.2021.666008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
704 Abiru N, Shimada A, Nishimura R, Matsuhisa M, Ozaki A, Ikegami H. Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults' Glycemia in T1DM subanalysis. Diabetol Int 2021;12:460-73. [PMID: 34567927 DOI: 10.1007/s13340-021-00504-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
705 Mohan V, Shanthi Rani CS, Saboo B, Mukhopadhyay S, Chatterjee S, Panneerselvam D, Gupta SS, Pendsey S, Chandrakanta J, Uma Sankari G, Amutha A, Sheryl S, Datta S, Gupta PK, Routary P, Jebarani S, N G S, Venkatesan U, Anjana RM, Unnikrishnan R. Clinical profile of long-term survivors and non-survivors with type 1 diabetes in India. Diabetes Technol Ther 2021. [PMID: 34569820 DOI: 10.1089/dia.2021.0284] [Reference Citation Analysis]
706 Udoh BE, Erim AE, Archibong BE, Paulinus SO, Ezeokpo BC, Agwu KK. Sonographic Optic Nerve Diameter and Clinical Biomarkers in Patients With Poorly Controlled Diabetes: A Comparative Analysis With Nondiabetic Subjects. Journal of Diagnostic Medical Sonography 2021;37:536-42. [DOI: 10.1177/87564793211044139] [Reference Citation Analysis]
707 Garcia-Tirado J, Lv D, Corbett JP, Colmegna P, Breton MD. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system. Comput Methods Programs Biomed 2021;211:106401. [PMID: 34560603 DOI: 10.1016/j.cmpb.2021.106401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
708 Huang L, Shen X, Huang L, Yan S, Wu P. Identification of independent risk factors for diabetic neuropathy progression in patients with type 2 diabetes mellitus. J Int Med Res 2021;49:3000605211044366. [PMID: 34559575 DOI: 10.1177/03000605211044366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
709 Pasqua MR, Tsoukas MA, Haidar A. Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin Therapy. J Diabetes Sci Technol 2021;15:1232-42. [PMID: 34558336 DOI: 10.1177/19322968211035411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
710 M Kabadi U. Improvement in cardiovascular and renal outcomes in type 2 diabetes: effect of glycemic control, not drugs. JDMDC 2021;8:76-77. [DOI: 10.15406/jdmdc.2021.08.00225] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
711 Frank JR, Blissett D, Hellmund R, Virdi N. Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy. Diabetes Technol Ther 2021;23:S36-44. [PMID: 34546079 DOI: 10.1089/dia.2021.0263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
712 Smigoc Schweiger D, Battelino T, Groselj U. Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes. Int J Mol Sci 2021;22:10192. [PMID: 34638531 DOI: 10.3390/ijms221910192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
713 Wright EE, Subramanian S. Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment. Diabetes Technol Ther 2021;23:S12-8. [PMID: 34546082 DOI: 10.1089/dia.2021.0191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
714 Riddle MC, Gerstein HC, Home PD. Lingering Effects of Hyperglycemia in Recently Diagnosed Diabetes During Long-term Follow-up of the DCCT/EDIC and UKPDS Cohorts: More Evidence That Early Control Matters. Diabetes Care 2021:dci210030. [PMID: 34548282 DOI: 10.2337/dci21-0030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
715 Lachin JM, Nathan DM; DCCT/EDIC Research Group. Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care 2021;44:2216-24. [PMID: 34548284 DOI: 10.2337/dc20-3097] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
716 Ipp E, Kumar M. A Clinical Conundrum: Intensifying Glycemic Control in the Presence of Advanced Diabetic Retinopathy. Diabetes Care 2021;44:2192-3. [PMID: 34548279 DOI: 10.2337/dci21-0029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
717 Runova GE. The role of glycemic self-control in diabetes management: based on the American Diabetes Association guidelines (2021). Medicinskij sovet 2021. [DOI: 10.21518/2079-701x-2021-12-286-292] [Reference Citation Analysis]
718 Hata M, Omi M, Kobayashi Y, Nakamura N, Miyabe M, Ito M, Ohno T, Imanishi Y, Himeno T, Kamiya H, Nakamura J, Miyachi H, Ozawa S, Miyazawa K, Mitani A, Nagao T, Goto S, Takebe J, Matsubara T, Naruse K. Sustainable Effects of Human Dental Pulp Stem Cell Transplantation on Diabetic Polyneuropathy in Streptozotocine-Induced Type 1 Diabetes Model Mice. Cells 2021;10:2473. [PMID: 34572120 DOI: 10.3390/cells10092473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
719 Vágvölgyi A, Maróti Á, Szűcs M, Póczik C, Urbán-Pap D, Baczkó I, Nemes A, Csajbók É, Sepp K, Kempler P, Orosz A, Várkonyi T, Lengyel C. Peripheral and Autonomic Neuropathy Status of Young Patients With Type 1 Diabetes Mellitus at the Time of Transition From Pediatric Care to Adult-Oriented Diabetes Care. Front Endocrinol (Lausanne) 2021;12:719953. [PMID: 34512550 DOI: 10.3389/fendo.2021.719953] [Reference Citation Analysis]
720 Kenning M, Puchert A, Salzsieder E. Evaluating the influence of hematocrit: comparison of three POCT devices pursuant to ISO 15197 guidelines. (Preprint).. [DOI: 10.2196/preprints.33574] [Reference Citation Analysis]
721 Daldal H, Turkyilmaz M, Balikoglu Yilmaz M, Berberoglu U. The Effect of Ranibizumab Loading Treatment on Vision-Related Quality of Life in Diabetic Macular Edema. Clin Pract 2021;11:659-70. [PMID: 34563010 DOI: 10.3390/clinpract11030081] [Reference Citation Analysis]
722 Copur S, Rossing P, Afsar B, Sag AA, Siriopol D, Kuwabara M, Ortiz A, Kanbay M. A primer on metabolic memory: why existing diabesity treatments fail. Clin Kidney J 2021;14:756-67. [PMID: 34512957 DOI: 10.1093/ckj/sfaa143] [Reference Citation Analysis]
723 Shelat T, Mastrandrea LD, Majumdar I, Quattrin T. Perceptions of Diabetes Self-Efficacy and Glycemic Control in Youth With Type 1 Diabetes. Diabetes Spectr 2021;34:313-20. [PMID: 34511859 DOI: 10.2337/ds20-0035] [Reference Citation Analysis]
724 DeFronzo RA, Abdul-Ghani M. Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney. Diabetes Spectr 2021;34:225-34. [PMID: 34511848 DOI: 10.2337/ds20-0071] [Reference Citation Analysis]
725 Tilinca MC, Tiuca RA, Niculas C, Varga A, Tilea I. Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review). Exp Ther Med 2021;22:1167. [PMID: 34504612 DOI: 10.3892/etm.2021.10601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
726 Callahan Fagan VR, Parsons K. The Lived Experience of Continuous Subcutaneous Insulin Infusion in Adults With Type 1 Diabetes Mellitus: A Phenomenological Inquiry. Glob Qual Nurs Res 2021;8:2333393620981058. [PMID: 34497866 DOI: 10.1177/2333393620981058] [Reference Citation Analysis]
727 Gubitosi-Klug RA, Braffett BH, Hitt S, Arends V, Uschner D, Jones K, Diminick L, Karger AB, Paterson AD, Roshandel D, Marcovina S, Lachin JM, Steffes M, Palmer JP; DCCT/EDIC Research Group. Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia. J Clin Invest 2021;131:143011. [PMID: 33529168 DOI: 10.1172/JCI143011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
728 Dhatariya K, Humberstone A, Hasnat A, Wright R, Lujan M, Nunney I. The Association Between Mean Glycated Haemoglobin or Glycaemic Variability and the Development of Retinopathy in People with Diabetes: A Retrospective Observational Cohort Study. Diabetes Ther 2021;12:2755-66. [PMID: 34491530 DOI: 10.1007/s13300-021-01146-3] [Reference Citation Analysis]
729 Sanada J, Kimura T, Shimoda M, Tomita A, Fushimi Y, Kinoshita T, Obata A, Okauchi S, Hirukawa H, Kohara K, Tatsumi F, Nakanishi S, Mune T, Kaku K, Kaneto H. Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study. Front Endocrinol (Lausanne) 2021;12:714447. [PMID: 34484124 DOI: 10.3389/fendo.2021.714447] [Reference Citation Analysis]
730 Lewis GF, Brubaker PL. The discovery of insulin revisited: lessons for the modern era. J Clin Invest 2021;131:142239. [PMID: 33393501 DOI: 10.1172/JCI142239] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
731 Lennerz BS, Koutnik AP, Azova S, Wolfsdorf JI, Ludwig DS. Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom. J Clin Invest 2021;131:142246. [PMID: 33393511 DOI: 10.1172/JCI142246] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
732 Huang JH, Lin YK, Lee TW, Liu HW, Chien YM, Hsueh YC, Lee TI, Chen YJ. Correlation between short- and mid-term hemoglobin A1c and glycemic control determined by continuous glucose monitoring. Diabetol Metab Syndr 2021;13:94. [PMID: 34488880 DOI: 10.1186/s13098-021-00714-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
733 Damhudi D, Kertia N, Effendy C. The Effect of Modified Diabetes Self-management Education and Support on Self-care and Quality of Life among Patients with Diabetic Foot Ulcers in Rural Area of Indonesia. Open Access Maced J Med Sci 2021;9:81-87. [DOI: 10.3889/oamjms.2021.6614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
734 Tran PMH, Kim E, Tran LKH, Khaled BS, Zhi W, Bai S, Hopkins D, Gardiner M, Bryant J, Bernard R, Morgan J, Bode B, Reed JC, She J, Purohit S. T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications.. [DOI: 10.1101/2021.09.01.21262996] [Reference Citation Analysis]
735 Crabtree GS, Chang JS. Management of Complications and Vision Loss from Proliferative Diabetic Retinopathy. Curr Diab Rep 2021;21:33. [PMID: 34477996 DOI: 10.1007/s11892-021-01396-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
736 Pedersen-Bjergaard U, Fabricius TW, Thorsteinsson B. Synthetic long-acting insulin analogs for the management of type 1 diabetes: an update. Expert Opin Pharmacother 2021;22:2251-9. [PMID: 34467826 DOI: 10.1080/14656566.2021.1970136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
737 Kjeldsen T, Kurtzhals P. A Hundred Years of Insulin Innovation: When Science Meets Technology. Diabetes 2021;70:e1-2. [PMID: 34417265 DOI: 10.2337/db21-0430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
738 B. Stentz F. Hyperglycemia- and Hyperlipidemia-Induced Inflammation and Oxidative Stress through Human T Lymphocytes and Human Aortic Endothelial Cells (HAEC). Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic 2021. [DOI: 10.5772/intechopen.94427] [Reference Citation Analysis]
739 Ferm ML, DeSalvo DJ, Prichett LM, Sickler JK, Wolf RM, Channa R. Clinical and Demographic Factors Associated With Diabetic Retinopathy Among Young Patients With Diabetes. JAMA Netw Open 2021;4:e2126126. [PMID: 34570208 DOI: 10.1001/jamanetworkopen.2021.26126] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
740 Huang C, Zong Y, Ding Y, Luo X, Clawson K, Peng Y. A new deep learning approach for the retinal hard exudates detection based on superpixel multi-feature extraction and patch-based CNN. Neurocomputing 2021;452:521-33. [DOI: 10.1016/j.neucom.2020.07.145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
741 Demir S, Nawroth PP, Herzig S, Ekim Üstünel B. Emerging Targets in Type 2 Diabetes and Diabetic Complications. Adv Sci (Weinh) 2021;8:e2100275. [PMID: 34319011 DOI: 10.1002/advs.202100275] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
742 Tuleta I, Frangogiannis NG. Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities. Adv Drug Deliv Rev 2021;176:113904. [PMID: 34331987 DOI: 10.1016/j.addr.2021.113904] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
743 Li H, Li T, Wang H, He X, Li Y, Wen S, Peng R, Nie Y, Lu Y, Yang H, Ye Y, Shi G, Chen Y. Diabetes Promotes Retinal Vascular Endothelial Cell Injury by Inducing CCN1 Expression. Front Cardiovasc Med 2021;8:689318. [PMID: 34458333 DOI: 10.3389/fcvm.2021.689318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
744 Shi L, Wei H, Zhang T, Li Z, Chi X, Liu D, Chang D, Zhang Y, Wang X, Zhao Q. A potent weighted risk model for evaluating the occurrence and severity of diabetic foot ulcers. Diabetol Metab Syndr 2021;13:92. [PMID: 34465375 DOI: 10.1186/s13098-021-00711-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
745 Kieu A, Govender RD, Östlundh L, King J. Benefits of the addition of continuous or flash glucose monitoring versus standard practice using self-monitored blood glucose and haemoglobin A1c in the primary care of diabetes mellitus: a systematic review protocol. BMJ Open 2021;11:e050027. [PMID: 34446495 DOI: 10.1136/bmjopen-2021-050027] [Reference Citation Analysis]
746 Grabarczyk TR, Roberts AW, Mahnken JD, Grauer D. Trajectories of glycemic control with clinical pharmacy specialist management of veterans with type 2 diabetes. Res Social Adm Pharm 2021:S1551-7411(21)00314-4. [PMID: 34481747 DOI: 10.1016/j.sapharm.2021.08.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
747 Prahalad P, Ebekozien O, Alonso GT, Clements M, Corathers S, DeSalvo D, Desimone M, Lee JM, Lorincz I, McDonough R, Majidi S, Odugbesan O, Obrynba K, Rioles N, Kamboj M, Jones NY, Maahs DM. Multi-Clinic Quality Improvement Initiative Increases Continuous Glucose Monitoring Use Among Adolescents and Young Adults With Type 1 Diabetes. Clin Diabetes 2021;39:264-71. [PMID: 34421201 DOI: 10.2337/cd21-0026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
748 Lacy ME, Whitmer RA, Lee SJ, Rushakoff RJ, Pletcher MJ. Identifying Potential Intervention Points for Acute Hypoglycemic Events in Patients With Type 2 Diabetes Using Retrospective Clinical Data. Clin Diabetes 2021;39:304-12. [PMID: 34421207 DOI: 10.2337/cd20-0057] [Reference Citation Analysis]
749 Liu J, Spakowicz DJ, Ash GI, Hoyd R, Ahluwalia R, Zhang A, Lou S, Lee D, Zhang J, Presley C, Greene A, Stults-Kolehmainen M, Nally LM, Baker JS, Fucito LM, Weinzimer SA, Papachristos AV, Gerstein M. Bayesian structural time series for biomedical sensor data: A flexible modeling framework for evaluating interventions. PLoS Comput Biol 2021;17:e1009303. [PMID: 34424894 DOI: 10.1371/journal.pcbi.1009303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
750 Venkatakrishnan P, Annamalai R, Muthukumar M. Visual Morbidity in Diabetic Retinopathy Associated with Diabetic Nephropathy - Our Experience in a Multispecialty Tertiary Hospital in Chennai, India. jemds 2021;10:2888-2893. [DOI: 10.14260/jemds/2021/589] [Reference Citation Analysis]
751 Phillips J, Chen JHC, Ooi E, Prunster J, Lim WH. Global Epidemiology, Health Outcomes, and Treatment Options for Patients With Type 2 Diabetes and Kidney Failure. Front Clin Diabetes Healthc 2021;2. [DOI: 10.3389/fcdhc.2021.731574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
752 Xiao L, Yang YJ, Liu Q, Peng J, Yan JF, Peng QH. Visualizing the intellectual structure and recent research trends of diabetic retinopathy. Int J Ophthalmol 2021;14:1248-59. [PMID: 34414092 DOI: 10.18240/ijo.2021.08.18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
753 Dos Santos TJ, Rodrigues TC, Puñales M, Arrais RF, Kopacek C. Newest Diabetes-Related Technologies for Pediatric Type 1 Diabetes and Its Impact on Routine Care: a Narrative Synthesis of the Literature. Curr Pediatr Rep 2021;:1-12. [PMID: 34430071 DOI: 10.1007/s40124-021-00248-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
754 Chatwin H, Broadley M, Valdersdorf Jensen M, Hendrieckx C, Carlton J, Heller S, Amiel S, de Galan B, Hermanns N, Finke-Groene K, Speight J, Pouwer F. 'Never again will I be carefree': a qualitative study of the impact of hypoglycemia on quality of life among adults with type 1 diabetes. BMJ Open Diabetes Res Care 2021;9:e002322. [PMID: 34400465 DOI: 10.1136/bmjdrc-2021-002322] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
755 Billion L, Charleer S, Verbraeken L Junior Registrar, Sterckx M Junior Registrar, Vangelabbeek K Junior Registrar, De Block N, Janssen C, Van Dessel K Nutritionist, Dirinck E, Peiffer F, Bolsens N, Mathieu C, Gillard P, De Block C. Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring. Diabetes Obes Metab 2021;23:2716-27. [PMID: 34402157 DOI: 10.1111/dom.14527] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
756 Kahkoska AR, Dabelea D. Diabetes in Youth: A Global Perspective. Endocrinol Metab Clin North Am 2021;50:491-512. [PMID: 34399958 DOI: 10.1016/j.ecl.2021.05.007] [Reference Citation Analysis]
757 Buse JB, Davies MJ, Frier BM, Philis-Tsimikas A. 100 years on: the impact of the discovery of insulin on clinical outcomes. BMJ Open Diabetes Res Care 2021;9:e002373. [PMID: 34400466 DOI: 10.1136/bmjdrc-2021-002373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
758 Durante W, Behnammanesh G, Peyton KJ. Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling. Int J Mol Sci 2021;22:8786. [PMID: 34445519 DOI: 10.3390/ijms22168786] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
759 Bashir M, Elhadd T, Dabbous Z, Gul W, Salameh O, Siddiqui M, Al-Muhannadi H, Petropoulos I, Khan A, Ponirakis G, Malik RA. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications. Diabetes Metab Syndr 2021;15:102241. [PMID: 34390975 DOI: 10.1016/j.dsx.2021.102241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
760 Öz NA, Arslanoglu I, Cangür S, Bolu S, Kocabay K. Low-carb Diet in Hospitalized Late Pubertal Type 1 Diabetic Girls: A Short-Term CGM Study. Indian J Endocrinol Metab 2021;25:31-7. [PMID: 34386391 DOI: 10.4103/ijem.ijem_176_21] [Reference Citation Analysis]
761 Wang L, Dai L, Liu H, Dai H, Li X, Ge W. Availability, affordability and price components of insulin products in different-level hospital pharmacies: Evidence from two cross-sectional surveys in Nanjing, China. PLoS One 2021;16:e0255742. [PMID: 34383816 DOI: 10.1371/journal.pone.0255742] [Reference Citation Analysis]
762 Xu Y, Li A, Wu C, Geng Z, Zhang J, Wang X, Li Y, Li H, Guo X, Tang F. Evaluation of the Accuracy and Safety of a Portable Metabolic Heat Conformation-Based Non-invasive Glucose Meter: A Multicentre Clinical Study. (Preprint).. [DOI: 10.2196/preprints.32333] [Reference Citation Analysis]
763 Hogervorst S, Adriaanse M, Brandt H, Vervloet M, van Dijk L, Hugtenburg J. Feasibility study of a digitalized nurse practitioner-led intervention to improve medication adherence in type 2 diabetes patients in Dutch primary care. Pilot Feasibility Stud 2021;7:152. [PMID: 34362471 DOI: 10.1186/s40814-021-00892-2] [Reference Citation Analysis]
764 Tang MCS, Teoh SS, Ibrahim H, Embong Z. Neovascularization Detection and Localization in Fundus Images Using Deep Learning. Sensors (Basel) 2021;21:5327. [PMID: 34450766 DOI: 10.3390/s21165327] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
765 Gazzo G, Salgado Ferrer M, Poisbeau P. The non-benzodiazepine anxiolytic etifoxine limits mechanical allodynia and anxiety-like symptoms in a mouse model of streptozotocin-induced diabetic neuropathy. PLoS One 2021;16:e0248092. [PMID: 34351930 DOI: 10.1371/journal.pone.0248092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
766 Ma Y, Ohr MP, Pan X, Roberts CJ. Quantifying the pattern of retinal vascular orientation in diabetic retinopathy using optical coherence tomography angiography. Sci Rep 2021;11:15826. [PMID: 34349166 DOI: 10.1038/s41598-021-95219-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
767 Dyson P. Type 1 diabetes: dietary modification over 100 years since insulin. Pract Diab 2021;38:40-4. [DOI: 10.1002/pdi.2351] [Reference Citation Analysis]
768 Curtis LR, Alington K, Partridge HL. Insulin pumps: are services and health equity undermining technological progression? Pract Diab 2021;38:27-32. [DOI: 10.1002/pdi.2349] [Reference Citation Analysis]
769 Josse J. My life with insulin. Pract Diab 2021;38:5-5. [DOI: 10.1002/pdi.2343] [Reference Citation Analysis]
770 Kumar D, Gupta C, Gupta MK, Agarwal V. PREVALENCE OF DIABETIC RETINOPATHY AMONG CHILDREN WITH TYPE 1 DIABETES MELLITUS TREATED BY INSULIN. IJAR 2021. [DOI: 10.36106/ijar/0502373] [Reference Citation Analysis]
771 Wang Y, Hao L, Huo Z, Liu Y, Sun Y, Song Z. Systematic review and Meta-analysis of 26 randomized controlled clinical trials of Compound Danshen Dripping Pill for non-proliferating diabetic retinopathy. Chinese Herbal Medicines 2021. [DOI: 10.1016/j.chmed.2021.08.002] [Reference Citation Analysis]
772 Moreno-Oyervides A, Aguilera-Morillo MC, de la Cruz Fernández MJ, Pascual EL, Jiménez LL, Krozer V, Acedo P. Clinical assessment of W-band spectroscopy for non-invasive detection and monitoring of sustained hyperglycemia. Biomed Opt Express 2021;12:5008-22. [PMID: 34513239 DOI: 10.1364/BOE.428524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
773 Boumali S, Benhabiles MT, Bouziane A, Kerrour F, Aguir K. Acetone discriminator and concentration estimator for diabetes monitoring in human breath. Semicond Sci Technol 2021;36:085010. [DOI: 10.1088/1361-6641/ac0c63] [Reference Citation Analysis]
774 Hur KY, Moon MK, Park JS, Kim SK, Lee SH, Yun JS, Baek JH, Noh J, Lee BW, Oh TJ, Chon S, Yang YS, Son JW, Choi JH, Song KH, Kim NH, Kim SY, Kim JW, Rhee SY, Lee YB, Jin SM, Kim JH, Kim CH, Kim DJ, Chun S, Rhee EJ, Kim HM, Kim HJ, Jee D, Kim JH, Choi WS, Lee EY, Yoon KH, Ko SH; Committee of Clinical Practice Guidelines, Korean Diabetes Association. 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association. Diabetes Metab J 2021;45:461-81. [PMID: 34352984 DOI: 10.4093/dmj.2021.0156] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 25.0] [Reference Citation Analysis]
775 Aleotti F, Nano R, Piemonti L, Falconi M, Balzano G. Total pancreatectomy sequelae and quality of life: results of islet autotransplantation as a possible mitigation strategy. Updates Surg 2021;73:1237-46. [PMID: 34319573 DOI: 10.1007/s13304-021-01129-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
776 Musthaffa Y, Hamilton-Williams EE, Nel HJ, Bergot AS, Mehdi AM, Harris M, Thomas R. Proinsulin-specific T-cell responses correlate with estimated c-peptide and predict partial remission duration in type 1 diabetes. Clin Transl Immunology 2021;10:e1315. [PMID: 34336205 DOI: 10.1002/cti2.1315] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
777 Kramer G, Kloos C, Müller UA, Wolf G, Kuniss N. Metabolic control and hypoglycaemia in people with type 1 diabetes: insulin pump therapy vs. intensified insulin therapy in an unselected cohort in routine care. Diabetol Metab Syndr 2021;13:80. [PMID: 34301317 DOI: 10.1186/s13098-021-00700-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
778 Faulds ER, Rayo M, Lewis C, Noble CW, Gifford R, Happ MB, Joyce L, Dungan K. Simulation Platform Development for Diabetes and Technology Self-Management. J Diabetes Sci Technol 2021;:19322968211029303. [PMID: 34293963 DOI: 10.1177/19322968211029303] [Reference Citation Analysis]
779 Suzuki R, Saita S, Nishigaki N, Kisanuki K, Shimasaki Y, Mineyama T, Odawara M. Factors Associated With Treatment Adherence and Satisfaction in Type 2 Diabetes Management in Japan: Results From a Web-Based Questionnaire Survey. Diabetes Ther 2021;12:2343-58. [PMID: 34283372 DOI: 10.1007/s13300-021-01100-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
780 Sugawa SW, Yoshida Y, Hikima Y, Sato H, Shimada A, Noda M, Kushiyama A. Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational Study. J Diabetes Res 2021;2021:7572326. [PMID: 34337073 DOI: 10.1155/2021/7572326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
781 Chanchal N, Goyal K, Vij D, Mishra RK. PREVALENCE, PATHOGENESIS, CLASSIFICATION, IMAGING, SCREENING AND MANAGE-MENT OF DIABETIC RETINOPATHY- A CRITICAL REVIEW. IAMJ 2021;9:1433-1442. [DOI: 10.46607/iamj1709072021] [Reference Citation Analysis]
782 Mattsson S, Adolfsson P, Jendle J, Bengtsson V, Sparud-lundin C. Empowered by Intertwined Theory and Practice – Experiences From a Diabetes Sports Camp for Physically Active Adults With Type 1 Diabetes. Front Clin Diabetes Healthc 2021;2. [DOI: 10.3389/fcdhc.2021.655238] [Reference Citation Analysis]
783 Brunetti G, D'Amato G, De Santis S, Grano M, Faienza MF. Mechanisms of altered bone remodeling in children with type 1 diabetes. World J Diabetes 2021; 12(7): 997-1009 [PMID: 34326950 DOI: 10.4239/wjd.v12.i7.997] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
784 Yuan L, Li F, Zhou Y, Sun R, Gao G, Zhang Q, Tang Y, Dai L, Wu J, Ma J. Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial. J Diabetes Res 2021;2021:5524313. [PMID: 34337072 DOI: 10.1155/2021/5524313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
785 Greene DS, King ND. Humor and A1C: the interaction between humor and diabetes control. HUMOR 2021;34:483-96. [DOI: 10.1515/humor-2020-0124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
786 Sakboonyarat B, Pima W, Chokbumrungsuk C, Pimpak T, Khunsri S, Ukritchon S, Imjaijitt W, Mungthin M, Kaewput W, Bhopdhornangkul B, Sathavarodom N, Tatsanavivat P, Rangsin R. National trends in the prevalence of glycemic control among patients with type 2 diabetes receiving continuous care in Thailand from 2011 to 2018. Sci Rep 2021;11:14260. [PMID: 34253809 DOI: 10.1038/s41598-021-93733-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
787 Clarke JO. Esophageal Involvement in Systemic Diseases. The Esophagus 2021. [DOI: 10.1002/9781119599692.ch18] [Reference Citation Analysis]
788 Jenkins AJ, Braffett BH, Basu A, Bebu I, Dagogo-Jack S, Orchard TJ, Wallia A, Lopes-Virella MF, Garvey WT, Lachin JM, Lyons TJ; DCCT/EDIC Research Group. Serum urate and cardiovascular events in the DCCT/EDIC study. Sci Rep 2021;11:14182. [PMID: 34244538 DOI: 10.1038/s41598-021-90785-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
789 Smits MM, Van Raalte DH. Safety of Semaglutide. Front Endocrinol (Lausanne) 2021;12:645563. [PMID: 34305810 DOI: 10.3389/fendo.2021.645563] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
790 Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Japanese Clinical Practice Guideline for Diabetes 2019. J Diabetes Investig 2020;11:1020-76. [PMID: 33021749 DOI: 10.1111/jdi.13306] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 40.0] [Reference Citation Analysis]
791 Tommerdahl KL, Nadeau KJ, Bjornstad P. Mechanisms of Cardiorenal Protection of Glucagon-Like Peptide-1 Receptor Agonists. Adv Chronic Kidney Dis 2021;28:337-46. [PMID: 34922690 DOI: 10.1053/j.ackd.2021.06.001] [Reference Citation Analysis]
792 Gubitosi-Klug R, Gao X, Pop-Busui R, de Boer IH, White N, Aiello LP, Miller R, Palmer J, Tamborlane W, Wallia A, Kosiborod M, Lachin JM, Bebu I; DCCT/EDIC Research Group. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes Care 2021;44:1499-505. [PMID: 33980605 DOI: 10.2337/dc20-3104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
793 Pollock C, Neuen BL. Sodium-Glucose Cotransporter 2 Inhibition: Rationale and Mechanisms for Kidney and Cardiovascular Protection in People With and Without Diabetes. Adv Chronic Kidney Dis 2021;28:298-308. [PMID: 34922686 DOI: 10.1053/j.ackd.2021.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
794 Brown SA, Forlenza GP, Bode BW, Pinsker JE, Levy CJ, Criego AB, Hansen DW, Hirsch IB, Carlson AL, Bergenstal RM, Sherr JL, Mehta SN, Laffel LM, Shah VN, Bhargava A, Weinstock RS, MacLeish SA, DeSalvo DJ, Jones TC, Aleppo G, Buckingham BA, Ly TT; Omnipod 5 Research Group. Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes. Diabetes Care 2021;44:1630-40. [PMID: 34099518 DOI: 10.2337/dc21-0172] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 32.0] [Reference Citation Analysis]
795 Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol 2021;17:400-20. [PMID: 34050323 DOI: 10.1038/s41574-021-00496-z] [Cited by in Crossref: 84] [Cited by in F6Publishing: 52] [Article Influence: 42.0] [Reference Citation Analysis]
796 Iakunchykova O, Averina M, Wilsgaard T, Malyutina S, Kudryavtsev AV, Cook S, Wild S, Eggen AE, Hopstock LA, Leon DA. What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposity. BMJ Open Diabetes Res Care 2021;9:e002021. [PMID: 33664061 DOI: 10.1136/bmjdrc-2020-002021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
797 Singh C, Prasad SP, Kaul S, Motwani D, Mishra A, Padmakumar V. Association of HbA1c levels with diabetic retinopathy. IJCEO 2021;7:339-345. [DOI: 10.18231/j.ijceo.2021.067] [Reference Citation Analysis]
798 Yang L, Yang G, Li X. Clinical and demographic features among patients with type 1 diabetes mellitus in Henan, China. BMC Endocr Disord 2021;21:131. [PMID: 34176476 DOI: 10.1186/s12902-021-00799-2] [Reference Citation Analysis]
799 Grigg W, Mahfooz F, Chaudhary D, Zapata I, Duffee D. HbA1c and FIB-4 as Serologic Markers for the Risk of Progression of Stage A Heart Failure.. [DOI: 10.1101/2021.06.24.21259475] [Reference Citation Analysis]
800 Susilowati S, Arto KS, Lubis AD. The Relationship between Glycated Hemoglobin Levels and the Quality of Life among Type 1 Diabetes Mellitus in Children. Open Access Maced J Med Sci 2021;9:316-320. [DOI: 10.3889/oamjms.2021.6351] [Reference Citation Analysis]
801 Lam PY, Chow SC, Lam WC, Chow LLW, Fung NSK. Management of Patients with Newly Diagnosed Diabetic Mellitus: Ophthalmologic Outcomes in Intensive versus Conventional Glycemic Control. Clin Ophthalmol 2021;15:2767-85. [PMID: 34234400 DOI: 10.2147/OPTH.S301317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
802 Turnin MC, Gourdy P, Martini J, Buisson JC, Chauchard MC, Delaunay J, Schirr-Bonnans S, Taoui S, Poncet MF, Cosma V, Lablanche S, Coustols-Valat M, Chaillous L, Thivolet C, Sanz C, Penfornis A, Lepage B, Colineaux H, Mounié M, Costa N, Molinier L, Hanaire H; Educ@dom Study Group. Impact of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Randomised Multicentre Study. Diabetes Ther 2021;12:2059-75. [PMID: 34160791 DOI: 10.1007/s13300-021-01095-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
803 Katsuyama A, Kusuhara S, Asahara SI, Nakai SI, Mori S, Matsumiya W, Miki A, Kurimoto T, Imai H, Kido Y, Ogawa W, Nakamura M. En face slab optical coherence tomography imaging successfully monitors progressive degenerative changes in the innermost layer of the diabetic retina. BMJ Open Diabetes Res Care 2020;8:e001120. [PMID: 32238364 DOI: 10.1136/bmjdrc-2019-001120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
804 Gomez-Peralta F, Dunn T, Landuyt K, Xu Y, Merino-Torres JF. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain. BMJ Open Diabetes Res Care 2020;8:e001052. [PMID: 32198165 DOI: 10.1136/bmjdrc-2019-001052] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 17.5] [Reference Citation Analysis]
805 Vilarrasa N, San Jose P, Rubio MÁ, Lecube A. Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges. Diabetes Metab Syndr Obes 2021;14:2807-27. [PMID: 34188505 DOI: 10.2147/DMSO.S223618] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
806 Tan JS, Lin CC, Chen GS. Vasomodulation of peripheral blood flow by focused ultrasound potentiates improvement of diabetic neuropathy. BMJ Open Diabetes Res Care 2020;8:e001004. [PMID: 32188594 DOI: 10.1136/bmjdrc-2019-001004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
807 Weisman A, Tu K, Young J, Kumar M, Austin PC, Jaakkimainen L, Lipscombe L, Aronson R, Booth GL. Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada. BMJ Open Diabetes Res Care 2020;8:e001224. [PMID: 32565422 DOI: 10.1136/bmjdrc-2020-001224] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
808 Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R, Mahfoud Z, Hassan M, Al Hamad H, Ramadan M, Alam U, Malik RA. Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study. BMJ Open Diabetes Res Care 2020;8:e001420. [PMID: 32576561 DOI: 10.1136/bmjdrc-2020-001420] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
809 Wysocka-Mincewicz M, Gołębiewska J, Olechowski A, Szalecki M. Diabetic Retinopathy in Children with Type 1 Diabetes-Occurrence and Screening Using Optical Coherence Tomography. Life (Basel) 2021;11:590. [PMID: 34205677 DOI: 10.3390/life11060590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
810 Aiello EM, Deshpande S, Ozaslan B, Wolkowicz KL, Dassau E, Pinsker JE, Doyle FJ. Review of Automated Insulin Delivery Systems for Individuals with Type 1 Diabetes: Tailored Solutions for Subpopulations. Curr Opin Biomed Eng 2021;19:100312. [PMID: 34368518 DOI: 10.1016/j.cobme.2021.100312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
811 Wszoła M, Nitarska D, Cywoniuk P, Gomółka M, Klak M. Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes. Cells 2021;10:1544. [PMID: 34207441 DOI: 10.3390/cells10061544] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
812 Bak JCG, Mul D, Serné EH, de Valk HW, Sas TCJ, Geelhoed-Duijvestijn PH, Kramer MHH, Nieuwdorp M, Verheugt CL. DPARD: rationale, design and initial results from the Dutch national diabetes registry. BMC Endocr Disord 2021;21:122. [PMID: 34134677 DOI: 10.1186/s12902-021-00782-x] [Reference Citation Analysis]
813 Crutzen S, Abou J, Smits SE, Baas G, Hugtenburg JG, Heringa M, Denig P, Taxis K. Older people's attitudes towards deprescribing cardiometabolic medication. BMC Geriatr 2021;21:366. [PMID: 34134649 DOI: 10.1186/s12877-021-02249-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
814 Soyoye DO, Abiodun OO, Ikem RT, Kolawole BA, Akintomide AO. Diabetes and peripheral artery disease: A review. World J Diabetes 2021; 12(6): 827-838 [PMID: 34168731 DOI: 10.4239/wjd.v12.i6.827] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
815 Yu HM, Park KS, Hong JH, Park KY, Lee JM, Ku BJ, Kim YJ, Oh TK. Comparison of the Efficacy and Safety of Insulin Detemir Administered Once Daily According to Two Titration Algorithms (3-0-3 and 2-4-6-8) in Patients with Type 2 Diabetes Mellitus. Endocrinol Metab (Seoul) 2020;35:142-8. [PMID: 32207274 DOI: 10.3803/EnM.2020.35.1.142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
816 Dildar S, Imran S, Naz F. Method comparison of Particle Enhanced Immunoturbidimetry (PEIT) with High Performance Liquid Chromatography (HPLC) for glycated hemoglobin (HbA1c) analysis. Clin Diabetes Endocrinol 2021;7:10. [PMID: 34120656 DOI: 10.1186/s40842-021-00123-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
817 Lee J. Diagnosis and management of pediatric type 1 diabetes mellitus. J Korean Med Assoc 2021;64:425-31. [DOI: 10.5124/jkma.2021.64.6.425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
818 Hopper W, Fox J, Dimucci-ward J. Assessment of Glycemic Control at St. Luke’s Free Medical Clinic: Retrospective Chart Review (Preprint).. [DOI: 10.2196/preprints.31123] [Reference Citation Analysis]
819 Mathiyalagen P, Kanagasabapathy S, Kadar Z, Rajagopal A, Vasudevan K. Prevalence and Determinants of Peripheral Neuropathy Among Adult Type II Diabetes Mellitus Patients Attending a Non-communicable Disease Clinic in Rural South India. Cureus 2021;13:e15493. [PMID: 34268025 DOI: 10.7759/cureus.15493] [Reference Citation Analysis]
820 Yoshikawa F, Uchino H, Nagashima T, Usui S, Miyagi M, Ando Y, Hirose T. Dipeptidyl peptidase-4 inhibitor improves glycemic variability in multiple daily insulin-treated type 2 diabetes: a prospective randomized-controlled trial. Diabetol Int 2022;13:124-31. [DOI: 10.1007/s13340-021-00513-6] [Reference Citation Analysis]
821 Pararajasingam G, Heinsen LJ, Larsson J, Andersen TR, Løgstrup BB, Auscher S, Hangaard J, Møgelvang R, Egstrup K. Diabetic microvascular complications are associated with reduced global longitudinal strain independent of atherosclerotic coronary artery disease in asymptomatic patients with diabetes mellitus: a cross-sectional study. BMC Cardiovasc Disord 2021;21:269. [PMID: 34078282 DOI: 10.1186/s12872-021-02063-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
822 Tang SC, Chan AT, Yiu WH, Lai KN. Pathogenesis of diabetic kidney disease. Diabetic Nephropathy 2021;1:9-13. [DOI: 10.2478/dine-2021-0004] [Reference Citation Analysis]
823 Ríos-garcés R, Espinosa G, van Vollenhoven R, Cervera R. Treat to target in systemic lupus erythematosus. Revista Colombiana de Reumatología 2021;28:101-106. [DOI: 10.1016/j.rcreu.2021.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
824 Fritsch M, Nagl K, Rojacher T, Dorninger L, Hofer S, Fröhlich-reiterer E. Spätkomplikationen. Paediatr Paedolog 2021;56:38-42. [DOI: 10.1007/s00608-021-00889-3] [Reference Citation Analysis]
825 Benhamou PY, Hanaire H, Renard E. L'insulinothérapie au xxie siècle : une symphonie de plus en plus harmonieuse. Médecine des Maladies Métaboliques 2021;15:3S53-3S63. [DOI: 10.1016/s1957-2557(21)00179-6] [Reference Citation Analysis]
826 Liu CF, Chen SC, Chen KJ, Liu L, Chen YP, Kang EY, Liu PK, Yeung L, Wu WC, Lai CC, Lo FS, Wang NK. Higher HbA1c may reduce axial length elongation in myopic children: a comparison cohort study. Acta Diabetol 2021;58:779-86. [PMID: 33587176 DOI: 10.1007/s00592-020-01631-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
827 Thivolet C, Benhamou P, Penfornis A, Joubert M, Delemer B, Barat P, Charpentier G, Favre S, Franc S, Hanaire H, Jacqueminet S, de Kerdanet M, Lablanche S, Leroy R, Renard E, Roussel R, Soggiu M, Thébaut J, Vannier A. Télésurveillance et diabète. Prise de position de la Société francophone du diabète (SFD). En collaboration avec la Société française d’endocrinologie et diabétologie pédiatrique (SFEDP), le Conseil national professionnel d’endocrinologie, diabétologie et nutrition (CNPEDN), la Fédération française des diabétiques (FFD) et l’Aide aux jeunes diabétiques (AJD). Médecine des Maladies Métaboliques 2021;15:437-448. [DOI: 10.1016/j.mmm.2021.05.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
828 Grubić Rotkvić P, Planinić Z, Liberati Pršo AM, Šikić J, Galić E, Rotkvić L. The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities. Int J Mol Sci 2021;22:5973. [PMID: 34205870 DOI: 10.3390/ijms22115973] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
829 Riveline J, Sablone L, Cosson E. SFDT1, une cohorte française de suivi de personnes vivant avec un diabète de type 1. Médecine des Maladies Métaboliques 2021;15:380-386. [DOI: 10.1016/j.mmm.2021.04.004] [Reference Citation Analysis]
830 Vialettes B. La normalisation de la glycémie dans le traitement du diabète : une évidence lente à s’imposer. Jean Pirart (1922–2014) et Georges Tchobroutsky (1930–2019), deux pionniers avant l’ère du DCCT et de l’UKPDS. Médecine des Maladies Métaboliques 2021;15:429-436. [DOI: 10.1016/j.mmm.2021.02.006] [Reference Citation Analysis]
831 Scheen AJ, Lefèbvre PJ. L'épopée des insulines des années 1930 aux années 1980. Médecine des Maladies Métaboliques 2021;15:3S25-3S31. [DOI: 10.1016/s1957-2557(21)00177-2] [Reference Citation Analysis]
832 Zhang J, Anshul F, Breidenbach JD, Liu J, Shaffner J. NRF2: A potential target for the treatment of diabetic nephropathy. Diabetic Nephropathy 2021;1:27-32. [DOI: 10.2478/dine-2021-0006] [Reference Citation Analysis]
833 Boscari F, Avogaro A. Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord 2021;22:217-40. [PMID: 33755854 DOI: 10.1007/s11154-021-09635-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
834 Rathsman B, Haas J, Persson M, Ludvigsson J, Svensson AM, Lind M, Andersson Franko M, Nyström T. LDL cholesterol level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes mellitus: A nationwide cohort study. J Intern Med 2021;289:873-86. [PMID: 33283333 DOI: 10.1111/joim.13212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
835 Haak T, Gölz S, Fritsche A, Füchtenbusch M, Siegmund T, Schnellbächer E, Klein HH, Uebel T, Droßel D. Therapie des Typ-1-Diabetes. Diabetologe 2021;17:411-421. [DOI: 10.1007/s11428-021-00764-6] [Reference Citation Analysis]
836 Valero-Vello M, Peris-Martínez C, García-Medina JJ, Sanz-González SM, Ramírez AI, Fernández-Albarral JA, Galarreta-Mira D, Zanón-Moreno V, Casaroli-Marano RP, Pinazo-Duran MD. Searching for the Antioxidant, Anti-Inflammatory, and Neuroprotective Potential of Natural Food and Nutritional Supplements for Ocular Health in the Mediterranean Population. Foods 2021;10:1231. [PMID: 34071459 DOI: 10.3390/foods10061231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
837 Chawla R, Mukherjee JJ, Chawla M, Kanungo A, Shunmugavelu MS, Das AK. Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus. Med Sci (Basel) 2021;9:38. [PMID: 34071359 DOI: 10.3390/medsci9020038] [Reference Citation Analysis]
838 Raman R, Ramasamy K, Rajalakshmi R, Sivaprasad S, Natarajan S. Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement. Indian J Ophthalmol 2021;69:678-88. [PMID: 33269742 DOI: 10.4103/ijo.IJO_667_20] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
839 Chazova IE, Shestakova MV, Zhernakova YV, Blinova NV, Markova TN, Mazurina NV, Ezhov MV, Tereshchenko SN, Zhirov IV, Komarov AL, Mironova OY, Yuricheva YA, Suhareva OY, Kislyak OA, Mkrtumyan AM, Podzolkov VI, Azizov VA, Zelveyan PA, Grigorenko EA, Rahimov ZY, Sarybaev AS, Kasymova SD, Narzullaeva AR. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021). Evrazijskij kardiologičeskij žurnal 2021. [DOI: 10.38109/2225-1685-2021-2-6-61] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
840 Choi J, Choi SK, Lee SH, Yoo KH. Clinical Outcomes and Risk Factor Analysis of Patients Presenting with Emphysematous Cystitis: A 15-Year Retrospective Multicenter Study. Medicina (Kaunas) 2021;57:531. [PMID: 34073208 DOI: 10.3390/medicina57060531] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
841 Pradhan P, Ghosh S, Neogi B. Nursing Care System Based on Internet of Medical Things (IoMT) through Integrating Non-Invasive Blood Sugar (BS) and Blood Pressure (BP) Combined Monitoring. Biomedical Signal Processing for Healthcare Applications 2021. [DOI: 10.1201/9781003147817-12] [Reference Citation Analysis]
842 Timmons JG, Boyle JG, Petrie JR. Time in Range as a Research Outcome Measure. Diabetes Spectr 2021;34:133-8. [PMID: 34149253 DOI: 10.2337/ds20-0097] [Reference Citation Analysis]
843 Aleppo G. Clinical Application of Time in Range and Other Metrics. Diabetes Spectr 2021;34:109-18. [PMID: 34149251 DOI: 10.2337/ds20-0093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
844 Marzban M, Nabipour I, Farhadi A, Ostovar A, Larijani B, Darabi AH, Shabankari E, Gholizade M. Association between anemia, physical performance and cognitive function in Iranian elderly people: evidence from Bushehr Elderly Health (BEH) program. BMC Geriatr 2021;21:329. [PMID: 34030664 DOI: 10.1186/s12877-021-02285-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
845 Santoro D, Torreggiani M, Pellicanò V, Cernaro V, Messina RM, Longhitano E, Siligato R, Gembillo G, Esposito C, Piccoli GB. Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives. Int J Mol Sci 2021;22:5425. [PMID: 34063872 DOI: 10.3390/ijms22115425] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
846 Andrikopoulos S, James S, Wischer N. What Gets Measured Gets Improved-Setting Standards and Accreditation for Quality Improvement for Diabetes Services in Australia. J Diabetes Sci Technol 2021;15:748-54. [PMID: 34008432 DOI: 10.1177/19322968211009910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
847 Evans LM, Mellbin L, Johansen P, Lawson J, Paine A, Sandberg A. A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease. Endocrinol Diabetes Metab 2021;4:e00259. [PMID: 34277983 DOI: 10.1002/edm2.259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
848 Kowluru RA. Diabetic Retinopathy and NADPH Oxidase-2: A Sweet Slippery Road. Antioxidants (Basel) 2021;10:783. [PMID: 34063353 DOI: 10.3390/antiox10050783] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
849 Pomposelli T, Schuetz C, Wang P, Yamada K. A Strategy to Simultaneously Cure Type 1 Diabetes and Diabetic Nephropathy by Transplant of Composite Islet-Kidney Grafts. Front Endocrinol (Lausanne) 2021;12:632605. [PMID: 34054721 DOI: 10.3389/fendo.2021.632605] [Reference Citation Analysis]
850 Brossard M, Paterson AD, Espin-garcia O, Craiu RV, Bull SB. Characterization of direct and/or indirect genetic associations for multiple traits in longitudinal studies of disease progression.. [DOI: 10.1101/2021.05.10.21256880] [Reference Citation Analysis]
851 Abdelgani S, Puckett C, Adams J, Triplitt C, DeFronzo RA, Abdul-Ghani M. Insulin secretion is a strong predictor for need of insulin therapy in patients with new-onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study. Diabetes Obes Metab 2021;23:1631-9. [PMID: 33852204 DOI: 10.1111/dom.14383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
852 Bakker E, Mol PGM, Nabais J, Vetter T, Kretzler M, Nolan JJ, Mayer G, Sundgren AK, Heerspink HJL, Schiel A, de Vries ST, Gomez MF, Schulze F, de Zeeuw D, Pena MJ; BEAt-DKD Consortium. Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting. Front Pharmacol 2021;12:662642. [PMID: 34025424 DOI: 10.3389/fphar.2021.662642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
853 Toffanin C, Magni L, Cobelli C. Artificial Pancreas: In Silico Study Shows No Need of Meal Announcement and Improved Time in Range of Glucose With Intraperitoneal vs. Subcutaneous Insulin Delivery. IEEE Trans Med Robot Bionics 2021;3:306-314. [DOI: 10.1109/tmrb.2021.3075775] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
854 Mima A. Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease. Adv Ther 2021;38:2201-12. [PMID: 33860925 DOI: 10.1007/s12325-021-01735-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
855 Lal RA, Maikawa CL, Lewis D, Baker SW, Smith AAA, Roth GA, Gale EC, Stapleton LM, Mann JL, Yu AC, Correa S, Grosskopf AK, Liong CS, Meis CM, Chan D, Garner JP, Maahs DM, Buckingham BA, Appel EA. Full closed loop open-source algorithm performance comparison in pigs with diabetes. Clin Transl Med 2021;11:e387. [PMID: 33931977 DOI: 10.1002/ctm2.387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
856 Keshavarzi S, Braffett BH, Pop-Busui R, Orchard TJ, Soliman EZ, Lorenzi GM, Barnie A, Karger AB, Gubitosi-Klug RA, Dagogo-Jack S, Paterson AD; DCCT/EDIC Research Group. Risk Factors for Longitudinal Resting Heart Rate and Its Associations With Cardiovascular Outcomes in the DCCT/EDIC Study. Diabetes Care 2021;44:1125-32. [PMID: 33632724 DOI: 10.2337/dc20-2387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
857 Edgerton DS, Moore MC, Gregory JM, Kraft G, Cherrington AD. Importance of the route of insulin delivery to its control of glucose metabolism. Am J Physiol Endocrinol Metab 2021;320:E891-7. [PMID: 33813879 DOI: 10.1152/ajpendo.00628.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
858 Hogervorst S, Adriaanse MC, Hugtenburg JG, Bot M, Speight J, Pouwer F, Nefs G. Medication Intake, Perceived Barriers, and Their Correlates Among Adults With Type 1 and Type 2 Diabetes: Results From Diabetes MILES – The Netherlands. Front Clin Diabetes Healthc 2021;2:645609. [DOI: 10.3389/fcdhc.2021.645609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
859 Bondar A, Popa AR, Papanas N, Popoviciu M, Vesa CM, Sabau M, Daina C, Stoica RA, Katsiki N, Stoian AP. Diabetic neuropathy: A narrative review of risk factors, classification, screening and current pathogenic treatment options (Review). Exp Ther Med 2021;22:690. [PMID: 33986855 DOI: 10.3892/etm.2021.10122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
860 Nordheim E, Geir Jenssen T. Chronic kidney disease in patients with diabetes mellitus. Endocr Connect 2021;10:R151-9. [PMID: 33830068 DOI: 10.1530/EC-21-0097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
861 Mulka A, Lewis BE, Mao L, Sharafieh R, Kesserwan S, Wu R, Kreutzer DL, Klueh U. Phenolic Preservative Removal from Commercial Insulin Formulations Reduces Tissue Inflammation while Maintaining Euglycemia. ACS Pharmacol Transl Sci 2021;4:1161-74. [PMID: 34151206 DOI: 10.1021/acsptsci.1c00047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
862 Gagloev BV, Pozdeyeva NA, Al-Darraji IO. [Concentration of VEGF-A in the intraocular fluid of rats with alloxan model of diabetes mellitus]. Vestn Oftalmol 2021;137:12-7. [PMID: 33881258 DOI: 10.17116/oftalma202113702112] [Reference Citation Analysis]
863 Colom C, Rull A, Sanchez-Quesada JL, Pérez A. Cardiovascular Disease in Type 1 Diabetes Mellitus: Epidemiology and Management of Cardiovascular Risk. J Clin Med 2021;10:1798. [PMID: 33924265 DOI: 10.3390/jcm10081798] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
864 Causes of complications. Handbook of Diabetes 2021. [DOI: 10.1002/9781118976074.ch14] [Reference Citation Analysis]
865 Lu P, Cui L, Wang Y, Kang K, Gu H, Li Z, Liu L, Wang Y, Zhao X. Relationship Between Glycosylated Hemoglobin and Short-Term Mortality of Spontaneous Intracerebral Hemorrhage. Front Neurol 2021;12:648907. [PMID: 33935947 DOI: 10.3389/fneur.2021.648907] [Reference Citation Analysis]
866 Tokutsu A, Okada Y, Torimoto K, Tanaka Y. Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study. Diabetol Metab Syndr 2021;13:45. [PMID: 33858481 DOI: 10.1186/s13098-021-00663-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
867 Nagaya M, Hasegawa K, Uchikura A, Nakano K, Watanabe M, Umeyama K, Matsunari H, Osafune K, Kobayashi E, Nakauchi H, Nagashima H. Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes. World J Diabetes 2021; 12(4): 306-330 [PMID: 33889282 DOI: 10.4239/wjd.v12.i4.306] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
868 Ben Y, Hao J, Zhang Z, Xiong Y, Zhang C, Chang Y, Yang F, Li H, Zhang T, Wang X, Xu Q. Astragaloside IV Inhibits Mitochondrial-Dependent Apoptosis of the Dorsal Root Ganglion in Diabetic Peripheral Neuropathy Rats Through Modulation of the SIRT1/p53 Signaling Pathway. Diabetes Metab Syndr Obes 2021;14:1647-61. [PMID: 33883914 DOI: 10.2147/DMSO.S301068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
869 Kane NS, Bloor LE, Michaels J. Enhancing Diabetes Self-Management Education and Psychological Services for Veterans With Comorbid Chronic Health and Mental Health Conditions. Fed Pract 2021;38:e22-8. [PMID: 34177225 DOI: 10.12788/fp.0106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
870 Mineoka Y, Ishii M, Hashimoto Y, Yuge H, Toyoda M, Nakamura N, Katsumi Y, Fukui M. Trigger finger is associated with risk of incident cardiovascular disease in individuals with type 2 diabetes: a retrospective cohort study. BMJ Open Diabetes Res Care 2021;9:e002070. [PMID: 33832915 DOI: 10.1136/bmjdrc-2020-002070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
871 Doblado L, Lueck C, Rey C, Samhan-Arias AK, Prieto I, Stacchiotti A, Monsalve M. Mitophagy in Human Diseases. Int J Mol Sci 2021;22:3903. [PMID: 33918863 DOI: 10.3390/ijms22083903] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
872 Kuniss N, Kramer G, Müller UA, Wolf G, Kloos C. Diabetes related distress is high in inpatients with diabetes. Diabetol Metab Syndr 2021;13:40. [PMID: 33836823 DOI: 10.1186/s13098-021-00659-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
873 Zohar O, Khatib M, Omar R, Vishinkin R, Broza YY, Haick H. Biointerfaced sensors for biodiagnostics. VIEW 2021;2:20200172. [DOI: 10.1002/viw.20200172] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
874 Grassi B, Onetto MT, Zapata Y, Jofré P, Echeverría G. Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile. Diabetes Metab Syndr 2021;15:695-701. [PMID: 33813244 DOI: 10.1016/j.dsx.2021.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
875 Scanlon PH. The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges. Acta Diabetol 2021;58:521-30. [PMID: 33830332 DOI: 10.1007/s00592-021-01687-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
876 Jurgen B, Baker CN, Kamps JL, Hempe JM, Chalew SA. Associations Between Depressive Symptoms, Fear of Hypoglycemia, Adherence to Management Behaviors and Metabolic Control in Children and Adolescents with Type 1 Diabetes. J Clin Psychol Med Settings 2020;27:385-95. [PMID: 31728880 DOI: 10.1007/s10880-019-09676-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
877 Jendle JH, Ampudia-Blasco FJ, Füchtenbusch M, Pozzilli P. Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination. touchREV Endocrinol 2021;17:12-20. [PMID: 35118442 DOI: 10.17925/EE.2021.17.1.12] [Reference Citation Analysis]
878 Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol 2021;58:401-10. [PMID: 32789691 DOI: 10.1007/s00592-020-01589-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
879 Zhu S, Zhang B, Wang Y, He Y, Qian G, Deng L, Zhang Z. A bilayer microneedle for therapeutic peptide delivery towards the treatment of diabetes in db/db mice. Journal of Drug Delivery Science and Technology 2021;62:102336. [DOI: 10.1016/j.jddst.2021.102336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
880 Yee JK, Mao CS. Diabetes Mellitus. Berkowitz’s Pediatrics 2021. [DOI: 10.1542/9781610023733-154] [Reference Citation Analysis]
881 Othman HO, Hassan RO, Faizullah AT. A newly synthesized boronic acid-functionalized sulfur-doped carbon dot chemosensor as a molecular probe for glucose sensing. Microchemical Journal 2021;163:105919. [DOI: 10.1016/j.microc.2021.105919] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
882 Purohit S, Tran PMH, Tran LKH, Satter KB, He M, Zhi W, Bai S, Hopkins D, Gardiner M, Wakade C, Bryant J, Bernard R, Morgan J, Bode B, Reed JC, She JX. Serum Levels of Inflammatory Proteins Are Associated With Peripheral Neuropathy in a Cross-Sectional Type-1 Diabetes Cohort. Front Immunol 2021;12:654233. [PMID: 33868296 DOI: 10.3389/fimmu.2021.654233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
883 Noh J. Diabetes and Stroke. J Korean Diabetes 2021;22:26-37. [DOI: 10.4093/jkd.2021.22.1.26] [Reference Citation Analysis]
884 Park S. Clinical Nutrition Therapy of Diabetic Nephropathy. J Korean Diabetes 2021;22:51-55. [DOI: 10.4093/jkd.2021.22.1.51] [Reference Citation Analysis]
885 Millard LAC, Patel N, Tilling K, Lewcock M, Flach PA, Lawlor DA. GLU: a software package for analysing continuously measured glucose levels in epidemiology. Int J Epidemiol. 2020;49:744-757. [PMID: 32737505 DOI: 10.1093/ije/dyaa004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
886 Urva S, Quinlan T, Landry J, Martin J, Loghin C. Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Clin Pharmacokinet 2021;60:1049-59. [PMID: 33778934 DOI: 10.1007/s40262-021-01012-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
887 Carral San Laureano F, Tomé Fernández-Ladreda M, Jiménez Millán AI, García Calzado C, Ayala Ortega MDC. Insulin doses requirements in patients with type 1 diabetes using glargine U300 or degludec in routine clinical practice. J Investig Med 2021;69:983-8. [PMID: 33771843 DOI: 10.1136/jim-2020-001633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
888 Moradi G, Shokri A, Mohamadi-Bolbanabad A, Zareie B, Piroozi B. Evaluating the quality of care for patients with type 2 diabetes mellitus based on the HbA1c: A national survey in Iran. Heliyon 2021;7:e06485. [PMID: 33768178 DOI: 10.1016/j.heliyon.2021.e06485] [Reference Citation Analysis]
889 Gurnurkar S, Owens L, Chalise S, Vyas N. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2021;34:311-7. [PMID: 33618445 DOI: 10.1515/jpem-2020-0587] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
890 Paul J, Jani R, Davoren P, Knight-Agarwal C. Association Between a Low Carbohydrate Diet, Quality of Life, and Glycemic Control in Australian Adults Living With Type 1 Diabetes: Protocol for a Mixed Methods Pilot Study. JMIR Res Protoc 2021;10:e25085. [PMID: 33769300 DOI: 10.2196/25085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
891 Ngassa Piotie P, Webb EM, Rheeder P. Suboptimal control for patients with type 2 diabetes in the Central Chronic Medicine Dispensing programme in South Africa. Afr J Prim Health Care Fam Med 2021;13:e1-7. [PMID: 33764132 DOI: 10.4102/phcfm.v13i1.2648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
892 Cagiltay E, Pouwels S, Erbas O, Taskiran D, Kalkanli Tas S, Aslan I. The Prophylactic Effects of Metoprolol, Diltiazem, and Pilocarpine on Hypoglycemia-Induced Prolongation of QT Interval. Cureus 2021;13:e14058. [PMID: 33898141 DOI: 10.7759/cureus.14058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
893 March CA, Becker DJ, Libman IM. Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications. Front Endocrinol (Lausanne) 2021;12:622901. [PMID: 33828529 DOI: 10.3389/fendo.2021.622901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
894 Hawkins J, Kloss K, Funnell M, Nwankwo R, Schwenzer C, Smith F, Piatt G. Michigan Men's diabetes project (MenD): protocol for a peer leader diabetes self-management education and support intervention. BMC Public Health 2021;21:562. [PMID: 33752609 DOI: 10.1186/s12889-021-10613-2] [Reference Citation Analysis]
895 Pan WW, Gardner TW, Harder JL. Integrative Biology of Diabetic Retinal Disease: Lessons from Diabetic Kidney Disease. J Clin Med 2021;10:1254. [PMID: 33803590 DOI: 10.3390/jcm10061254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
896 Schubert L, Laroche S, Hartemann A, Bourron O, Phan F. Impaired hypoxic ventilatory drive induced by diabetic autonomic neuropathy, a cause of misdiagnosed severe cardiac events: brief report of two cases. BMC Cardiovasc Disord 2021;21:140. [PMID: 33731006 DOI: 10.1186/s12872-021-01944-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
897 Eberle C, Stichling S. Telemetric Interventions Offer New Opportunities for Managing Type 1 Diabetes Mellitus: Systematic Meta-review. JMIR Diabetes 2021;6:e20270. [PMID: 33724201 DOI: 10.2196/20270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
898 Martins RB, Ordaz-Briseño SA, Flores-Hernández S, Bós ÂJG, Baptista-Rosas RC, Mercado-Sesma AR. Comparison of prevalence of diabetes complications in Brazilian and Mexican adults: a cross-sectional study. BMC Endocr Disord 2021;21:48. [PMID: 33726717 DOI: 10.1186/s12902-021-00711-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
899 Ibrahim N, Treluyer JM, Briand N, Godot C, Polak M, Beltrand J. Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial. PLoS One 2021;16:e0248549. [PMID: 33720997 DOI: 10.1371/journal.pone.0248549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
900 Jin, Zhang Y, Zhang Y, Huang W, Meng X, Yang F, Bao Q, Zhang M, Yang Y, Ni Q, Lian F, Tong X. Efficacy and Safety of TangWang Prescription for Type 2 Non-Proliferative Diabetic Retinopathy: A Study Protocol for a Randomized Controlled Trial. Front Pharmacol 2021;12:594308. [PMID: 33790783 DOI: 10.3389/fphar.2021.594308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
901 Cai X, Lin C, Yang W, Nie L, Ji L. Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Metab J 2021;45:312-25. [PMID: 33705649 DOI: 10.4093/dmj.2020.0171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
902 Bellofatto K, Moeckli B, Wassmer C, Laurent M, Oldani G, Andres A, Berney T, Berishvili E, Toso C, Peloso A. Bioengineered Islet Cell Transplantation. Curr Transpl Rep 2021;8:57-66. [DOI: 10.1007/s40472-021-00318-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
903 Triolo TM, Bellin MD. Lessons from Human Islet Transplantation Inform Stem Cell-Based Approaches in the Treatment of Diabetes. Front Endocrinol (Lausanne) 2021;12:636824. [PMID: 33776933 DOI: 10.3389/fendo.2021.636824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
904 Seng JJB, Monteiro AY, Kwan YH, Zainudin SB, Tan CS, Thumboo J, Low LL. Population segmentation of type 2 diabetes mellitus patients and its clinical applications - a scoping review. BMC Med Res Methodol 2021;21:49. [PMID: 33706717 DOI: 10.1186/s12874-021-01209-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
905 Chaila MZ, Viniegra M, Gagliardino JJ, Martínez A, Simesen de Bielke MG, Frusti M, Monaco L, Salgado P, Buso C, Gonzalez CD, Commendatore VF. Glycated Hemoglobin Measurement: Comparison of Three Methods Versus High Performance Liquid Chromatography. J Diabetes Sci Technol 2021;:1932296821997179. [PMID: 33686874 DOI: 10.1177/1932296821997179] [Reference Citation Analysis]
906 Creo AL, Cortes TM, Jo HJ, Huebner AR, Dasari S, Tillema JM, Lteif AN, Klaus KA, Ruegsegger GN, Kudva YC, Petersen RC, Port JD, Nair KS. Brain functions and cognition on transient insulin deprivation in type 1 diabetes. JCI Insight 2021;6:144014. [PMID: 33561011 DOI: 10.1172/jci.insight.144014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
907 Honoki H, Yagi K, Tsuda S, Wada T, Enkaku A, Nakagawa-Yokoyama M, Kamigishi M, Shikata M, Takikawa-Nishiday A, Fujisaka S, Chujo D, Sasaoka T, Nakashima A, Saito S, Tobe K. Type 1 diabetes woman with repeated miscarriages successfully gave birth after introducing an insulin pump with a predictive low glucose suspend feature. Diabetol Int 2021;12:324-9. [PMID: 34150440 DOI: 10.1007/s13340-020-00489-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
908 Menzen M. Individuelle Therapieziele für Menschen mit Diabetes. Diabetologe 2021;17:347-60. [DOI: 10.1007/s11428-021-00734-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
909 Gómez-Peralta F, Menéndez E, Conde S, Conget I, Novials A; en nombre de la SED y de los investigadores del estudio SED1. Clinical characteristics and management of type 1 diabetes in Spain. The SED1 study. Endocrinol Diabetes Nutr (Engl Ed) 2021:S2530-0164(21)00003-3. [PMID: 33664001 DOI: 10.1016/j.endinu.2020.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
910 Sellbom M, Nilsson C. Evaluation of insulin degludec as baseline insulin therapy in children and adolescents with type 1 diabetes. Pract Diab 2021;38:13-19. [DOI: 10.1002/pdi.2327] [Reference Citation Analysis]
911 Caviglia GP, Rosso C, Armandi A, Ribaldone DG, Pellicano R, Bugianesi E. Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum. Minerva Biotechnol Biomol Res 2021;33. [DOI: 10.23736/s2724-542x.20.02710-x] [Reference Citation Analysis]
912 Rhee CM, Kovesdy CP, Kalantar-Zadeh K. Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease. Semin Nephrol 2021;41:96-103. [PMID: 34140100 DOI: 10.1016/j.semnephrol.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
913 Najem S, Majaliwa E, Ramaiya K, Swai A, Jasem D, Ludvigsson J. Glycemic control and complications of type 1 diabetes among children in Tanzania. Journal of Clinical & Translational Endocrinology 2021;23:100245. [DOI: 10.1016/j.jcte.2020.100245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
914 Carroll RM, Bracha P, Miller CG, Brucker AJ. Management of Diabetic Retinopathy in the Anti-Vascular Endothelial Growth Factor Era. Retina 2021;41:461-3. [PMID: 33315828 DOI: 10.1097/IAE.0000000000003071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
915 Heise HM, Delbeck S, Marbach R. Noninvasive Monitoring of Glucose Using Near-Infrared Reflection Spectroscopy of Skin-Constraints and Effective Novel Strategy in Multivariate Calibration. Biosensors (Basel) 2021;11:64. [PMID: 33673679 DOI: 10.3390/bios11030064] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
916 Rabbani N, Thornalley PJ. Protein glycation - biomarkers of metabolic dysfunction and early-stage decline in health in the era of precision medicine. Redox Biol 2021;42:101920. [PMID: 33707127 DOI: 10.1016/j.redox.2021.101920] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
917 Dulkadiroğlu E, Özden H, Demİrcİ H. The evaluation of intracellular energy metabolism in prediabetic patients and patients newly diagnosed with type 2 diabetes mellitus. Turk J Med Sci 2021;51:238-45. [PMID: 33128355 DOI: 10.3906/sag-1912-60] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
918 Fujita Y, Murakami T, Nakamura A. Recent Advances in Biomarkers and Regenerative Medicine for Diabetic Neuropathy. Int J Mol Sci 2021;22:2301. [PMID: 33669048 DOI: 10.3390/ijms22052301] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
919 Gunton JE. Hypoxia-inducible factors and diabetes. J Clin Invest. 2020;130:5063-5073. [PMID: 32809974 DOI: 10.1172/jci137556] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 14.5] [Reference Citation Analysis]
920 Arman Bilir Ö, Mengen E, Kocaay P, Vidinlisan S. Tip 1 Diabetes Mellitus’lu Çocuk ve Adolesan Hastaların Retrospektif Olarak Değerlendirilmesi: Tek Merkez Deneyimi. Turkish Journal of Pediatric Disease 2021. [DOI: 10.12956/tchd.845703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
921 Liu Y, Wu N. Progress of Nanotechnology in Diabetic Retinopathy Treatment. Int J Nanomedicine 2021;16:1391-403. [PMID: 33658779 DOI: 10.2147/IJN.S294807] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
922 Gazzo G, Ferrer MS, Poisbeau P. The non-benzodiazepine anxiolytic etifoxine limits the sensory-affective expression of pain following streptozotocin-induced diabetic neuropathy.. [DOI: 10.1101/2021.02.22.432248] [Reference Citation Analysis]
923 Miller RG, Orchard TJ, Onengut-Gumuscu S, Chen WM, Rich SS, Costacou T. Heterogeneous long-term trajectories of glycaemic control in type 1 diabetes. Diabet Med 2021;38:e14545. [PMID: 33605492 DOI: 10.1111/dme.14545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
924 Linton K, Stimson RH, Dover AR, Forbes S, Madill K, Annoh R, Strachan MWJ, McKnight JA, Wright RJ, Gibb FW. Substantial HbA1c Reduction Following Intermittent-Scanning Continuous Glucose Monitoring Was Not Associated With Early Worsening of Retinopathy in Type 1 Diabetes. J Diabetes Sci Technol 2021;:1932296821994091. [PMID: 33605149 DOI: 10.1177/1932296821994091] [Reference Citation Analysis]
925 Allehdan S, Basha A, Tayyem R. Gestational diabetes mellitus management: diet and lifestyle. NFS 2021;51:300-22. [DOI: 10.1108/nfs-03-2020-0095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
926 Eberle C, Stichling S. Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review. J Med Internet Res 2021;23:e23244. [PMID: 33605889 DOI: 10.2196/23244] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
927 Iskra DA, Kovalchuk VV, Barantsevich ER. Role of pathogenetic therapy for diabetic polyneuropathy. RJTAO 2021;13:44-50. [DOI: 10.14412/2074-2711-2021-1-44-50] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
928 Babaya N, Noso S, Hiromine Y, Taketomo Y, Niwano F, Yoshida S, Yasutake S, Kawabata Y, Ikegami H. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes. Sci Rep 2021;11:4006. [PMID: 33597626 DOI: 10.1038/s41598-021-83599-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
929 Yankova G, Tur D, Parshin D, Cherevko A, Akulov A. Cerebral arterial architectonics and CFD simulation in mice with type 1 diabetes mellitus of different duration. Sci Rep 2021;11:3969. [PMID: 33597584 DOI: 10.1038/s41598-021-83484-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
930 Ravaut M, Sadeghi H, Leung KK, Volkovs M, Kornas K, Harish V, Watson T, Lewis GF, Weisman A, Poutanen T, Rosella L. Predicting adverse outcomes due to diabetes complications with machine learning using administrative health data. NPJ Digit Med 2021;4:24. [PMID: 33580109 DOI: 10.1038/s41746-021-00394-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
931 Wright EE Jr, Kerr MSD, Reyes IJ, Nabutovsky Y, Miller E. Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy. Diabetes Spectr 2021;34:184-9. [PMID: 34149259 DOI: 10.2337/ds20-0069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
932 Gurgel Penaforte-Saboia J, Couri CEB, Vasconcelos Albuquerque N, Lauanna Lima Silva V, Bitar da Cunha Olegario N, Oliveira Fernandes V, Montenegro Junior RM. Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus. Diabetes Metab Syndr Obes 2021;14:565-73. [PMID: 33603422 DOI: 10.2147/DMSO.S294742] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
933 Mehta SN, Tinsley LJ,